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CHAPTER I
DUCHENNE MUSCULAR DYSTROPHY
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1. INT RODU CTION
1.1 Genetic Status
Duchenne Muscular Dystrophy (DMD) is an X-linked 
recessive lethal disease with a high incidence of 1 in 
3067 male births (Gardner-Medwin, 1970).
Davie (1978) and Caskey, Nussbaum, Cohan and 
P ol lac k ( 1980) proposed that 1/3 of all cases of X-linked 
DMD are new mutants, the remainder being sons of carriers, 
by using the cre at ing phosphokinase test (cpk test) as 
carrier de tection  method. But lonasescu and Hanson ( 1980) 
and Roses and A p pel  ( 1976) hold a different opinion, 
lonas esc u e_t aJL. examined rlbosomal protein synthesis 
in muscle of DMD carriers and non carriers (mothers of 
isolated cases), and this study revealed that the new 
mut ati on rate was much smaller than the 1/3 value. Roses 
e_t a_l. (1976) found the endogenous phosphoryla tion of 
peak II (on SDS e lectr oph or ogr am of erythrocyte membrane 
proteins) was significantly increased in definite, 
probable and possible carriers while some of these carrie rs  
had normal serum cpk activity. They concluded the cases 
previously considered  to be new mutationsare much less 
common than estimated. However, no firm conclusions 
about the m u t ation  rate of DMD can be drawn at the present 
t i m e .
      ^
1.2 Symptoms and Diagnostic Signs
DMD is the most severe form of muscular d y s t r o ­
phies. The affected boys show c l i ni cal symptoms as 
early as 2-3 years of age. First they show cl umsiness 
in walking and are unable to run properly. At four 
years old, they show a waddling gait, delayed psychomotor 
development and sometimes immaturity of speech. They 
also show hy pot onia of shoulder muscle and p s e u d o h y p e r ­
trophy of the calf muscle. This also occurs in about 
8% of carriers.  Weakness of individual muscles progresses 
to shoulder, arm and pelvic girdle. The muscle becomes 
p se ud ohypertro phic as the muscle fibres are replaced by 
fat and fibrous tissue. The mean age at which there is 
inability to walk is about 9.5 years but this may vary 
f r o m  about seven to fourteen years. S p inal deformity may 
dev elo p in most cases within a few years after they 
become unable to walk.
The e l e c t r o ca rd io gram is abnormal in almost all 
patients. Some patients may have mental retardatio n,  
the feature s of which can not be att ributed to effects 
of primary muscle pathology. Wea kness of the paraspinal 
muscles contr ibu tes to the ev en tual thorac ic d i s t or ti on 
and this in turn is a major factor in the chronic r e s ­
piratory insufficiency from  which most patients die, 
usually in their early twenties (Gardner-Medwin, 1980).
The microscopic morphology of muscle deg eneration 
and serum chan ges  in the disease are discusse d in the 
following sections. Since carriers may exhibit similar
4-
symptoms, although to a lesser extent, both patients 
and carriers wil l  be discussed together.
1.2.1 Muscle Necrosis
According to Cullen and Fulthorpe (1975) ftbre 
breakdown in DMD can be divided into five stages by 
electron microscop ical examination.
Stage 1 The fibres appear normal, but the volume
f r a c t i o n  of the mitochondria was less than 
normal. The amount of sarcopl asm is 
clearly higher than in healthy fibres.
Stage 2 Fibres were overstretched, caused by strong
overcontracti on of the sarcomeres in other 
areas of the same fibres. Sar coplasmic 
reticulum, parts of which are dilated, loses 
its reg ular distribution. Mitocho ndria are 
similarly displaced.
Stage 3 Localized cont ractio n has con tinued to the
extent that the stretched areas between the 
clumped myofibrils are partly empty of 
contractile material. Isolated segments of 
myofibril are scattered between the c o n ­
tracted areas. The greater part of the 
interstitial areas is occupied by sar coplasm 
containing empty vesicles, degenerating 
mitochondria, glycogen particles and 
occasional lipid droplets.
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Stage 4 The clumps of contr actile material are
further conden sed and their outlines are 
more rounded. Around the con tract io n 
clumps are large areas of granular sarc oplas m 
which contain little apart from occasional 
ves ic les or mitochondria.
Stage 5 The fibre, which is progressively invaded by
macrophages, now consists only of structurless 
cytopla sm  containing no contractile material. 
Occ asionally regenerating fibres are found 
in the vicinity of these final remnants.
R e g e n e r a t i o n  of muscle fibres has been shown to 
com pe nsat e for deg enerated fibres. This has been 
suggested by the increased turnover of muscle cont ra ctile  
proteins assessed by 3 -methyhistidine and creatine 
e x c r et io n (Ballard, 1979), However, the r e g e n erat io n 
does not fully com pe ns ate for necr-osis. The regenera tin g 
fibre s do not always attain normal size indicating an 
e nd oge nou s alt e r a t i o n  in the muscle. Other fibres are 
thus able to hypert rophy and the number of muscle cells 
decreases. C o l l a g e n  progressively accumulates in dense 
bu ndles lying bet ween and parallel to the muscle cells, 
presumably as a sequel of necrosis when r e g e n e r a t i o n  fails 
to take place (Carpenter and Karpati, 1979).
1.2.2 Serum Changes
Almost all of the enzyme activities that are 
increased in serum in DMD patients and carriers are 
normally cytoplasmic, or only loosely attached to 
organelles or myofilaments. Enzymes that are bound 
to membranes or other structures in muscle are not 
ordinarily found in the plasma of DMD patients (Rowland, 
1980). Not only enzymes from skeletal muscles, but also 
those f ro m heart, liver and erythrocytes were found to 
be increased in serum, indicating a generalised enzyme 
re l e a s e .
Some enzymes increased in serum of DMD patients 
and carriers are summarized in Table 1.
The increased serum enzyme activities return 
toward normal values when the boys grow older and, 
concomitantly, muscle mass gradually diminishes (Dreyfus, 
Schapira and Demos, 1958).
N on-enzymic proteins were also found to be increased 
in the serum of DMD patients and carriers. They are 
summarized in Table 2.
1.2.3 Urinary E x c r eti on  Changes
Some bre ak do wn products of muscle are usually found 
in DMD urine.
1. Creatine and creatinine
Creatinine is found in most muscle disease i n c l u d ­
ing DMD. These changes are primarily a non-specific 
conseque nce of muscle wasting (Pennington, 1980).
21
-7-
TABLE 1 Soluble muscle specific enzymes found in pyp serum
Enzymes
Isoenzyme Pattern 
Patients Carriers Remarks Refs.
creatinephosphokinase(cpk)
Myi (muscle) MB (cardie) MXlfaint MB resemblefetalmuscle
Yaanir^ h, 1978; Rowland, 1980
Aldolase muscle type muscletype Schapira, Dreyfus and Schapira, 1957
Lactatedehydrogenase(LDH)
LDH-5reduced LDH-5increased Somer, Dormer, Murros and Konttineus, 1973
Pyruvate kinase (pk) Zatz and Otto, 1980
TABLE 2 Non-enzymatic protein reported as being elevated 
in serum of DMD patients
Protein Remarks References
Myoglobin not specific to muscular dystrophies Adomato, Kagen and Engel, 1978
Hemopexin as a carrier to fix the in­creased myoglobin released from muscles
Askanas, 1966; Daniel! and Angelini, 1976
ag^ macro-
globulin
plasma inhibitor of the muscle lyoscmal protease, Cathepsin B, suggested to be a counterbalance of increased protein catabolism in EMD muscle
Jones, 1982
-9-
Cr ea tlni ne  excre tion was also found to be decreased 
(Kobayashi, S h i n n o k  and Mawatari, 1979). These changes 
might be due to  the redu ced  muscle mass, much of the 
creatine having escaped f ro m uptake into the _muscles 
and co n v e r s i o n  to cre atinine  (Pennington, 1980).
2. Amin o acids
Taurine, proline, ornithine, 3 - me thy 1 -histidine 
and dim eth ylargi ni nes were found to be inc reased in 
DMD urine (Bank, Rowland and Ipsen, 197 9 ; Lou, 1979).
These results indicated a re lation be twe en  protein 
méthylation processes and muscle dystrophies .
3. Polyamines
Russel, and Stern (1981) found increases in p o l y ­
amines, putrescine, spermidine and s per mine in DMD 
patient urine. The marked increase of urinary p o l y ­
amines in DMD may result from altered intracellular 
a ccumu la tion patterns of poly amines in dystrophic 
muse le .
4. Proteins
Tw o additional, uni dentified proteins were found 
in the urine in DMD patients and 60% of carriers but 
in none of the controls (Fear s o n , Taylor and Percy, 1981). 
They suggested that these might be a conseq uence of 
muse le d a m a g e .
To summarize, most of the sera 1 and urinary
changes in DMD patients and carriers are secondary
isymptoms of muscle wasting . They can be a diagnostic ;|
too l and for m the basis of carrier de te ction methods 
but probably tell us little about the primary defect 
of DMD.
-10-
1.3 Theories for the Pathogenesis of DMD
1.3.1 N e u r og en ic and Vascdlar Hypotheses
McComas, Sica and Upton (1974) demonstr ated a 
progressive r e d u c t i o n  in the number of fun ctioning 
motor units. The motor neurons were referred to as 
" ’sick', a state cha rac teriz ed  by difficulty in m a i n ­
taining sa tisfactory synaptic connections with muscle 
fibres". The theory was postulated that muscular 
dystrophy is a chronic dy sf unction of motor neurons, 
eventually leading to their physiological failure.
But McComas' theory could not explain the increase of 
cpk in DMD patients and carriers, the different serum 
enzyme patterns and the cardiac abnormality in DMD, The 
neurogenic theory seems to be fading nowadays.
The vascul ar hy po the sis was first proposed by 
Kune and Okimaka, 1930. They suggested that inadequate 
blood flow might account for the deg enera ti on of d y s ­
trophic muscle. But this simple idea was abolished by 
the finding of Paulson, Engel and Oomez (1974). They 
found that blood flow at rest and during the hy peremia 
which follows exercise was normal and capillary dif f u s i o n  
capacity was unimpaired. No other evidence of a 
structural or f u n c t i o n a l  defect in the mic ro ci r c u l a t i o n  
of DMD patients was found,
1.3.2 Me mbran e Theory
This is the most popular and widely accepted theory 
to explain the primary defect of DMD, but encompasse s 
a large number of variants.
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The membrane theory proposes that there is a 
systemic abnormality in the plasma membrane. This 
abnormality in the membrane, according to classical  
genetic theory, should be manifest in all tissues, even 
though it is apparently exp ressed as a c l i nical defect 
in muscle. Roses (1977) has suggest ed that 'whether or 
not a particular tissue presents cl inical symptoms or 
signs may depend on the re lative importance of the 
specific biochemical defect for the fu n c t i o n  of that 
t i s s u e * .
Muscle necrosis and the serum changes can be
explained by the Mem br ane theory. Duncan (1978) proposed
that in DMD, the significant genetic defect is in the 
2 +Ca -channels of the muscle plasma membrane so that
Ca^^-influx is increased. Ca ^^ -uptake by sar coplasmic
reticul um  (SR) may also  be impaired. As a conseque nce
Ca^* rises in the sa rc opl asm and the muscle attempts to
correct the position by storage of Ca^* in the nucleus
and mitochondria. Ca^^ is released from the SR in
2 +exci ta tion and, in DMD muscle, Ca may then be raised 
to a level sufficient to promote a Ca ^^-induced release 
of Ca^* from the SR due to a positive f e e d - b a c k  mechanism, 
so increasing Ca^^ to a c o n c e n t r a t i o n  which triggers 
protease activity directly or indirectly, or promotes 
the release of lysosomal enzymes, which leads to fibre 
mecros i s .
Similarly, Wro g e m a n n  and Pena (1976) proposed a 
sarcolemmal defect increased the net influx of Ca^* 
into cells which triggers a ’vicious cycle of mitochondrial.
1
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ca l c i u m  overloading, energy depletion and then cell 
n e a r o s i s '.
The hypothesis can be summarized by the following 
di agram :
Genetic abnormalities 
in a variety of muscular 
dystroph ies
insufficient
Ca^^ pumped 
out of cell
1sar colemmal defects1increased net influx of 2 +Ca1excess uptake of Ca 
by mitochondria
2 +
1f uncti on al and later, 
structural damage of 
mit och ondria1Lack of energyI
elevated cytoplasmic 
Ca^^ levels1
hypercont raction  of 
muscle fibresI
Cell necrosis
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Bradley and Fulthor pe  (1978) studied the integrity 
of sarcolemma with the dye Procion Yellow. The dye 
entered fibres more often than in control fibres. They 
a 1^0 suggested that s arco le mmal defects may allow entry 
of a high co nc e n t r a t i o n  of Ca^ "*" into the sar copl as m 
with consequent fibre damage due t o  activ ation of protein- 
ases by Ca^^ .
A physical i n t e rrupti on  of the muscle cell or 
surface membrane has been  proposed as the cause of the 
increased serum enzyme activi ties in patients with DMD, 
but the story seems more compl ic at ed. Two lines of 
evidence support this assumption.
1. Increased serum enzyme activities can be measured 
before there is actua l muscle necrosis (Carpenter 
and Karpati, 1979).
2, There does not seem to be strict proportionality 
between the number of necrotic fibres and the 
magnitude of the serum enzyme abnormality in 
either DMD patients or car riers (Roy and Dubowity, 
1970).
In short, the evidence implies that a genetic 
abnormality of surface membrane may be the f u n d a m e n t a l  
cause of the high ser um enzyme activity in DMD (Rowland, 
1980).
Most of the res ea rch work in the muscular dystrophy 
field is directed towards cells other than muscle cells. 
The practical problems in obtaining muscle biopsies 
and pure sarcolemma free of c o ntamina ti on from co n n e c t i v e
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tissue (which j s more abundant in DMD muscle) and the 
relatively poor state of knowledge about the structure 
and f u n ct io n of the normal sarcolemma and sarcoplasmic 
reticulum, have directed most of the research work 
towards red blood cells (RBC) and fi broblasts. F i b r o ­
blasts are attractive as experimen ta l materia l because 
of the relative ease of culture v itr o , but most 
investigations on non-muscle cells have been with RBC.
RBC provide an easily accessible, repeat able, control-  
able source of material  for experiments (Roses, 1977). 
Much of our knowledge of normal membrane structure and 
fu n cti on  has been obtained from studies on these cells. 
Some workers consider this approach to be mistaken 
because the RBC is a highly specialized cell that is not 
only different in structure from muscle cells but als o  
is unable to perform many normal b i o c h emica l functions, 
e.g. protein synthesis, oxidative phosphorylation, since 
it lacks subcellular organelles (Lucy, 1980). Roses 
(1977) also argues that muscle cells in culture from 
patients may no longer demonstrate the biochemi cal defect 
since they are a product of the dystrophic process and 
may represent a sel ective population consisting only of 
healthy regenerating cells.
Ir res pective  of the relative merits of using 
cells other than muscle cells in studying the primary 
defect of DMD, much evidence to support the Membrane 
Theory has been found in muscle (both biopsied and in 
culture), RBC, cultured skin fibroblasts, lymphocytes
-15
and other somatic tissue. The following sections will 
present the evi de nc e found in recent years.
-16-
1 .4 Evi de nce to Su ppo rt Membrane Theory
1.4.1 M e m b r a n e  Lipids
1.4.1.1 RBC
Many c o ntradic to ry r%sults have been obtained for 
analysis of the pho spholipids, neutral lipids and their 
fatty acids by different groups of workers.
Content of ch olesterol and total phospholipids  
as well as pho spho lipid composition were found to be 
normal in RBC in both patients and carriers. (Kobayashi, 
Mawateri and Kuroiwa, 1978; Koski, Jungalwala and Kolodny, 
1978; M c L a ugh li n and Engle, 1979; Godin, Bridges and 
MacLeod, 1978). In contrast, Kalofoutis, Oullien and 
Spanos (1977) found a decrease in phos ph atid y l - c h o l i n e  
(PC), but increas es in sphingomyelin (SM) and lyso- 
p h o s p h a t i d y l c h o l i n e  (LPC).
Some wor kers found a normal lipid class c o m p o s i t i o n  
in RBC me mb ra ne but altered fatty acids components.
An inc re ase in stearic acid ^^28*0^ d decrease 
in behenic acid (C^ q .q ) were found in the LPC fr a c t i o n  
of DMD RBC (Ruitenbeek, 1978). Three reports described 
a decrease of palmitoleic acid; in diglyceride and 
t r i g ly ce ride (Ruitenbeek, 1978; Howland and Iyer, 1977) 
and in SM and pho sph atidy l eth anolamine (PE) (Beyer, Bieth, 
Freysz, Robert and Uhl, 1981). An increase in arachidonic 
acid (CgQ.^) in SM fr a c t i o n  was also found in the RBC of 
patients and carriers (Beyer et. ëA*  » 1981).
Kunze, Reichmann, Egger, Leuschner and Eckhardt
(1973) showed an increase in SM in RBC membr ane and a
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normal content of plasma log ens . An incr eased content 
of dimethyl acetals and a decrease in ara chido ni c acid 
(C2 0 .4 ) were found in PE. An increased percentage of 
stearic acid ( C" ^  g . Q ). but decreased palmitic acid 
tetr ac osadien oic acid (^24.2 ) linoleic acid (^2.3 .2 ^
were found in S M . This report and that of Kalofou tis  
et a 1 . (1977) were critisized by most of the subsequent 
workers. The relative percentages of SM , PC, PE and 
ph os ph at idy Iser ine (PS) of normal RBC obtained by 
Kunze e ^  were different from the no rm al accepted
figures (PC. 34.6%, SM 30.7%, PE + PS 34.6% compared to 
PC 29%, SM 25-27% and PE + PS 42%).
Some workers argued that the diminished content 
of the rela tively more unsatu rat ed compone nt s (PS and 
PE) and the increased percentage of SM obtained by 
Kunze e 1^  a^. and Kalofoutis was due to the lack of 
in c l usion of antioxidant in ex t r a c t i o n  and chr omat og raphy 
solvents and other precautions against lipid peroxidation 
during the experiment. Dodge and Phillips (1966) 
indicated that autoxid at ion of lipids may lead to loss 
of the more unsaturated species, PE and PS, and to a 
lesser extent PC. The increase in SM reporte d by these 
two groups in DMD may, therefore, be a r t i f a c t u a l  and due 
to the preferential loss of the more unsa tu rated g l y cero- |
■Iphospholipids. However, if the samples in their studies |
were all treated identically (especially length of time j
be tw ee n sampling and analysis) the fact that a difference 
was found between patients and controls may infer s i g ­
nificantly increased susce ptibility  of lipids to
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peroxidation (Hunter, Brzeski and de Vane, 1981).
In summary, six reports of a normal phospholipid 
distribution were presented compar ed with only two 
-tab or at or ies which found abnormal  phospholipid c o m ­
position. Now it is generally accepted that, in the 
RBC membrane, no abnormality of major phospholipid 
composition exists. The highly variable and sometimes 
conflicting data concerning fatty acid c o m p o s i t i o n  need 
further c o n f i rmat io n before any conclusions can be 
drawn. Nevertheless, it is still possible that there 
is an abnormality in some quant it at ivè ly minor but 
functionally important lipid components, e.g. glyco- 
lipids and phosphoi nositid es  .
1.4.1.2 Muscle
1.4.1.2.1 Muscle biopsies
N i ebro j- Dobosz (1980) was able to show an increase 
in total conce n t r a t i o n  of phospholipid in total DMD 
muscle plasma membrane.
The SM content of DMD muscle biopsies was reporte d 
to be increased (Kunze and Olthoff, 1970; Hughes, 1972;; 
Takagi, 1971; Pearce, Oohnsen, Wysocki and Kokulas,
1981) whilst that of PC was found to be decreased (Kunze 
et al., 1970; Hughes and Takagi, 1971). The lipid 
components were also reported to be changed and different 
causes were proposed for these alterations.
Kunze e_t a_l. (1970) suggested the decreased PE and 
increased LPC were the consequ ence of an enzyme defect 
in the disease. A similarity betw een  immature muscle 
and DMD muscle was proposed by Hughes (1972 ) as he found
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•>an increase in total c hole st erol and a decrease in 
choline plasmalogens in DMD muscle biopsies. Pearce e ^  a l . , 
(1981) attributed the cha nges they found in DMD muscle 
biopsies to the incre ased amounts of fat which inf iltrate 
the dystrophic muscle since the var i a t i o n  observed was 
found to p a r a l l e l  the degree of i n filtr at ion of muscle 
with fat and c o n n ectiv e tissue as observed micro sc opicall y.
Conflicting data exist regarding the fatty acid 
co mposit ion of dystrop hic  muscle. Susheela (1968) r e p or te d  
a normal free fatty acid c o n c e n t r a t i o n  in muscle of DMD 
patients. Kunze, Rei chman, Egger, Olthoff and Dohler 
(1975) and Takagi, Muto, Takahashi and Nakas (1968) 
showed a normal fatty acid pattern in triglycerides, SM 
and PE of DMD muscle, but noted changes in the PC fractio n.  î
A decrease in linoleic acid (^28*2^ and a corresponding 
increase in oleic acid were found. They showed 4
that the fatty acid pattern of PC of DMD muscle was 
different from that of neonatal muscle, in contrast to 
Hughes (1972) s uggest io n that their lipid co mpositions  
are similar.
The lipid co mp onent s of sarcoplasmic  ret ic ulum of 
DMD muscle were reported to be changed by Takagi,
Schotland and Rowland (1973) who found an increase of 
SM and a decrease in PC and phosphatidyl inositol (PI).
However, they suggested that it was due to c o n t a min at ing 
tissue.
Surveying the re port s of the phospholipid content 
of dystrophic muscle, a decrease in PC and increased SM f
4
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are the most consistent results obtained by different 
groups of worker s. However the possibility still 
remains that the muscle studied was contami nated  by 
the inf iltrated adipose and connective tissue as 
suggested by Pearce e ^  a_l. (1981).
1.4.1.2.2 Cultur ed Muscle
Bonsett, Rudman and Elliott (1979) studied DMD 
muscle explants and showed an increased number of fat 
droplets compa re d with controls under identical tissue 
culture condition. They suggested an abnormality in 
fat me t a b o l i s m  in DMD skeletal muscle and/or other cell 
types.
1.4.1.3 Cultur ed Skin Fi broblasts
No abnormality of the phospholipid profiles and 
fatty acid co mp osition  of DMD cultured skin fibroblast s 
was found in either young or old cultures (K ohlschu tt er , 
Wies man n, Herschko wi tz and Ferber, 1976). This is the 
only published report on lipid co mpositi on in this cell 
type although preliminary studies in our laboratory 
.(Hunter, unpub li shed observations) confirm these findings.
Overall, the repo rts of the lipid and fatty acid 
com posit io ns of dystrophic RBC, muscle (biopsies and 
cultur ed explants) and culture d skin fibroblasts, show 
no a b no rm alitie s in the major phospholipid classes. 
Althou gh some changes were found in dystrophic muscle 
biopsies, it was strongly suspected to be c o n t a m i n a t i o n 
from infiltrate d fat and connective tissue. However, 
few studies have been performed to investigate the minor 
lipid com pon en ts which may be fun ctionally important, 
this may be a profitable field of further study.
—2 1 —
1.4.2 Me mb rane Proteins
1.4.2.1 S p e c t r i n
The e r y t h r o c y t e  membrane *cyt oskelet on' is a two- 
dimen sio nal network of proteins located at the inner 
(cytoplasmic) surf ace  of the red cell membrane. The 
major proteins of this network are spectrin (bands 1 
and 2 in the SDS e l e c t r o p h o r o g r a m ) and actin (band 5).
Since spectrin cons titut es  approximately 60-70% of the 
c y t o s ke leton proteins, it is likely that these structu res 
represent fibres of the cyt oske leton (Palek and Liu,
1980). Spect ri n is likely to be involved in determining 
the shape of RBC, in stabilizing the lipid bilayer and 
may also c o n t r i b u t e  to some of the lipid asy mmetry of 
the red cell membrane (Marchesi, 1979). The state of 
spectrin p h o s p h o r y l a t i o n  may also influence the shape 
of RBC (this will be discussed in more detail in the 
following section ), the asymmetrical arr angement of 
the lipid bilayer and, in consequence, the a c t i viti es  of 
some membran e bound enzymes (Marchesi, 1979).
Mi s sir li s (1978) and Vickers, McComas, Kohn and 
Rathbone (1978) were able to show the rates of p h o s p h o r ­
y l a tion of spe ct rin and band 3 protein were significa nt ly 
higher in ghosts prepared from DMD patients. Rates for 
both spectrin and band 3 were altered to the same extent
and they sug gested a common cause, possibly the lipid
32environment. An increase in P in c o r p o r a t i o n  into 
membrane protein in DMD carriers was indicated (Tagliavini, 
Grassi, Rossi and Conterio, 1980). Mabry and Roses (1981) 
found an increase in phosphorylation of tryp tic peptides 
of spectrin II in DMD RBC. The enzyme which is res-
iI
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ponsible for the phosphorylation of spectrin is the 
protein kinase which was found to be increased by 
Mi s s i r l i s  e ^  aj^. (1978),
The p h os phoryl at ion of Band II has been  studied 
in detail by Roses e ^  a^. (1975; 1976 ; 1977 ; 1979; 1981) 
and was found to be increased. They indicated a sen-
2 -fsitive inte r r e l a t i o n s h i p  between Ca and the increased 
p ho s p h o r y l a t i o n  of Band II and suggested Ca^* may play 
a role in maintaining membrane integrity.
In another study by Roses and Appel, (1976) the 
in v i v o  ph osph ory lated state of spectrin in the membrane 
was found to be the same in DMD and controls RBC.
F u r t he rm ore the kinetic evaluation of protein kinase 
d em onstrat ed no differe nce  in DMD, They suggested an
abn or mal substrate or alteration in the state of the I
v e c t orial  and geom e t r i c a l  r e l a tions hi p of substrate to j1enzyme due to other membrane factors or c o n s t i t u t e n t s . j
This might therefore  explain the discre pan cy betw een  |
in V itr o and ^  vi v o  fin dings. The individual segments j
of spectrin have variable efficiencies as substrate |
for the endogenous protein kinase. Roses e ^  (1981)
tried to identify the abnormal substrate in Band II
32and found more than 50% of the P was ass oci ated with 
a single cyanogen bromide cleavage band only (CN-A), 
although the CN-A band only represents about 2% of the 
total peptide protein.
Roses (1977) rel ated the si gni fic ance of increased 
ph ospho r y l a t i o n  of band II to the pathogenesis of DMD.
The a m ino acid co mp o s i t i o n  of spectrin is similar to
J
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muscle moysin. He proposed that an abno rmal type or 
polymorphic fo r m  of my osin may be present in DMD, This 
abnormality might affect the exquisite 3 -dimensional 
st ructure of the m y ofi br illar elements resulting in 
dissolution, dystrophy and multiple secondary effects.
Roses' con c l u s i o n  needs further c o n f i r m a t i o n  since 
cont rad ictory results f r o m  several laborat ories have 
been presented. Tortolero, Fischer, Pian, Delaunay and 
S cha pira (1979); Iyer, Hoenig, Sh erblo m and Howland
(1977); Fischer, Tortolero, Delaunay and Sch apira (1978); 
Falk, Campion, Guthrie, Sparkes and Fox (1979) found 
no differe nce  in Band II phosp ho rylat ion but agreed with 
Roses that the protein kinase activity was unchanged 
(Tortolero e ^  » 1979).
In add iti on to the controver si al data on spectrin 
pho sph orylation, Tsu chiya, Sugita, Ishiura and Imahori 
(1981) and Nagano, Wong and Roses (1980) indicated 
spectrin e x t r a c t a b ilIty was significantly re duced in DMD 
ghost s and suggested that spectrin from DMD patients was 
more tightly bound to the membranes.
In a critical r e v i e w  by Tsung and Palek (1980) 
conflicting results for RBC membrane protein p h o s p h o r ­
yl ation  were related to differences in methods including 
g h o s t - p r e p a r a t i o n  and e n zy me -assay  conditions. They
su spected the data of Roses ejb to be difficult to
32interpret, due to extremely low P per mole of spectrin, 
that is, only about 40% of the total number of e x c h a n g e ­
able phosphorus atoms per mole of spectrin. .•-1
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Due to the clo&e r esembla nc e between RBC spectrin 
and muscle myosin, the importance and sig nificance of 
the ph os ph ory lated state of band II can not be ignored 
pnd needs further inve stigation .
1,4.2.2 Fr e e z e - F r a c t u r e  Studies
Using the fre e z e - f r a c t u r e  electron  microscope 
technique, Wakay ama, Hodson, Pleasure, Bonilla and 
Schotland ( 1978) and Wakayam a, Schotland, Bonilla and 
Orecchio (1979) showed a decrease in number and uniform 
distribution of in tramem branous particles (P phase and 
E phase) in DMD RBC membrane. They suggested this was 
the co nsequ ence of a change in properties of band 3 
peptides or in the membrane lipid with which they interact 
to form the intramem bra nous particles.
In DMD muscle, n o n - u ni form dis tr ibution  of intra- 
membr anous particles including orthogonal arrays were 
found on both protoplasmic and extracellular faces of 
the plasma mem brane (Schotland, Bonilla and Meter,
1977; Schotland, Boni lla and Wakayama, 1980; 1981). In 
contrast, O s a m e , Engel, Rebouc he and Scott (1980) found 
a normal frequency and dis trib ution  of int ram embra nous  
particles in culture d DMD muscle fibres.
Study of membranous protein dist ri bution by 
observing c o nc an avalin  A binding under E.M. showed normal, 
regular and co nt inuous  binding sites in cultured DMD 
muscle ( H e i m a n - P a t t e r s o n , 1982). But Bonilla, Sch ot la nd  
and Wakayama (1978) found  the DMD muscle fibres (plasma 
membrane and basal lamina) showed irregular and patchy
___
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c on ca navali n binding sites. They suggested the focal 
abnormal regions of Con A binding sites were associated 
with a focal increase in extracellular colla gen, and 
al terati ons in distribu tion of a-D -mannose, a-D -g lucose  
and a - D - f r u c t o s e .
The negative results both came from studying 
cultured muscle fibres in contrast to the positive 
results obtained by using DMD muscle biopsies. The 
difference between DMD fresh muscle fibres and cultured 
muscle fibr es is unknown, but it may be that only healthy 
muscle cells will establish themselves in cu lt ure (Roses, 
1977).
1.4.2.3 Culture d Skin Fibroblasts
Jones and Wit kowski (1981) measured the ag gr egation 
of cultu re d fibrob lasts in a Couette v iscome te r. Results 
showed the DMD cells have a low intercellular a d h e s i v e ­
ness and forme d small numbers of very large aggregates 
which were absent in normal cells. They su ggested these 
might be an al te ratio n in the surface of dyst ro phic cells 
But the mean particle densities and c o e f f i c i e n t s  of 
dis per sion of the int ram embranous  particles of DMD c u l ­
tured skin fib roblasts showed no difference from that of 
normal ceils) (Jones, Severs and Witkowski, 1981). One 
might expect the abnorma l surface ch aracters of the DMD 
cultured fib ro blasts to reflect some abno rm ality in 
their membrane proteins and/or lipids especia lly g l y ­
co proteins or glycolipids. A recent study (Burghes,
Dunn, St a t h a m  and Dubovvitz, 1982) of DMD cu ltured  skin 
fibrobla st s protein by SDS-gel e l ectrop ho resis showed
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the regions of 73, 000 -68,0 00  and 48 ,000 MW were d e c ­
reased while those of 175,000 and 53,000 MW were 
significantly elevated. A normally fu nctioning c y t o ­
sk el et on was observed by staining with c o n c a naval in  in 
DMD skin cul tured  fib roblasts (Newman, 1982 ). Pena, 
Vust, Tucker, Hamen to n and Wr oge mann (1978) a lso d e m o n ­
strated a normal dist ribution of sub cellular fractions  
and normal major protein components.
Evidence f rom DMD RBC spectrin pho sphor ylation, 
f r e e z e -fractu re  E.M. of muscle and RBC, and e l e c t r o ­
phoretic analysis of cultured skin fibr o b l a s t s  favors an 
abnormality in membrane protein, which might explain most 
of the abnormaliti es found so far. However, the evi den ce  
relating to spectrin is equivocal and isolat io n of an 
abn or mal protein from muscle or fibrobla sts has not been 
achieved and this area needs further inv estiga ti on to 
e l u c id at e this problem,
1.4.3 Phy sic al Properties of Membranes
1.4.3.1 Shape a n d D e f o r m a b i i i t y  of RBC
The def orm abiiity of the RBC depends essentially 
on three factors (Mohandas, Phillips and Bessis, 1979).
1. The state of the cell contents i.e. the intern al 
viscosity of the intracellular haem o g l o b i n  milieu, 
as re gulated by the mean cell ha em o g l o b i n  c o n c e n ­
t r a t i o n  and the state of ha emoglobin aggregation ,
2. The geometry of the cell i.e. the overall shape 
and the surface area to volume r e lation sh ips.
3. The membrane properties i.e. the defor mobility, 
elasticity, viscosity and fragility of the 
m e m b r a n e .
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The membrane def ormabiiity, flexi bilit y and m o r ­
phology (shape) are primarly dependent on, and controlled 
by, a sub-membranous c y t o s k e l e t o n  (Lux, 1979; Marchesi, 
1979; Palek and Liu, 1980). The phosphorylated state of 
spectrin will markedly influ ence the shape and def or­
mabiiity of the RBC me mbranes  (Birchmeier and Singer , 
1977). Thus the deform abi iity and shape of RBC may 
reflect the intrinsic bi oc h e m i c a l  state of the membrane. 
Shear Modulus (dyne/cm) is a measure of the visc oelasti c 
properties of the membrane. Increase in Shear Modulus, 
i.e. increase re sistance to deformation were found in 
DMD RBC (Brain, Kohn, McComas, Missirlis, Rathbone and 
Vickers, 1978 ; Missirlis and Kohn, 1978; Kohn, Miss irlis, 
MdC oma s and Brain, 1977). But Somer, Chieu Sung and 
Thuru (1979) dem onstrated  no significant differe nce  in 
membrane def ormabiiity determined by mic rosieving and flow 
cha nne l measurements. A normal hae moglobin content, 
viscosity and flex ibility of DMD RBC membrane, which 
reflects a normal deformabiiity has also bee n indicated 
(Tillman, Lenard, Wagner, Dongs and Shroter, 1979).
An increased percentage of echinocytes (distorted 
RBC) in DMD blood w a s  found by Mat hes on and Howland
(1974); Korczyn, Fishman, Dja ldetti and Berginer (1977); 
Lumb and Emergy (1975); Grassi (1978); Beyer, Stephan, 
Oberling and Daya (1977); Howells (1976); Percy and 
Miller (1975); Miller, Roses and Appel (1975). Both 
Percy and Miller (1975) and Howells (1976) suggested an 
abnormality in spectrin and actin might be responsible. 
Conflicting reports of a normal percentage of ech inocytes
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In DMD blood have also appeared (Szentistvanyi and Janka 
( 1977); Miale (1975); So ltan (1977); and M ollica (1980)) 
and this normality is also seen after g 1 ut a r a I d e h y de fi x a t i o n  
under phase contrast and scanning E.M. (Sz entistvanyi and 
Janka, 1977). Ma theson  (1976) ret racted his finding of 
changed RBC morpholo gy (Matheson, 1974) after using 
various methods to prepare erythrocyte samples for 
observing morphology and found no significant abnormality 
of RBC shapes. He con cluded that RBC shape was very 
sensitive to various type of cell treatment and might be 
the cause of the controv er sial reports about DMD RBC 
morph ology .
At the present time, there is still no unchallenged 
finding regarding the def ormabiiity and morphology of DMD 
RBC. However a membrane defect (perhaps of spectrin) may 
exist and be ref le ct ed by the different resp on ses of 
DMD and normal cells to various cell treatments.
1.4.3,2 Osmotic Fragility of RBC
Osmotic fragility of RBC is governed by the excess 
surface area to volume r a t i o  (i.e. degree of swelling) 
and by the elastic properties of the membrane which 
enable it to undergo these deformat ions with out lysis 
(Weed and Reed, 1966). The rate of lysis is determined 
by the degree of rupturing of the lipid bilayer, which 
occurs after the cells have become spherical. Osmotic 
fragility of the cellular membrane is directly p r o ­
portional to the degree of fluidi ty of the lipid bilayer.
It seems that the spectrin network and degree of membrane
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def ormabiiity are not the rate determining factors of 
h ae mol ysi s (Araki and Rif kind, 1981). Any changes in 
degree of fragility  therefore, may reflect a fluidity change 
in the m e m b r a n e .
Danieli and Marc he sini (1980) showed an increased 
RBC osmotic fragility in both DMD patients and carriers 
and this phe nomenom was enhanced by ATP depletion. This 
result (in DMD patients) was confirmed by Lloyd and Nunn,
(1978); Fisher, Silvestri, Vester , Nolan, Ahmad and 
Danowski (1976); Kim, Luthra, Watts and Stern (1980). But 
Ruitenbeek, E d i x h o v e n  and Scholte (1979) found that after 
ph ospholipase (EC 2.1.1.4) treatment (from pancreas 
snake venom or bee venom) there was no difference 
be tween the osmotic fragility of DMD and control RBC, 
both being increased by the same amount. They concluded 
that phospholipid packing was not much altered in DMD 
patients. A more direct way to measure phospholipid packing 
and fluidity is by using various kinds of probes and 
spe ctr oscopic tec hniques, particularly ESH, NMR and 
flu ore scen ce  .
1.4.3.3 Spec troscopic  Studies
Biophy sic al probe techniques yield detailed i n f o r ­
mation on molecular organization. The techniques 
commonly used are ele ct ron spin res onance spectroscopy 
(ESR), fluore scent  techniques and nuclear magnetic 
reson anc e spectros copy (NMR). Using ESR and lipid soluble 
spin probes with different chain lengths it is possible 
to measure the fluidity at different depths of the lipid
$
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bilayer. Fluidity is a co ns e q u e n c e  of the degree of 
unsaturation, chain length of the fatty acyl groups and 
henc e the phospholipid packing of the lipid bialyer.
Probes can also give i nform at ion about c o n f o r m a t i o n  of 
the intrinsic protein, mem brane polarity and protein- 
lipid interactions. Any change in lipid bilayer physical 4
properties may affect the c o n f o r m a t i o n  of intrinsic 
proteins and, in co nse quenc e, membrane fun ction s.
Many conflicting results have been presented c o n ­
cerning the lipid fluidity of the polar (surface) region, 4
hydrophobic (non-polar) core and the protein c o n f o rm ation  
of the DMD RBC, They are summarized in the following 
three tables (Tables 3, 4, and 5).
Different results may depend on the type of spin 
label used or the type of ESR. The report of Wilkerson,
Perkins, Roelofs, Swift, Da lt on  and Park (1978) is n o t e ­
worthy because they used the same kind of probes (5-NS) as 
that of Butterfield, Chesnut, Appel and Roses (1976);
Butt er field (1977); Butt e r f i e l d  and Markesbery (1980) and 
Laurent,Daveloose, Leterrier, Fischer and Sch ap ir a (1980), 
but studied with the s p e c i a l i s e d  te chniqu e ST-EPR. ST-EPR 
can study motions of m a c r o m ol ec ules and slower molecular r e ­
orientations as slow as 10 ^ sec, while the lower limit 
of convent io nal ESR is 10 ^ sec. It seems that the 
results (decreased fluidity in polar r e g i o n  of DMD ghost) 
of W i l k e r s o n  et al. (1978) is therefore more reliable 
than previous findings. A different method (fluorescence 
polarization) and different probes used ( 1 ,6 -dipheny 1 
1 , 3 , 5 - h e x a t r i e n e ) by Dunn (1980) also gave a similar result 
to that of Wilke rs on et al. (1978).
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Fluidity Probes used Techniques
... .. ■ » .
Remarks Refs.
Normal 1(1.14) ESR Sato, Nishikida, Samuels and lyier, 1978
Normal 5-NS ESR Butterfield et al., 1976; 1977; 1980
Normal 5-NS ESR Laurent et al., 1980
Decreased 1,6-diphenyl,1,3/5-hex-atriene
fluorescencepolarization most app­arent at less than 
22PC
Dunrv 1980
Decreased 5-NS saturationtransferelectronparamagneticresonance
measuresslowermotions thai ESR
Wilkerson et al. 1978
Altered lipid-soluble spin labels ESR depletion of extrin­sic pro­teins and intramem­branous particles?
Falcioni, Ferretti, Mazzanti and Caratola, 1982
Increased 5-NS ESR alterations in lipid- protein organis­ation?
Dellantonio, Angeleri, Capriotti, Lenaz^  Curatola, Mazzanti and Bertoli, 1980
Table 3
Lipid fluidity at the surface (polar) region of DMD 
ghost.
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fluidity Probes used Techniques Remarks Refs.
Increase 1(1.14) ESR different protein­lipidinteractions?
Sato et al., 1978
Altered lipid-soluble spin labels ESR previoustable Falcioni et al., 1982
Increased 16-NS ESR Structural alteration of the phospho­lipid organ­isation of DMD RBC membrane?
Laurent et al., 1980
Altered 16-NS ESR abnormallipiddemain?
Leterrier, Daveloose, Laurent, Fischer and Schapira, 198C
Normal C-12 ESR Measured at 7-5CPC on whole RBC
Branca, Gamba, Mastropado, Secra and Sulas, 1980
Normal 16-NS ESR Dellantonio et al., 1980
Table 4
Lipid fluidity at the hydrophobic region of DMD ghost
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In addition, Sarpel, Lubansky, Danon and Omachi (1981)
measured the lipid profile (especially PC) on whole RBC
31of DMD patient by P NMR, and found a normal lipid feature.
Conformation Probes Technique Remarks Refs.
Altered MAL-6 ESR Butterfield et al., 1976; 1977; 1980
Altered MAL—6 ESR Alteredmembranearchitect­ure?
Dellantonio et al., 1980
Normal maleimide nitroxide III ESR
Laurent et al., 1980
Normal MAL-6 ESR Measured at 7-50°C on vhole cell
Branca et al., 1980
Table 5 Protein Conformation of the DMD Ghost 
Footnotes of the Tables:
1(1.14) 2-(14-carboxytetradecyl)-2-ethyl-4,4-dimethy1-3-
oxazol-idinyloxyl 
5 NS 2-(3-carboxypropyl)-2-tridecyl-4,4-dimethyl-3-
oxazolindinyl-oxyl; (5 nitroxide stearic acid)
MAL 6 2,2,6,6-tetramethylpiperidin-oxyl-4-maleimide
16 NS 16-nitroxide stearic acid
C 12 4-hydroxy-2,2,6,6-tetramethylpiperidinooxyl
dodecane
Polarity was found to be increased by Statham, Dunn, 
Rice and Evans (1981) and Scarlato, Merla, Silani, Manfredi, 
Battiroli and Zanelk (1979) using a fluorescent probe.
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The lipid fluidity of the hydro pho bic region of 
DMD RBC seems to be altered since four reports indicated 
this using two different kinds of probes, and only two 
reports gave a negative result.
A change in lipid profile may influence membrane 
protein c o n f o rmation  and may be refl ected in the altered 
protein co nf o r m a t i o n  suggested by D e l l a n t o n i o  ej^ a 1 .
(1980) and Bu tterf ield aJ^. (1976; 1977 ; 1980).
Although the physical techniques mentioned above 
enable the observation of the intr amembrane ous m i c r o ­
environment, the limitations of these techniques can not 
be ignored. Many spi n- la bel reporter groups and f l u o r ­
escent molecules are rather bulky. When attached to 
normal membrane constituent s such as phospholipids or 
fatty acids, they may cause local perturbations of 
membrane structure. Thus the probe molecules may actually 
report the physical properties of an unnatural m i c r o ­
environment which they create themselves, rather than 
accurately indicating the physical properties of the 
membrane itself. This dis adv antag e can be minimized by 
the synthesis and ultili zation of spin-label or 
fluorescent probes which more closely res emb le native 
membrane constituents. The locati on of the probes may 
not be as designed, but depend on the depth of penetr ation 
and problems resulting from lateral phase separation. A 
change in flu ores ce nce intensity of probe molecul es may 
indicate an al te rat ion in its environment polarity, but 
it may also be due to static or dynamic quenching, 
absorption  effects, energy transfer and solvent
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im mo bilizat ion. Failure to consider such problems may 
lead to  erroneous co nclusions (Barchi, 1980). But even 
if some biophysical data is artefactual, when the c o n tr ol  
and DMD cells are treated identically a different result 
obtained between DMD and normal cells may still mean that 
there is an essential difference  in membra ne properties.
Although a normal phospholipid dist ribution is found 
in DMD RBC, a change in lipid packing, for example, a 
change in the as ymm e t r i c a l  dist ributi on  of the p h o s p h o ­
lipid, could influence the fluidity of the membrane which 
may be refle cte d in a change in d e f o r m a b i l i t y , ,osmotic 
fr agility and physical state of the RBC membrane. The 
re sults presented so far seem to favor a change in the 
physical state of the DMD RBC membrane.
1.4.4 Ion Transport and ATPases
Any change in the overall physical state of the 
mem bra ne may affect either passive or active ion t r a n s ­
port. All ion transport enzymes (pumps) are membrane- 
bound, and changes in their activities may reflect the 
a bn or mal ities occuring in the membrane.
1.4.4.1 Ion Transport
1. 4.4 .1.1 Ion Transport in RBC
Dise, Goodman, Lake, Ho dso n and Rasimusse n (1977) 
were able to dem onstrate an increase in efflux from 
RBC of DMD patients and proposed that this phenomenon 
might be due to increased sensitivity to Ca^^. Converse 
f ind ings were obtained by S z e n t i s t v a n y i , Oanka and Heiner 
(1980) who found a sig nificant reduc ti on in Ca^ ^-de pe ndent 
efflux and suggested these changes might be due to
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alt era tions in Ca^* ho meostasis and/or in the mec ha nism
of active and passive Ca^^ transport of intact red cells.
Mollman, Carden as and P l e a s u r e , (1979; 1980) prepared
inside-out v_gsicles and examined the mean and V^ax
(for Ca^^) of the Ca^^ transport protein (ATPase).
Results showed a significantly increased K and V inm  rn Q X
RBC of patients with DMD, i.e. a decreased affinity for
Ca^^ but transport of Ca^^ at a faster rate. They
suggested this might be due to an abnormal i nt er action
be tween the ion -transport activator and the transport
system rather than to a primary defect in transport
system itself. But a later report (Shoji, 1981) found
2 +no si gnificant  difference in Ca influx and efflux in 
DMD and control RBC.
2 +Be cause of the possible important role of Ca in 
activating the proteolytic enzymes, which may be the 
cause of the dege ne ration of muscle fibres, Ca^* has 
received much attention. Conflicting resu lts  concerning 
Ca^* tra nsport were presented, so some re sea r c h  workers
4- 4-examined Ca -ATPase rather than ion transport itself in 
RBC (see section 1.4.4.2.1).
1.4.4.1.2 Ion Transport in DMD Muscle
The kinetics of Ca^^ accumu lation by isolated 
sarcotubular vesicles was found to be impaired (Takagi, 
Schotland and Rowland, 1973; Wood, Sorenson, Eastwood, 
Charash and Reuben, 1978), as demonstr ated by a si gnifi cant 
decrease in the ability of isolated vesicle s to accum ul ate 
Ca^^. This conflicted with the finding of Peter (1969)
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2 +that the capaci ty of vesicles to accumul ate Ca , in
excess Ca^^, was normal.
2 +An increa se in Ca in DMD skeletal muscle was
found by Ca^^-st ainin g in DMD muscle biopsies (Bodensteiner
and Engel, 1978). They suggested that the Ca^^ was
intracellular , and might be due to alteration of me mbrane
permeability or structural defects in sarcolemma. An
increase in eos inophilic fibres (i.e. containing Ca^^)
was found in fet al DMD muscle (Emery and Burt, 1980), which
suggested that it was an early bioc hemical change in the
disorder. Since increased intracellular Ca^^ would
account for various biochemical and cli nical features
of the disease, it might be related to the primary defect.
The least conflicting and con tra dictory results
2 +discussed so far concern Ca ac cu mulat ion in muscle.
1.4.4.2 A T P a s e
1.4.4.2.1 (Na+K+)-ATPase in DMD RBC
(N a ^ K ^ )-ATPase (Na^-Pump) in erythrocytes has been 
extensively studied by many laboratories and con trov ersial
Hh 4.results obtained. The effect of ouabain on DMD (Na K )- 
ATPase has re ceived  much attention.
A change in the res ponse  of the enzyme to an 
inhibitor (or effector) may reflect a change in the shape 
of the alloste ric or active sites, i.e. a co nforma ti onal 
change. Since the lipid domain of the membrane is 
important in affecting the conf orm ation of membran e-
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bound enzymes, study of the response of the enzyme to 
its inhibitor may indicate abnormalities in the lipid 
d o m a i n .
Arrhenius  plots of membrane-bound enz ymes can 
demonstrate the lipid comp ositi on  and arran gemen t in 
the immediate vicinity of the enzyme, since in many 
cases discontinu ities in Arrhenius plots of mem brane-  
bound enzyme or transport functions reflect lateral 
phase separat ions and phase transitions occuring in the 
lipid en vironment  surrounding the protein.
The Arrhenius plot of the (Na^K^ )-ATPase of normal 
ghosts is biphasic and has a break at 21^C. The 
Arrhe niu s plot of DMD ghosts was found to be normal by 
Dunn, Burghes and Dubowi tz (1982) but abnormal (linear) 
by Austin, Kwok, Erickson, May and Geffrey (1979) and 
Austin, Kwok, May and Geffrey (1980), suggesting a more
fluid environment for the enzymes in DMD cells. |
1In normal RBC ghosts (N a ^ K ^ )-ATPase is inhibited |
by the cardiac glycoside , ouabain, which binds to the 
extracyto pl asmical ly  exposed protein of the pump. C o n ­
flicting results about the effect of ouabain on (Na^K^)~
ATPase of DMD ghosts have been presented and probably 
cons ti tute the most contr oversial experimental  finding s 
so far in r e l a t i o n  to the disease. These are summarized 
in the following Table (Table 6 ).
The co nflicti ng re sults for DMD ghost (Na^K^)- 
ATPase activity and its response to ouabain may be due 
to differences  in ghost preparation, the ion content and 
compositi on  of the buffer, time of incubation etc. Some
Basal Activity
— 4 0 “
Response of ATPase activity to 10~^ M ouabain
Remarks References
Decreased stimulated K influx, Na efflux %ere in­hibited iy oubain
Pearson, 1978
Decreased stimulated Stimulated in both low sodium and high sodium (optimal to the enzyme) system
Niebroj- Dobosz, 1976
stimulated Guidic, 1980; Brown, Chatt- opadhyay, 1967; Araki,MavHtari,
1971..
Either no in­hibition or stimulation
Galbraith, Watts, 1980
Normal inhibited but less sensitive
f^ewatari,
Shiro, Olarte, Schonberg, 1976.
stimulated or less sensitive also shown in normal RBC if incubated with DyiD serum prior to isolation of ghost or before assay. Peter et ,(1969) suggested seme factor(s) in DMD blood might be responsible. This might be an auto- allergic process ■ in vhich damaged muscle membranes induced an anti­body to membranes in general
Peter, Vforsfold> Pearson, 1969; SiddiQui, Pennington,1977; Lloyd, Emery, 1980
Basal Activity
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Response of ATPase activity to 10~4]yi 
ouabain
Remarks References
Normal inhibited Klassen, Blostein, 1969; Hodson, Pleasure, 1977; Wacholtz, Raible, Jackowski, Redan, Sha'afi, Rodan,
1979; Ruitenbeek, 1979; Souweine, Bernard, Lasne, Lachanat, 1978; Dunn, Burches, Dubowitz, 1982; 
Probstfield, Wang, From, 1972; .Mawatari, Igisu, Kuroivj.a, Miyoshino, 1981
Table 6 Activity of (Na K )-ATPase and its response to 
ouabain in DMD erythrocytes
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work ers  omitted EDTA from their assay to completely 
elimi nat e Ca^*, so that, the so-called (N a ^ K ^ )-ATPase 
activity included the activity of (Ca^^Mg^*) ATPase which 
is i n s e n s i t i v e  to the effect of ouabain. However, not 
all di screpanc ies in resu lts were due to obvious 
differences in procedure. Klassen and Blostei n (1969) 
f oll owed the same method as Brown et. (19&7) t o
measure the ( N a ^ K ^ )-ATPase activity and res ponse to 
ouabain, and obtained the opposite result to Brown, 
i.e. inhibition of DMD ATPase. Mawatari e 1^  (1981)
tried to solve this controversy by measuring the (Na^K^)- 
ATPase activity under different experimental conditions. 
They found the type of anticoagulants, extent of washing 
of the RBC, whether mechanical or osmotic d i s r uptio n of 
the cells was used, presence or absence of EDTA in the 
washing solution for the ghosts, inten tio nal removal 
of the peripheral proteins of the membranes, additi on of 
DMD plasma to the assay system and different tem pera tures  
of membrane storage caused no significant differences 
between  DMD and co nt rol in (Na^K^ )-ATPase or in respon se  
of the enzyme to ouabain.
If the abnormal activity of (N à ^ K ^ )-ATPase in DMD 
RBC exists, it might be due to a change in the lipid 
domain as proposed by Maw ate ri et. ÊA' (1976). PS might
be a suitable candidate  as Roelofsen and van  Deenen (1973) 
indicated the (N a ^ K ^ )-ATPase activity was strongly 
dependant on the presence of PS.
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1.4.4.2.2 (CaZ + _Mg^+)ATPase in DMD RBC
Dunn and Burghes (1980; 1981; 1982) d em on strated  
an increa se dactivi ty  of (Ca^^-Mg^^)ATPase in DMD and 
carriers RBC, which confirmed the results of Luthra,
Stern and Kim (1979). The and activation  energy
of this enzyme were also elevated. They suggested a 
change in the lipid domain may be responsible. Luthra 
et a l . (1979) indicated that this enzyme in DMD ghosts 
was stimulated by a cytoplasmic activator to  the same 
extent in patients and controls so that the diff erence 
was rela ted  to a difference in membrane str uctu re  in DMD 
ghosts rather than to alterations in the act ivator "1
protein. Another two reports also found inc reased 
activity of (Ca ^^-Mg^^)ATPase (Hodson and Pleasure, 1977; 
Ruitenbeek, 1979). Ru itenbeek (1978) proposed that 
calcium m e t a b o l i s m  in RBC of DMD might be impaired as a 
co nsequence. Also he found two affinity sites were 
present in DMD (Ca^^-Mg^^)ATPase while that of the controls a 
only had one affinity site. Unlike many other re ported
abn orm alities  in DMD RBC, Only one group has found a 
normal (Ca^^-M g^^)ATPas e activity (Tsuchiya, Siigita, 
Ishuira and Imahori, 1981).
A study of the lipid requirement of (Ca^^-Mg^^) 
ATPase  in human RBC by Roe lofsen and S c h a t z m a n n  (1977) 
sug gested that only the g l y c er op hospho li pids are involved 
in the ma intenance  of the (Ca^^-Mg^^)ATPase activity and 
in particular that fra ct ion of these phospholi pids 
located in the inner half of the membrane. An elevated
' -I,-,-, '• - ' ' ' ' . ' - 'V. •j.r’V- 1-44- ^
( C a ^ ^ - M g^^)A TP ase activity in DMD RBC may the refore be 
due to the changes in this lipid domain which ié 
normally co mposed  predominately of PS and PE with 
smaller amounts of PC and LPC.
Un li k e  the con flicting results relating to 
(Na K^)- AT Pase, increased activity of (Ca^^-M g^^)A TP ase 
has been c o n f irmed by four groups and only one group 
re por te d a normal activity. An abnormal lipid 
(probably PS and PE at the inner side of the bilayer) 
could explain the ge neralized abnormal activities of |
(Na^K^ )-ATPase and (Ca^^-Mg^^)ATPase. Further work is 4
needed to confirm this hypothesis, especially to 
clarify the activity of (Na^K^)-ATPase and its re spons e 
to ouabain.
1.4 .4.2.3 A T P ases  in DMD Muscle
Both (Na^K*)-ATPas e and (Ca^^-Mg^^)ATPase in 
muscle biopsies and isolated sarcoplasmic ret iculu m have 
been i nv es tigate d by several laboratories. The resu lts 
are su mmarized in the following Table. (Table 7).
Totally conflicting results concern ing ATPase 
activity in sarco lem ma, sarcoplasmic r e t icu lu m and 
muscle biopsies  have emerged making any firm c o n c lu sion 
impossible. The c o ntr ov ersial res ults might be due to 
the practic al d ifficul ti es of obtaining pure sarcole mma  
free of contaminat in g connect ive tissue and fat tissue 
which ex tensi vely in fil trates the DMD muscle. Also 
knowledge about mem brane- bo und enzymes in no rm al s a r c o ­
lemma is not as com pl ete as that in RBC. Further 
studies on the nature of normal sarcolemma may thus be
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ATPase Activity Site Remarks References
+ + (Na^ K )ATPase decreased sarcolemma suggested a sar- colentnal defect Dhalla, McNamara, Balaruleramanian, Greenlaw, Tucker, 1973
(NaV)ATPase decreased stiimilated by 10*" M ouabain
musclebiopsies suggested a change in activator/in­hibitor, or dis­organization of membrane structure probably a change in PS
Niebrej-Dobosz, 1981
(NaV)ATPase increased(ouabainsensitive)
musclebiopsies Sandhya, Das, 1982
ATPase
increased sarcolemma suggested a sarcolemmal defect Dhalla et al,, 1973
%2+)
ATPase
decreased musclebiopsies suggested the cell may be unable to maintain high extracellular/ intracellular Ca gradient, causing some inactivation of muscle fibre function
Niebroj-Dobosz, 1980
ATPases decreased sarcoplas­micreticulum
also found low initial rate, low total uptake of Ca2+
Samaha, Gergely, 1969
Table 7 Activity of ATPases in DMD muscle
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necessary before any concl us ion about DMD muscle can 
be drawn.
1.4.5 Me mbran e - R e l a t e d  Enzymes in DMD
As a major type of gene product, altered activities 
of an enzyme(s) may reflect the primary genetic defect 
in DMD as is the case for a large number of other i n ­
herited diseases. Although no abnormal a cc umulat io n of 
any substrate, intermed iate or end product has been 
found in the serum or urine of DMD patients, the primary 
defect may n ev erthele ss  be a met abolic one (example 
of enzyme deficienc ies are known where the substrate for 
the defective enzymes does not accumulate). Alt ernativel y 
t h e d e f e c t  may be manifest as an alteration in non-enzyme 
protein (e,g, receptor or str uctural protein), or ion 
content of the tissue.
Unders ta ndably  much effort in the field of DMD 
research has been directed to measuring enzyme activity, 
particularly of me mbrane-bou nd enzymes (including ATPases 
men tioned in the previous section),
1.4.5.1 Enzym e Changes in DMD RBC
The properties of the membrane lipid bilayer have 
received much attention due to its important role in 
the normal functioning of various mem bran e- bound enzymes. 
Many workers have proposed a change in the physical 
state of the lipid domain in DMD RBC, which has led to 
the study of enzymes involved in lipid met abolism.
Sherblom, McAllister, Macul and Howland (1980) 
studied the iji vitr o inco rp oration  of ^^C -ol eate into 
RBC membrane phospholipids. Results showed a diminished
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2 +in cor p o r a t i o n  and decreased Ca -sti mulation of fatty 
acid in cor p o r a t i o n  in RBC of patients with DMD compare d 
with control. However, Kunze e_t aJL^ . (1973) rep or ted 
that— the im v i t r o  influx of oleic acid and its
in cor po ra tion int o  PC and PE increased. M o o r e  and Appel
(1980) studied the m é t h y la ti on of PE to form  successively  
N - m o n o m e t h y l p h o s p h a t i d y 1 ethanolamine (PMME), N, N - D i m e t h y l -  
p h o s p h a t i d y l e t h a n o l a m i n e  (PDME) and PC but this was normal 
in RBC of DMD patients.
Iyer, K a t y a r e  and Howland (1976) d e m o n st ra ted an 
increased phosp ho lipase A activity in DMD RBC, whilst 
ph ospholip ase C is rep or ted to be 25% decre as ed (Austin, 
Kwok, Erickson, May and Geffrey, 1979). The activa ti on 
of long chain fatty acids by acyl-CoA synt hetase and 
carn iti ne pal mi t o y l t r a n s f e r a s e  activity in DMD RBC were 
una ltered (Ruitenbeek and Scholte, 1979). In their 
previous report in 1978, the same workers fou nd  palmitoleic 
acid (C^g.j) was decreas ed in tri glyc eride and d iglycer id e 
and so concluded that the change in pa lmitoleic  acid was 
not due to impa ir ment of the acti vation nor intra- 
mit och on drial transport of this fatty acid.
Lipid per oxi dation, known to be inv olved in memb ra ne 
damage in a large number of pathological states has 
also been proposed to underlie the membrane changes in 
DMD. Some enzymes re sp onsible for protection from lipid 
per oxi dati on  have been investigated but have gi ven  c o n ­
troversial results.  Burri, Chan, Berry and Y a r n e l l (1980)
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indicated a 19% dec re ase of RBC superoxide dismutase 
(SOD) activity in patients with DMD, but both plasma 
SOD and plasma and RBC glutat hi one peroxidase were 
found to be normal. Matkovics, L a sz lo  and Szab o _j(1 982 ) 
reported inc reas ed  activities in SOD, catalase and lipid 
per oxi dati on  in RBC of DMD patients. Hunter, Breski 
and de Vane (1981) and Hunter, Amin and de Vane (1983) 
showed normal acti vi ties of SOD catalase and g lutathi on e  
peroxidase in RBC of patients with DMD. Their study 
did show a sig ni fi cant decrease in glutathione reduct as e 
activity although it was thought that this would not 
lead to in cre ase d peroxid ation and membra ne damage.
Another study of unfrac tionated and age f r a c t i o n a t e d  no rmal 
and DMD RBC showed normal glut at hione  red u c t a s e  activity 
although this study included only two DMD patients 
(Galbraith and Watts, 1980). Adenylate cyclase, a 
membrane -bound enzyme was found to have decreased 
activity in DMD gh osts (Wacholtz, Raible, Gackowski,
Rodan and Sha^afi, 1979).
Relatively few studies of membrane related enzymes 
(particularly lip id- re lated) have been carried out and 
those that ha v e  been reported are largely controversial , 
once again, making firm conclusion s difficult, but
the report of Iyer ejb (1976) of an inc reased
phospholipas e A activity in DMD RBC is noteworthy since 
the product of pho spholi pa se A ( ly soph osphat ides ) are 
well-known to be membra ne disrupting agents.
J
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1.4.5.2 Enzyme Changes in DMD Muscle
Some abn orma li ties have been found in lipid b i o ­
synthesis i_n vitr o in DMD muscle. Kunze, 01th off and 
Bonsch (1971) showed def ective in cor poration of linoleic 
acid by DMD muscle , using ^ ^ C - l a b e l l i n g . They found 
decreased linoleic acid in cor p o r a t i o n  into SM , t r i g l y ­
ceride and PC, and also decreased incorporation of palmitic 
acid into S M . A later study (lonasescu, Monaco, Sandra, 
lonasescu, Bur meist er , D e p ross e and Stern, 1981) showed 
a significant increase of glycerol incorp or ation
into PC, PS and ph osphatidy linositol (PI) and t r i g l y ­
ceride in muscle biopsies and cultured muscle from DMD 
patients. As this inco rpo ratio n pattern was similar to 
fetal muscle, they suggested the lipid alte ra tion in 
dystrophic muscle might be related to a defect in 
ma tu ration and lead to triglyce ri de accumulation. The 
similarity be twe en  fetal and dystrophic muscle had 
previously been pointed out by Hughes (1972) on the basis
of lipid composition. Kunze and Olthoff (1969) studied 
32the in vitro P i n c o r p o r a t i o n  into phospholipid.
Results showed the specific activity of PC and LPC 
were especially increased. As PC was found to be d e c ­
reased in DMD muscle, Kunze and Olthoff (1969) supposed 
increased turnover of PC might occur in DMD muscle. In 
a later report (1972) by the same authors, the acyl ation  
of LPC with stearic acid (C^g.g), palmitic acid (C^^.^) 
and linoleic acid was reported to be normal.
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l.e. acyItran sf erases were normal in biopsied muscle.
The results of this work are highly doubtful however, 
beca use  they used two females and one male with different 
fo rms  of muscular dy st rophies for experiment.
Chalovich (1979) demonstr ated that muscl e of DMD 
patients was deficient in g l y c e r o l - 3-pho s p h o r y l c h o l i n e , 
and suggested this reflect ed changes in mem b r a n e  met a b o l i s m  
through its precursors PC and LPC. Iyer et a_l^ . (1976) 
observed an increase phos pho lipas e A activity in DMD RBC 
which implies possible accumulation of LPC. These 
pheno men a prompted Schiselfeld,  Barany , Danon, Abra ham 
and Klep s (1981) to invest iga te LPC acyl hy drolas e activity 
in DMD muscle. They found a normal ma ximal  activity 
but decreased  affinity (raised ) for LPC. Kunze, Rustow 
and Olthoff (1980) were able to show normal activities 
of CDP-choline: d i g l y c e r i de -p-ch ol ine transferase,
CDP -ch oline: ce ramide-p-ch  oline transf erase and of PC 
d eg ra dation  in DMD muscle. Berthillier (1982) showed 
incre ase d activities of palmitoyl carnitine tr an sferase 
and palmitoyl coenzyme A hyd ro lase but normal activity 
of palmitoyl coenzyme A synthetas e in DMD muscle. Kar 
and Pear son (1975) ind icated increased lipase activity 
(by 71%) in DMD muscles, and proposed the lipid a c c u m ­
ulation in DMD muscle might be due to a defect in muscle 
lipases. In DMD muscle mitochondria, specific acti vities 
of the matrix enzyme, pr opiony 1-CoA carboxylase, was 
found to be increased while palmitoyl-CoA synt hetase  
activity was unchanged (Scholte and Busch, 1980). From
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the decreased recovery of all outer membrane enzymesin 
the m i t o c h o n d r i a l  f r a c t i o n  they suggested an increased 
fr agi lity of the outer mit och ondrial membrane in DMD 
muscl e and proposed m i t o c h o n d r i a  were involved early in 
the disease process.
Although the r e p orts with respect to lipid m e t a b o l i s m  
are controvers ial, particul arl y concerning PC, on balanc e 
it is possible that the metabolism of PC might be altered.
As a major phospholi pi d component in DMD muscle, any 
alt er at ion in PC m e t a b o l i s m  may give rise to a profound 
e f f e c t .
An increased level of lipid peroxidation in d ystroph ic  
muscle in which the ly so s m a l  membrane is disrupted by 
the lipid peroxides, caus ing  release of the hydr olytic 
enzymes into t h e c y t o p l a s m  which leads to muscle damage 
has been proposed (Kar and Pearson, 1979). They found 
the level of th i obar bit ur ic acid-reactive products and 
the specific a c t i vities of catalase and g lutathi on e 
re ductase were s i gni fi cantly higher, while SOD activity 
was normal in DMD muscle. The increases in the lipid p e r ­
o xi da tion-p ro tective  enzymes (catalase and g lutath io ne 
reductase) may refl ect a response to.the increased lipid 
peroxid at ion in muscle.
Other workers have .-studied various prot einases and 
other hyd ro la ses and their possible role in sa rc o l e m m a l  
disruption (muscle degeneration). Necrosis of muscle 
fibres in DMD was found to be due to an increased rate of 
proteolysis whilst p r o tei n synthesis was not impaired
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(Kar and Pearson, 1976; 1978; 1980). They demo nstrate d
increased activities of lysosomal cath epsins (most of
them probably originating from the proliferating c o n n ectiv e
t i s s u e ^  fat cells and macrophage s), other lysosomal acid
2 +hydrolases, neutral proteinase, a Ca -activated ne utr al
proteinase, a chym otryp sin like esterase, alkaline
proteinase (for which myoglobin was substrate) and
dipeptidyl peptidase IV (probably micros omal)  in muscular
dystrophies, including DMD. They suggested that these
phenomena were a nonspecific feature of degenerating
muscle and usually parallel with the severity of muscle
2 +damage. Also they emphasized the important role of Ca 
activated proteinase in muscle breakdown, implying a 
membrane defect in Ca^^ transport. In their later work 
(1982 ), they found a thiol proteinase in muscle h o m o g e n a t e s  
from muscular dystrophies which was significantly increased 
and proposed it also might be involved in the muscle 
wasting process.
To summarise, then, there have been many rep orts 
of increased catabolic-, enzyme act ivi ties (lipase, 
proteinase) in DMD muscle. Increased  activities of the 
membrane lipid peroxidation protecting enzymes (catalase, 
glut at hione red uctase)  may reflect the increased lipid 
peroxidatio n in the muscle membrane, which may also lead 
to membrane damage. The results may explain the process 
of muscle degeneration, but say little about the u n d e r ­
lying primary defect.
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Little agreement about the activities of membrane- 
bound enzymes is found in DMD RBC and muscle, but repo rts 
of increased lipase activity in both DMD RBC and muscle 
are noteworthy. Any change in membrane bo un d^e nzyme 
activity may be due to a common defect, for example, a 
change in their lipid domain in their immediate vicinity. 
If the membrane d e g e n er ation of DMD muscle is due to (or 
at least, in part) the increased activity of lipases, it 
is interesting that no gross membrane dege neratio n occurs 
in DMD RBC.
1.4.6 Findings in Tissues Other Than Musc le Biopsies and 
RBC
1.4. 6,1 L ympho cy te Capping
Normally, membran e proteins (such as I g - r ec eptors  ) 
are uniformly dispersed across the lym pho cy te surface 
and are anchored by microtubules. In r e s po ns e to ce rt ain 
stimuli, (e.g. drugs, temperature) the proteins will move 
from the dis persed state through various stages of 
a gg reg ati ons (clusters) to an asymmetric dis tribution of 
larger agg regat es (patches) and finally into a large 
single aggregate (cap) sitting on the cell surface. This 
process may be observed microsco pically after labelling 
cell surface antigens (which are spanning proteins) with 
fl uor es cence antibodies. This capping technique  permits 
one to observe the la te ral mobility of integral membrane 
protein in the plane of the cell surface. Ca^* and the 
mem bra ne associated con tr ac tile elements, (the m i c r o ­
fi laments and the anchoring mic rotubules) may influence
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the specific cell membrane protein to mi gra te to one pole 
of the cell, forming the cap. It may be assumed that a 
large number of factors can bring about surface Ig-receptor 
antibody mo bilit y changes, including abn or malitie s in 
mem br ane conform ation and composition, and in the 
availability of energy in the for m  of ATP. Thus, 
me asu rement of membrane protein mobility appears to be a 
sensitive indicator of a multitude of possib le i n t r a ­
cellular and associated cell surface changes (Pickard, 
Grauemer, Verrill, Isaacs, Robinson, Nance, Myers and 
Goldsmith, 1978).
Pickard et. Ë_L* (1978) incubated lymphocytes with 
f lu or e s c e i n - l a b e l l e d  polyvalent ant i-h uman immunoglobulin 
and found diminished cap formation in B and T lymphocytes 
from both patient and carriers. The diff erence s are 
i n d is tingu is ha ble between patients and carriers. Similar 
results were obtained by Verrill and Pickard (1977);
Ncrdal, Ande rson and Diet richson  (1982) and Ho, Reitter, 
Stojakowits, Fiekn and Weisser (1980).
However no abn ormality in l ym ph ocyte capping was 
found by Fit zsimmons, McL a c h l a n  and Reever (1980);
Stern, K a h a n , anid Dubowitz (1979) and H a u s e r ,  Weiner,
Ault and Unanne (1979), Stern et. âi* (1979) explained 
the dis crepancy in result in term of the difficulty in 
evaluat ion  of ly mp hoc yte capping. No further reports 
have been forth coming to solve this cont rover sy. T h e r e ­
fore, at present, lymphocyte capping is not the reliable 
carrier de tection technique as it was first proposed.
'S
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1.4.6.2 M u sc le  Tissue Culture in DMD
A later onset of growth of DMD muscle in tissue 
culture has been observed in some la boratories (Kakulas, 
1968; Bateson, Hindle amd Warren, 1972 ; Morgan, Coh en  
and Cohen, 1973). But O ’Steen (1963) and Thomp so n (1977 ) 
found no abno rmali ty  in the growth c h a r a c te ristics  of 
DMD muscle tissue culture. The size of the myo tu bu les  
was de mon s t r a t e d  to be larger by Geiger and Garvin (1957) 
and Kakulas (1973) while O'Steen (1963) indicated 
shorter and wider myo tub ules in his DMD muscle tissue 
culture. Numb ers  of nuclei in the myot ubule s in the 
cultured DMD muscles were found to be increased (Geiger 
and Garvin, 1957) whereas another report (Morgan e ^  a 1 . 
1973) showed a decrease. Both Morgan ej^ a_l. (1973) and 
Vassilop oui o s , Emery and Gordon (1977) showed larger 
nuclei in the DMD cultured muscle.
An incre ased cell stickness was dem onstrated  by 
Y a sin (1979). She found an increased number of nuclear 
overlaps beca use the cells stick on top of one another 
to form cell cluster s and proposed a number of mo lecule s  
might be impl ic ated in cell-cell interactions, cell- 
substrac ti ons in teractio n and c y t o s k e l e t o n - m e m b r a n e  
interactions. These s urf *ace-ass oc iat ed elements include 
collagen, fibronecti n,  g l y c o s a m i n o g l y c a n s , lectins, 
desmin and g a n g l i o s i d e s . But E c o b - 3 ohnston and Brown
(1981) found a normal membrane surface adherence in 
cultured DMD muscle while the DMD cells, like normal
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culture did not form multilayer ed  clusters. Al s o  
Mawatari, Mi randa and Rowland (1976) and lonas escu 
(1976; 1979) showed no morpho lo gical differenc e in their 
DMD cultured muscle cells when compared to control.
Few abnorma litie s of growth or cytology of DMD 
muscle in culture have been reported, therefore, and 
those which have are either unconfirmed observations 
from  a single laboratory or are the subject of contrary 
reports by other workers.
1 . 4 . 6 .3 Cultured Skin Fib robla st s in DMD
DMD cultured skin fibr obl asts are rep orted to 
exhibit increased doubling time and a tendancy to be 
more vo lu min ous cells (Liechti^gallati, Moser, Siegrist, 
Wi e sma nn  and H e r s c h k o w i t z , 1981) whereas Pena, Vust, 
Tucker, H ament on and Wrogemann ( 1978) found normal growth 
c h arac te ristics  and via lll ity.
Other workers have studied membrane surface c h a r ­
acte ris tics of the cultured DMD fibroblasts. 0 ones 
and Wit kowski (1979) found no gross difference in cell 
surface morphology. In a later report (1981) they 
suggested there might be an alterati on in the surface of 
dystrophic cells by studying the agg regation of the 
cultured fi br oblasts in a Couette viscometer. They found 
the cells have a low inter cellular adhesiveness and fo rmed 
small numbers of very large aggregates which were absent 
in normal cells. Observed under the el ec tron micr os cope 
the DMD cultured fibr oblas ts  revealed the presence of 
abundant lamellar bodies, a mor phologic abnormality
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commonly a s s o ci ated with impaired lysosomal fu nc tion  
(Gelman, Davis, Mor ris and Gruenstein, 1981). One might 
expect the abnormal surface characters of the DMD 
"cultured f i b r o b l a s t s  to reflect some abnormality in their 
membrane pro teins and/or lipids. Newman (1982) indicated 
a normally fun ctionin g cyto ske leton by staining with 
concanavalin A. Pena ejb (1978) demonstr ate d a
normal d i s t r i b u t i o n  of subcellular fractions and normal 
major protein components. A recent study (Burghes,
Dunn, Statham and Dubowitz, 1982 ) of DMD cultured skin 
fibroblasts prot ein by SDS-gel el ectrophor esis showed 
the regions of 7 3 , 0 0 0 - 6 8 , 0 0 0  and 48,000 MW were dec reased 
while those of 1 7 5,000 and 53,000 MW were sig nificantly 
e l e v a t e d ,
No abnorma li ty was found in the phospholipid profiles
and fatty acid co mp o s i t i o n  of DMD cultured f i b r ob la sts
of either young or old cultures  ( K o h l s c h u t t e r , Weismann,
Herschk ow itz and Ferber, 1976). But Rounds, Gepson,
McAllister and Howl and (1980) found that the c o n c a n a v a l i n - A
32induced increase in P i nco rp oration  into phosphatidic 
acid (PA) and decreased label in PI was sig nificantly 
greater in DMD skin fibroblasts. They suggested there 
was a dimini shed rate of PI res yn thesis from PA. But 
the activit ies of the two transfer ases involved were 
found to be normal, so they proposed that there might be 
a deficiency in ac y l a t i o n  of PA to give PI.
Willers (1982) showed a normal 5 '-nucleotidase 
activity in DMD culture d skin fibroblasts. But
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Liec hti gallati  ejt (1981) indicated an elevated 5 ’-
nucleotidase activity, and together with an increased 
doubling time in,DMD cul tu red fibroblasts, they suggested 
the DMD cells behaved similarly to prematurely aging cells. 
Adenylate cyclase activity was not different from control 
in DMD cultured fibro bl asts (Cerric, 1982). An al teration 
in the properties of the lysosomal membra ne in DMD cultu re d 
fibrob las ts was proposed by Gelman, Davis, Morris and 
Gruenstein (1981). Trea tment of lysosomes with the 
nonionic detergent Tr ito n X-100 causes an activ ation of 
a membra ne-bound ly sos oma l enzyme dipeptidyl amino- 
peptidase-1. This acti vat ion was markedly diminished in 
cultured DMD fibrob lasts. Ca^^ transport in cultured 
DMD fibroblast s was studied by Statham and Dubowitz (1979). 
They found no dif fere nc e in calcium exchange studied by 
^^Ca and a normal in cr ea se of Ca^^ exchange induced by 
calcium ionophore A 23187.
Although rel at ivel y little work has been done on 
cultured skin fibr oblas ts , so that most of the reported 
abn ormalities have not been tested in other laborator ies 
yet, a membrane defect appears possible, especially in 
view of the observations on adhesiveness. It would 
seem timely to inve st igate all surface glycopr ot eins and 
glyc oli pids in more detail.
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1.5 Aim of This Work
Much evidence, although some contro ver sial 
suggests that the primary defect of DMD is a systemic 
membrane abn ormality which is manifest in other tissues 
as well as muscle. A defect in lipid • or ganization or 
me tabol is m seems^ a pos si ble and attractive unifying 
e x p l an at ion of the observed abnormal mem br ane and 
m e m b r a n e - a s s o c i a t e d  properties. As several reports have 
already shown that membran e lipid c om po sition  is normal 
in the disease, the aim of this inve st igation  was to 
examine the possi bility of a perturbed me mb ra ne lipid 
asymmetry in the bilayer in RBC from patients with DMD, 
using p h ospholi pa se A^ from bee venom to hyd ro lyze the 
outer layer lipids in intact RBC.
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2. MATER IAL S AND METHODS
2 .1 Ge ner a 1
Glassware
Prior to use, all glassware (including Pasteur 
pipettes, TLC tanks) were soaked overnight in 5% Dec on 
90 (Decon Labo rat ories , Brighton, England). Decon  90 
is a p h osphate -f ree detergent which is important since most 
laboratory detergents contain high levels of phosphate and 
can lead to co nta m i n a t i o n  of the phosphorus assay.
S ojvents
All organic solvents (except glacial acetic acid) 
were red is tilled  and contained the ant ioxidant 2 ,6 -ditert- 
buty 1 -p-cre.s ol (butylated hydr oxy t oluene , BHT, Sigma) 
50mg/L. BHT does not interfere with the chr omatog ra phy or 
subsequent analysis (Christie, 1976).
Other Che micals
Glacial acid A.R. and disodium EDTA were f rom May 
and Baker. 72% perchloric acid (Anala R), am mo nium moly- 
bdate and Tris were from B D H . Authentic standards PC, LPC, 
PE, LPE, PS, EPS and SM were from Sigma. L y o p hilis ed  bee 
venom (Apis mellifera) phospholipase A^ (EC 3.1.1.4) was 
from Sigma and was made up in 50% glycero l to 200 units/ml 
and stored at -20^C (solution does not freeze, and reta ins  
activity for 1-2 years). (Roelofsen and Zwaal, 1977).
The enzyme was stated (by Sigma) to have a minute amount
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of prot einase activity, and gave a single band on SDS-  
PAGE but was not purified prior to use.
TLC Plates
20 X 20 cm precoated with 0.25 mm thi ck Silica gel 
60 were from Merck.
The Patients
All the patients are definite DMD according to 
their family history, CPK test, muscle histology and 
e l e c t r o cardi og ram. The p a t i e n t s ’ ages ranged from 14-22 
whilst those of controls ( 2F , 8M ) were 20-42.
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2.2 I s o l atio n of Wa shed Whole Erythrocytes
10 ml of blood was drawn from a precubital vein 
into a 10 ml h e p a r i n - p r e c  oated tube. The contents were 
mixed by gentle shaking. The blood was cen trifuged at 
1500 X g for 10 mins and the plasma aspirated off. The 
packed RBC were t r a n s ferred  to 30 ml Q and Q tubes and 
resuspended in an equal volume of buffered isotonic 
saline (0.87% NaCl, 0.25 mM C a C l ^ > 0.25 mM MgClg, adjusted 
to pH 7,4 with 0.05 M Tris). The cells were cent rifuged 
at 1500 X g for 15 mins and the buff y coat (white cells 
and platelet aggregates) removed along with the top 2 mm 
of red cells (consisting of damaged erythrocytes). The 
packed red cells were washed twice more with fresh 
aliquots of the same buffer. 10 ml of blood produced 
about 3.5 ml of washed packed RBCs.
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2 . 3 I s o l a t i o n  of Ghosts
The method was modified from Dodge, Mitchell and 
Hanahan (1963) with extending the haemolytic time from 
10 mins to 50 mins. Red cells were washed twice with 
isotonic phosphate buffer (pH 7.4, 0.103 M Na^HPO^,
0.155 M NaHgPO^) in order to minimize the amount of Ca^^ 
which will promote the endogenous breakdown of p h o s p h o ­
lipids. The procedure is shown in the following figure.
Ghost Prep a r a t i o n
3ml washed packed RBC 
su spended in 54 ml cold 
isotonic phosphate 
buffer
stood at 4^0 for 30 mins 1tra ns fe rred to 30 ml Q & Q tubes 
c en tr ifuged  for 15 mins at 1500 x g
I *--- 1supernatant packed cells
(discarded )
transferred with washing 
to  a beaker with total 
54 ml hypotonic phosphate 
buffer (isotonic,phosphate 
buffer diluted 2/:29 with 
distilled water, adjusted 
to pH 7.4)!
Haemolyzep  at 4°C for 50 mins 
with stirring
transferred to 10 ml propylene 
tubesi
centrifuged for 40 mins at 50,000 
X g
4-------------  &supernatant residue
( d i s c a r d e d )
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1
washed twice with 
fresh aliquots of 
hypotonic buffer
1
gh ostsIstored at -70°C
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2.4 Treatment of Intact RBC with Phospho lipase
The method was modified from Roelofsen and Zwaal 
(1977). Cells were treated with the enzyme within 2 
hrs of sampling to minimize haemolysis and other possible 
changes in membrane organization known to occur with 
storage. In order to optimize the condition to obtain 
ma ximal deg radati on  of the phospholipids at the outer 
layer of RBC accompanied by min imal haemolysis several 
va riation s in proce dure were investigated.
1 . Amount of enzyme added.
5U, lOU, 1 5 U  and 20 U o f  the enzyme were added per 
0.2 ml packed cell.
2 . Length of i nc ub ation time
The cells were incubated with enzyme for 1 hr,
1.25 h r s ,  1.5 h r s ,  2 h r s  and 2.5 h r s at 37°C on a 
r o l l e r “S h a k e r .
3. C o n c e n t r a t i o n  of Ca^^ and EDTA
Both 10 mM CaClg and 0.25 mM CaCl^ were used in 
the inc ub at ion and washing buffers. EDTA Na^ (in the 
isotonic saline) was added to stop the e n z y m e “i n c ub ât ion 
at fina l c o nc en tratio ns  of 8.33 mM and 16.6 mM .
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Flnal Procedure
0.2 ml packed RBC 1mixed with 5 ml isotonic saline 
(with 0.25 mM CaCl )1
^incubated with 2 Ou enzyme at 
37 C on roller- sh aker for 2 hrsIEDTA Na^ added (final conc. 16.6 mM )
c e n t ri fu ged for 15 mins 
at 1500 X g
4----- 1su pernata nt packed cells1 Icheck haem olysis % lipid extra ction
(see 2 .6 )I
0.1 ml su perna tanti
diluted with 5 ml 
dis tilled water
1read O.D.Zfie nm against 
a distilled water bla nk
A cont rol with no enzyme added was incubated for 
the same time to determine the extent of any endogene ous
pho sphol ip as e act ivity. 1 0 0 % haemolysis was determine d
by suspending 0.2 ml packed cells in 5 ml disti lled water. |
The O.D.^^g nm of the supernatant from this second 
control was defined as 100% haemolysis. Progress of 
h ae mo lysis with time was also examined by incubating 0.2 ml 
packed R B C  in 5 ml saline with 2 0 Û  enzyme. 1 ml extrac ts 
were taken every 15 mins to determine haemolysis.
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2 .5 Treatment of Ghosts with Ph os ph oli pase
The method of Ro e l o f s e n  and Zwaal (1977) was m o d ­
ified. The ghosts (derived from 0.2 ml of packed RBC) 
were suspended in 5 ml of Tris buffer (0.1 M Tris,
0.25 mM CaCl^, 0.25 mM MgCl^, adjusted to pH 7.4) and 
incubated with 2 0 U of ph osph olipase A^ at 37^C for 2 hrs 
on a ro lle r-s haker. At the end of incubatio n 100 mM 
EDTA Na^ (final conce n t r a t i o n  16.6 mM ) was added to stop 
the enzymatic activity. The suspension was centrifuged 
for 40 mins at 50,000 x g . The supernatant was removed 
and the pellet subjected to lipid extraction (2 .6 ).
A control (without enzyme) was treated identically. 
As SM is not the substrate of the enzyme, it is used as 
an internal standard. SM% and degradat ion % are c a l ­
culated by the following formula;
SM % = (amounts of PC or PE)/amount of SM x 100
SM% of PC (or PE) of contr ol sample -
n ^ ^ 4-' 5M% of PC (or PE) of enz yme-treat edDegradation^ = sample ^
SM% of PC (or PE) of control sample
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2.6 Lipid E x t r acti on
Five methods of lipid extrac tion were tested for 
their efficiency.
1. Hexane :Isopr opanol 3:2 (v/v) _=
(Hara and Radin, 1978)
1 vol. packed RBC (or ghost from 1 vol. 
of packed RBC)1
3 vol. isopropanol1
ho mogeni zed in an M SE -topdr iv e 
homogenizer for 3 x 30 secs1
2 vol. hexane1
Stood for 10-20 mins with 
occasional stirring1
cent ri fuged at 150 0 x g for 
15 mins at 4^C
 ^
residue
r eex tracted  twice with 
5 vol. of h exan e/ Iso- 
propanol(3 :2  (v/v)) 10 
mins, shaking each time1centrifuged at 1500 x g for 
15 mins at 4^C
1
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i
residue 
( d i s c a r d e d )
combined supernatants
shaken with 6 vol. 
of 6 .6% N a ^SO for 
2 mins1
c en tr ifuged at 1500  x g for 
10 minsiupper organic 
layer
lower aqueous layer
washed twice with an equal 
vol. of hexane/ i s o p r o p a n o l 
7:2 (v/v)Icentrifuged at 1500 x g for 10 
mins at 4°C /
combined upper layersit ra ns fer red to 50 ml 
round bottomed flask
red uce d to dryness on 
a rotary evaporator at 
37°C under vacumI
dried r e s idu ei
'-J.'
-70-;r e d i ssolv ed  in 
c h l o r o f o r m / m e t h a n o l  1:1 (v/v)1
t ra ns ferred  quantitatively 
to a small vial1reduced to dryness on a heating 
blo ck under a stream of1r ed i s s o l v e d  in chloroform/ 
me t han ol  1:1 (v/v) to give a 
c o n c e n t r a t i o n  of lipid equivalent 
to 1 ml packed cell in 0.1 fnlI
1
2.5 ml distilled water1
stood for 10 mins to 
complete hae molysis
stored at -20°C for a maximum 
of 2 4 hrs prior to c h r o m a t o ­
graphy
2. C hlo ro form/me th anol 1:1 (v/v)
(Zwaal and Roelofsen, 1977)
0.25 ml packed cells was added to 5 ml of methanol i| 
and stirred for 5 mins. Then 5 ml of chl or of orm was 
added and stirred for another 5 minutes. The sus pe nsion  
was centrifuged, at 1500  x g and the ex tractio n repeated 
once more. The combined lipid extracts were co nce ntr ated 
as descr ibed above,
3. Chlo roform /m ethanol  1:1 (v/v) and 2:1 (v/v)
(Broekhuyse, 1969)
2.5 ml packed cells (or ghosts 
frtom 2.5 ml-packed dell)
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1
20 ml methanol
shaken 10 mins
20 ml chloroform1
stirred 15 minsI
c en tr ifuged  at 1500 x g 
for 10 mins
supernatant
c ombined 
supernatants12 0 ml c hlo ro form and 
20 ml 0.1 M KCl1centrifug ed
 i____
lower 
ch 1 or of orm 
phase
 1upper
ague ous 
layerI
c oncentrated 
as des cribed 
above
!
residueIre- ex tracted  with 
13 ml methanol and 
26 ml c hlor of orm
centrifug ed
dis carded
1re sidue1dis carded
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4. Method 3 but haemolys is omitted.
*5. Method 4 but KCl washing omitted.
* Method 5 was finally adopted as giving the best 
re cov ery of all phospholipids.
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2 .7 2-D TLC of Ph ospholipids
TLC plates (precoated with silica gel 60H, 20 x 20 
cm, 0.25 mm thick) were used. Prior to applying sample, 
the plate was activated in a 112°C oven for 1 hr. After 
the plate had cooled, the samples were applied with a 
mic ros yringe (Terumo grad ua ted 10 pi, or Behring 20 pi 
dispenser) on to a small spot of rhodamine solution 
(0.00 12% in c h l o r o f o rm/me th anol 1:1 (v/v)) in the b o tt om  
right hand corner of the plate, 1" from edges of silica.
This spot served to  pinpoint the origin for accurate 
loading of the samples. During development of the plate 
rhod ami ne also helped to locate the solvent front as it 
will run faster than all the lipids in both dimensions.
The plates were devel ope d in two-dimen sions in 
three solvent systems in an attempt to optimize r e s o l u t i o n  
of the polar lipids.
All solvent ratios  are v/v:-
1. Adapted from Roelofs en  and Zwaal (1979) by Hunter 
(personal communi ca tion)
First dimension:
c hl o r o f o r m / m e t h a n o l / a m m o n i a  (25% w/v)/water, 
80/44/5.5/5.5 
Second dimension:
c h l o r o f o r m / m e t h a n o l / g l a c i a l  acetic acid/water I
100/54/12/2
Brophy (personal co mm u n i c a t i o n )
First dimension: 1
c h l o r o f o r m / m e t h a n o l / a m m o n i a  (35% w / v ) / H 20 
29 0/174 /12 .7/25
M
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Second dimension:
c h l o r o f o r m / m e t h a n o l / a c e t o n e / g l a c i a l  acetic a c l d / H 20 
4 0 0 / 1 3 0 / 1 5 0 / 1 2 0 / 8 0  
*3. Adapted fro m 1.
First dimension: 1.
Second dimension:
c h l o r o f o r m / m e t h a n o l / g l a c i a l  acetic acid 
50/27/12
* This solvent pair was finally adopted for the 
majority of the work.
Solvent mixtures were prepared daily to avoid 
possible chemi c a l  interacti on s between com pon ents and 
losses by evap orati on. Tanks were washed with solvent 
and the sides of the tank lined with a 20 cm high strip of 
Wh atman 3 MM paper, soaked with and dipping into the 
solvent to ensure a sat urated atmosphere. The tanks were 
sealed by a strip of 2 inch wide parcel tape around the 
rim and were allowed to satura te for at least 1 hr at 
4°C before the TLC plates were inserted.
Duplicate TLC plates were developed at the same 
time. The solvent front; was allowed to run withi n 1 cm 
(approximately) of the top of the plates. Devel opment 
times (approximately) for system 3 were 2 hrs (1st 
dimension) and 3 hrs (2nd dimension).
Betw een  runs in the different systems, plates were 
dried under a warm  hair-dr yer  for about 15 mins. This 
step is critic al for good separation. It is important 
that almost all traces of the first dimension solvents 
are removed.
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2 ,8 D e t ec ti on of Lipid Components
After developing the second dimension, plates 
were dried under a warm hair-dryer for about 20 mins.
Three kinds of detection agents were tried;
1. Charring agent
The dried plates were sprayed with charring reagent 
(1.2 g Kg Cr gOy in 200 ml 55% H^SO^ (Kates, 1978) and 
heated for 20 mins at 180^C in a for ce d - d r a u g h t  oven to 
char the organic matter. The phospholipids should appear 
as black spots on a white background,
2. Rh odamine 6G
The dried plate was sprayed with aqueous Rhodamine 
solution (0 .0 0 1 2 %) and examined wet under ult raviolet light 
(366 nm). Acidic phospholipids e.g. PS and LPS will give 
a purple colour, PC, PE and SM will appear as yellow  spots 
while other neutral lipids appear pink.
3. Io din e Vapor
The dried plates were inserted into an iodine c o n ­
taining tank. The tank was gently warmed with a h a i r ­
dryer to  hasten s ub blimat io n of the I^ . The phospholipids 
appear as brown-y ellowis h spots on a pa le-yellow  b a c k ­
ground. For reasons gi ven later this method was adopted 
for ro ut ine detection.
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2 . 9 Q u a n t i t a t i v e  Ana lysis of Phosp holipids ( R o u s e r , 
1 9 6 9 )
2.9.1 Standa rd Phospho rus Curve
N a ^HPO ^ solution (Stock, 5 yg pho sphorus/ml) was 
used to prepare the standard curve. A p p r o p r i a t e  volumes 
of solution were added to tubes containing 0.9 ml 72% 
pe rchloric  acid and the total volume was made up to
2.9 ml with dis tilled water. To each, 5 ml of distilled 
water was added, followed by 1 ml 2.5% ammonium moly bdate 
and 1 ml 1% ascorbic acid (freshly prepared). The test 
tubes, with marbles over the mouth to prevent evaporation, 
were he ated in a boiling water bath for 5 minutes. A 
rea gent bank was heated at the same time. The O.D.Q20 
was read after the tubes had cooled to room temperature. 
The c a l i b r a t i o n  series were done in duplicate. A plot 
of O.D.g^Q against yg of phosphorus was linear up to 
10 yg phosp hor us.
2.9.2 D i g e s t i o n  of Phospholipids
The optimum time of digestion of au the ntic p h o s ­
phol ipi ds (in the presence of and silica) to  ensure 
com pl ete re le ase of organic phosphorus was determined. 
A ut he ntic st andards of PS containing ide ntical amounts 
(about 5 yg) of phosphorus were spotted onto a TLC plate. 
The spots were detected by iodine vapor (without running 
c h r om at ography ),  scraped onto a piece of clean filter 
paper and tr an sferred to a 30 ml Kjelda hl tube con taining 
0.9 ml 72% per ch lo ric acid. The mixture was digested
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under gentle reflux  in an elect ri cally-heated  Kjeldahl 
rack within a fume cupboard. Vigorous boiling was 
avoided to prevent loss of perchloric acid and boiling 
off of any phosphoric acid formed. Digest ion was c o n ­
tinued for 10 mins, 20 mins, 30 mins, 40 mins and 
50 mins. At these times tubes were removed, cooled in 
air for 15 mins and the walls of the tubes rinsed down 
with 5 ml distilled
1 ml 2.5% ammonium  molybdate, 1 ml 10% ascorbic 
acid and 2 ml distilled water were added as described 
befo re and the contents transfe rred to 10 ml ce nt rif uge 
tubes. After heating in a boiling water bath for 5 mins, 
the tubes were centrifu ged at 1500 x g for 10 minutes to 
p rec ipitate  the silica particles. The O.D.q^q the
super nat ant was determi ned  after cooling. A curve of the 
rec ov ery of PS against digestion time was plotted (graph 
showed in result section) and showed that a digestion 
time of 30 mins gave the highest recovery of PS.
2.9.3 Phos phorus De ter m i n a t i o n  of Ind ividu al Phosphol ipid 
Classes
After the ph ospholipids  spots were located by the 
de tection reag ent (in duplicate), each ind iv idual spot 
was scraped onto a piece of clean filter paper and 
di gesti on  perform ed as described in 2.9.2. A blank spot 
of the same size as the individual pho spholipid spots 
was also scraped off to determine the ba ck gro und phosphorus 
co ntent of the plates. A standard was always included 
in an estima ti on to com pensate for daily va riation s in 
re agents, conditions, etc.
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2.9.4 Recovery of Phosp horus from TLC Plates
Al i q u o t s  of authentic SM standard containing about 
5 yg of phosphorus were placed inside the 30 ml Kjelda hl  
tube and evaporate d to dryness. The contents were 
digested for 30 mins with 72% perchloric acid and 
ph osphorus determined as described above. This served 
as a c o n t r o l  to indicate the total phosphorus in the 
sample. The same amounts of SM were spotted onto a TLC 
plate and separated by 2 -dimensional chromatogr aphy, 
stained and scraped off. Digest io n and phosphorus d e t ­
e r m i na ti on were performed as described before. The 
phosphorus re covered  after TLC was expressed as a p e r ­
centage of the total SM loaded.
- 7 9 -
2.10 I n c u bati on  of Normal RBC with DMD Plasma
Lloyd and Emery (1981) incubated normal e r y t h r o c y t e 
ghosts in Duchen ne  plasma, determined the (Na^, K^ ) A T P a s e  
activity and fou nd an increased enzyme activity on 
subsequent exposure to ouabain i.e. normal cells could |
be made ”Du ch enne-like"  by incubate with Duchenne plasma. j
They suggested there might be a circulating plasma factor I
in DMD r es po nsible for the abnormal response to ouabain. |
In order to inve s t i g a t e  the possible existence of a |
'circulating plasma factor' which may influence the lipid ^
ibilayer organization of the normal RBC incu batio n of |
normal RBC with DMD plasma was done. j
1.5 ml of normal packed cells were mixed with J
0.75 ml of plasma fro m patients with DMD and then 
incubated for 2 hrs at 37^C. At the end of incubation, 
30 ml of isoton ic saline were added. The supernatant 
was removed by suction after centrifugation for 15 mins 
at 1500 X g . P h o s p ho li pase A^ digestion of whole cells 
(plus an approp ri ate control) and analysis of p h o s p h o ­
lipids was then carried out as before.
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3 . RESULTS AND DISCUSSION
3 .1 Lipid Ex t r a c t i o n  Methods
Five methods of lipid extraction were compared for 
their efficiency in extracting phospholipid classes fro m  
whole ery throcytes. The results are shown in Table 8 .
A typical thin-layer c hr om atogra m of total red cell lipid 
extracted by method II is shown in Fig. 1,
Membrane lipid ex tr act ion is usually acc omplis he d 
by the use of a mixture of a relatively non-polar solvent, 
such as chlorof orm which will disrupt h yd rophob ic  bonds and 
a more polar species such as methanol which will also 
disrupt other’ lipid - protein interaction, such as h y d r o g e n  
bonds as well as acting as a protein dénaturant. C h l o r o f o r m  
methanol mixtures are usually the solvents of choice, 
often in the proportions rec ommended by Folch, Lees and 
Stanley (1957), which comprised a c h l o r o f o r m / m e t h a n o l  
(2:1 v/v) and a wash (water or salt s o l ut ion such as KCl). 
Hara and Radin (1978) recommen ded a new solvent system: 
he xa ne/i so propano l,  fo llowe d by washing the extract with 
aqueous sodium sulfate which can remove nonlipids, and 
a back wash of the aqueous layer with H/IP 7:2 if compl et e  
recovery of the lipids is needed. Although they claim ed 
this extr ac tion method was only inefficient for the 
extractio n of g a ng li os ides , the results of this work 
showed a very low recovery of PS and of t o t a l  phosp holip id 
compared with the literature. One reason may be the 
sticky mass formed after the addition of is opropanol (in
— 81 —
Table 8 Extraction Methods (see 1.2.)
Phospholipid I (n=3) II (n=3) III (N=3) IV (n=3) V (n=3)
PC 32.4+0.9 28.6±0.6 30.210.1 30.4IO.7 29.610.2
SM 23.6±1.9 27.1+0.2 29.210.4 24.412 .2 28.010.8
PS 3.4+0.6 9.2±1.9 8.010.5 11.011.3 11.010.7
PE 39.7±2.4 29.711.3 28.810.3 28.010.9 30.310.4
LPC Tr.^ 0.810.5 1.110,5 0.810.4 Tr.^
DPI N.D.b N.D.b N.D.b 1.610.9 Tr.^
PI Tr.^ 0.710.2 0.810.“1 0.710.2 0 .410.4
PA 0.810.2 1.310.8 1.310.1 1 .710.4 0 .510.5
Origin N.D.^ 2.511.0 0.610.1 1.410.4 Tr.^
yield (ymoles lipid P/ml 1.8410.15 3.1110.26 2.8910.09 3.4010.06 3.55IO.44packed cell)
Recovery of P after TLC 
(%) 89.4±4.0 90.515.6 96.112.5 90.411.8
98.915.2
Remarks : 
Tr,^
N.D.
Detectable by 1^ vapour but below detection limit 
of colorimetric P assay, less than 0.3% total 
lipid P.
Not detectable on TLC.
— 8 2 —
PA
PE
PC
PS
o
Fig. 1 Red Cell Lipids Extracted by Method II
(see 2.6.). Loading: Lipid from 0.3 ml
Packed Cells.
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our hands) which limited the access of the solvent to 
the membrane material, and the aqueous washing step. The 
aqueous washing procedure will remove most of the gang- 
liosides and ceramid e polyhexosides in the orig^inal 
extract. Not only are these carb ohydrate - containing 
lipids lost in the aqueous wash, but the acidic p h o s p h o ­
lipids, such as PS, PA and PI are carried into the 
aqueous phase (Nelson, 1972). The disadvan ta ge of a 
washing proce dure in this respect are shown by comparing 
the results of method III and method IV. Higher levels 
of PS, DPI and PA were found using method IV tha n method 
III, in which the only difference was the inclu sio n 
(method III) and absence (method IV) of the KCl wash.
C h l o r o f o r m / m e t h a n o l  (1:1 v/v) and reextraction with 
the same solvent system was used in method II which gave 
a rel atively  low PS recove ry and a large amount of heme 
(large heme spot on TLC). Nelson (1972) recom me nded a 
change in the solvent syste m for re - e x t r a c t i o n  as the 
r ec overed pro portions of lipids are the same if using the 
same solvent system for re-extract i o n . In method V, 
r e - e x t r a c t i o n  using a different solvent system (C/M 2:1) 
gave a greater recovery of PS and total phospholipid and 
a relativ ely small amount of heme. Heme is known to 
catalyze aut oxi da tion of unsaturated lipids (van Deenen 
and De Gier , 1974) which will lead to a loss of p o l y ­
un sat urated lipids, such as PS and PE and a r e l at iv e increa se 
of the more saturated fractions, such as SM and PC (Dodge 
and Phillips, 1966).
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Comparing the re su lts  for IV and V it is apparent 
that neither omitting the initial haem oly sis step nor 
increasing the solvent: cell r a ti o improves the
extraction efficiency. It is not necessary to gri nd or 
disrupt the cells if they are added dropwise to me thano l  
with stirring (Nelson, 1972), which was done in this work. 
Although heavy losses of lysophosphol ipids have been 
reported to occur when ch lor of orm -methanol mixtures are 
used, and butanol extra ct ion is suggested to overcome 
this (Bjerve, Daae and Bremer, 1974), the recoverie s 
of ly s o-der ivatives after phosph olipase A^ treatment of 
intact cells and ghosts in this work were good using 
method V (results shown in later section).
It is con cluded from this study that, where ma ximum 
recovery of t o tal phospholipid, and especially of acidic 
classes, is required from erythrocytes, the method of 
Br oek huyse is recomm ended, but with the omission of the 
KCl wash. This will obviously lead to the presence of 
non-lipid contami na nts in the extract but these do not 
interfere with the TLC and the colorimet ric est im ation 
after chr oma tograph y. Phos ph orus- containin g non-lipid 
contaminants, however, may account for the rather low 
(<v 85%) recovery of lipid P after TLC found sometimes in 
this work.
Method V for lipid extract ion was used for all 
subsequent experiments. A co mp a r i s i o n  of the red cell 
lipid com position obtained using method V and two 
acceptedly rel ia bl e literature values are shown in Table 9
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Table 9 Red Cell Lipid Composition In this Work and 
Literature (expressed as % phosphorus w/w)
Phospholipid (n=3) This work Broekhuyse (1969) Dodge and Phillips (1967)
PC 29.6+0.2 28.312.1 29.211.5
SM 28.0+0.8 25.8+1.7 25.411.4
PS 11.0+0.7 12.711.3 14.811.7
PE 30.3+0.4 26.711.0 27.511.5
LPC Tr.^ 1.410.8 1.010.8
DPI Tr.^ 1.010.8 -
PI 0.4+0.4 1.910.6 0.610.5
PA 0.5±0.5 1.010.2 1.110.5
Origin Tr.^ - 0.4+0.6
Yield (y moles lipid P/ml packed cell)
3.55+0.44 3.9510.26 3.910.23
Recovery of P after TLC 
(%)
98.9±5.2 96.413.9 94.514.0
Remark : 
Tr.^ Detectable by vapour but below detection limit 
of colorimetric P assay, less than 0.3% total lipid P.
~  36 —
3.2 Solvent Systems for TLC
Thin-layer chr omato gr aphy was achieved at 4^C 
using precoated silica gel 60 (Merck) plates. Low 
t em pe rature  can improve r e s o l u t i o n  by minimising dif fusion 
of spots and help prevent aut oxidation of poly unsat urated 
species, such as PS and PE, which ca n lead to losses 
(Dodge and Phillips, 1966).
Three solvent syste ms were used to separate standard 
phospholipids. Typical c h r o m atogram s are shown in 
Figs . 2, 3 and 4.
Fig. 2 shows lipids separated by solvent system I 
from Zwaal and Roelofsen (1977) modified by Hunter. There 
is good reso l u t i o n  of PC, S M , L P C , EPS, PE and PA, but 
PS gi ve s a large diffuse spot and always overlaps with 
LPE and PI, Fig. 3 shows the chr om a t o g r a m  obtained with 
.solvent system II from Brophy (personal communication).
This gives good se paration of PE, PC, PS, LPC, S M , PA 
and PI. But the disadva nt age of this solvent system is 
overlap of LPS and LPE with PC, SM , PS and PI. Fig. 4 
shows another modif i c a t i o n  from Zwaal and Roelofsen (1977) 
(solvent system III); PC, S M , LPC, PE and PA are in 
similar positions to Fig, 1, but PS become more condensed 
and moved faster in the 2nd dimension. This gives a 
better separation from LPE. LPS overlaps with a glyc ol ipid 
but this does not interfere with following phosphorus 
determ in ations . As it was necessary to resolve all the 
major phospholipid classes and their lyso~d erivative s 
(following ph osph olipase A^ treatment), solvent system 
III was used for all sub sequent experiments.
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PE Pc
S MPA P® LPE m^  LPc
LPs
O
Pig. 2. Phospholipid Standards Separated by 
Solvent System I (Zwaal and Roelofsen 
(1977) Modified by Hunter) (see 2.7.) 
Loadings: 5 yg of Phosphorus in each
Phospholipid.
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I
PE
PC
PSPA ~  LPC\  w
p. t LPS
Fig. 3. Phospholipid Standards Separated by 
Solvent System II (Brophy, Personal 
Communication) (see 2.7.). Loadings:
5 yg of Phosphorus in Each Phospholipid
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i
PE
PC
PA LPE
w Lpc
 ^ IPs \O
Fig. 4. Phospholipid Standards Separated by
Solvent System III (Another Modification 
from that of Zwaal and Roelcfsen (1977)) 
(see 2.7.). Loadings; 5 yg of Phosphorus 
in each Phospholipid.
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3 . 3 Det e c t i o n  Methods
Three kinds of det ection methods, i.e. rhodamine, 
charring and iodine, have been used to detect the lipid 
spots on TLC. Neither rhodamine nor charring gave 
consistent results. Rhodamine is not as sensiti ve a 
method as the other two and may lead to some loss of 
minor lipids and of small amounts of lipid at the periphery 
of spots. Charring is very sensitive and re acts with 
all lipids, but some losses, especially of PS, were 
found. The plate is heated in a 190°C oven after 
spraying with charring agent, and oxidation products of 
the organic phosphorus, e.g. phosphoric acid may be 
volatili sed which lead to some losses. The extent of 
re a c t i o n  of different lipids with sulfuric acid may be 
different which will give inconsis ten t results. Iodine 
is a sensitive method which again detects all lipids.
The pro cedure is simpler than the other two de tection 
methods and no losses were found. Therefore, this 
method was used in all subsequent experiments.
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3.4 Time Course Test of Release of Lipid P by D i g es tion 
with Perchloric Acid
Standard PS was used in this experiment to determine 
optimal digestion time. The amount of P reco vered was 
linear with time up to  30 mins, and 30 mins. was found 
to be the optimal time for both PS samples digested directly 
and those recovered  f rom TLC plates (in the presence of 
adsorbant  but without actual chr omatography). I n t e r e s t ­
ingly, for di gestio n times longer than 50 mins., the 
subsequent co lor ime tric P method gave a dark-blue colour 
independent of the phosphor us content. This may be due 
to change in acidity, since prolonged digestion will 
result in loss of some perchloric acid. With insuf ficient 
perchlori c acid present, molybdate seems to be directly 
reduced to a blue colour independent of the phosphorus 
content. This was testing by mixing ammonia molybdate, 
ascorbic acid and an a p p r op riate amount of water, boiling 
for 5 mins. after which the solution turned dark blue 
even though no phosphorus was present. This time co urse  
curve is shown in Fig. 5,
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§
O
6050
Digestion time (mins)
A.
B
Pure PS Ô-
PS and adsorbant from TLC plate %r
Fig. 5. Time Course Experiment of PS digestion.
• i> ’A-.- -V"
-92-
3,5 Standard Phosphorus Curve and C a l c u l a t i o n  of Results
Two separate assays were performed. The r e su lt s of 
two^ sta nd ard P estimat ions are shown in Fig. 6 . The 
slope was plotted after d e t e r m i n a t i o n  by linear r e g r e s s i o n  
using the mean data from both assays. The slope of the
graph was found to be constant from day to day.
O . D . q 2 o converts to yg phosp horus as follows:
1
yg P = O. D.Q^ n ^ ----------0.124666
For c o n v er sion to yg of phospholipids, the m u l t i ­
pl ica ti on factor is 23 for PC, PS, PE and SM and 16 for
ly 5 o-der i v a t i v e s , since the proportio n of pho sphor us is 
■^% and 6% w/w re spectivel y.
The increase in O . D . g ^ o  found to be linear up to
10 yg of phosphorus. However, the ma ximu m amount of 
phosphorus per spot was always adjusted to about 5 yg to 
ensure it was within the linear portion of the curve and 
on the most efficient range of the s p e ctroph ot ometer.  A 
phosphorus standard was run together with all the samples in 
each experiment to ensure the accura cy of pho sphorus 
determination and minimise the daily vari abilit y of the 
reagents (especially ascorbic acid which was prepared 
freshly at each experiment).
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;iig  Phosphorus
Fig. 6. Phosphorus Standard Curve,
Expt. 1 X X
Expt. 2------ -
Each point is the mean of two readings
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3 .6 Recovery of Lipid Phosphorus from TLC Plates
The recovery of ph osphorus from TLC plates from 
standard SM and RBC lipid extracts was determined. The 
average recovery percentage in either case was over 90% 
and is shown in Table 10.
Table 10 Recovery of Phos pho rus from Sta nd ard SM and RBC 
Lipid Extracts
Lipid X + S . D n
Standar d SM 91.2 ±4.6 7
0.3 ml packed
cell lipids 98.9±5.2 6
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3 .7 H ae mo lysis Time f or Ghost Preparation
10, 20, 40 and 50 minutes were used to in vestigate  
optimum time of haemolysis-=f or ghost preparation. It 
was found that 50 minutes gave complete hae molysis  as 
judged by the colour of the ghost pellet and the size 
of the ha em o g l o b i n  spot on TLC of ghost lipids. The 
re su lt ant ghosts were cream in colour and there was 
only a tiny haem og lobin  spot on the TLC plate.
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2 +3 .8 Presen ce of Ca in the Buffers and the B r e a k d o w n  
of Ph os pholipids in Ghosts
The red cells used to prepare ghosts, and for
phospho lip ase tre atment of intact cells, were previously
2 +washed with 0,25mM Ca -containing saline buffer. After 
the ghosts had been washed three times with hypotonic 
buffer, the final washing is performed in a T r i s -C aC l^- 
MgCl^ buffer, before storage. During ph ospholipase 
treatment, both control gh os ts  and phosph olipase treated  
ghosts were incubated for 2 hrs in the same Tris-CaCl^
Mg Cl 2 buffer. After ghost preparation by this original 
method and i n c u bation  for 2 hrs for 37^C, phosphlipids
in the control ghost s were found to be partially bro k e n  down
into their lys oder ivat ives even though no phosph olipase 
was added. This b r e a k d o w n  of phospholipids in the 
control ghosts must be due to the a ct ivation  of endogen ous 
p h o s p h o l i p a s e . It seems likely that this does not occur 
in intact cells since the intracellular Ca^^ c o n c e n t r a t i o n  
is ma in tained at a low level by the Ca ^^ -ATPas e and all 
int rac ellular ph o s p h o l i p a s e s  A require Ca^^ for acti vation 
(van den Bosch, 1980). Triplett, Wingate and Carraway 
(1972) have shown that the presence of CaCl^ in the 
hemolyzing medium  may re su lt in activation of prot einase
and it can be assumed a similar activat ion  of pho sp holipas e
A would result and lead to breakdown  of the phos pholipid.  
Mo di fi cation s to  the procedure were the refore tried:
(i) using an isotonic ph osphate buffer to wash the cells 
instead of using C a ^ ’*'-containing saline buffer, and (ii) 
omitting the final wash with Tr is-CaCl^- MgCl^ buffer.
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These modif i c a t i o n s  probably drastically reduce the Ca^*
adsorbed old the surface of the ghosts and thus minimize
the subseque nt act iv at ion of phosp holipase A and
p h o s p holi pi d breakdown. Results after these mod ifi catio ns
showed a deer e a s e d b r e a k d o w n  of phospholipids. However, as 
2 +Ca is re qu ir ed for the activity of the exQqenous bee
ven om pho spholip as e A^ added, the Tris buffer used for
2 +i n c u batio n had to contain Ca in both control and 
e n z y m e -treate d ghosts. It was found that, not s u r ­
prisingly, some phospholipid breakdown still occured in 
the co nt rol ghosts (Fig. 7). Nevertheless, the phpspho- 
lipid c o m p o s i t i o n  (combining the intact g lycer ophos ph o-  
lipidsand the corresponding lyso- der ivati ves ) was similar 
to that of normal intact cells (results shown in later 
section). This confirms the findings of Schwoch and 
Passow (1973) that there was no measurable loss of 
phosphol ip ids fro m the membrane during the preparation 
of ghosts.
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PE
PC
S MLPEP S . I PC
Fig. 7. Normal Ghost Lipid. Extracts.
Loading: Ghosts Originated from 0.3 ml
Packed Cells.
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3.9 P h o s p h olipase Treatment of Intact Red Cells and 
Gh osts
3.9.1 Effect of Ca^^ and EDTA Conce nt rations  on
Pho sphol ip ase Activity
B ec aus e lOmM Ca^^ was reported to be the maximum
c o n c e n t r a t i o n  for ac t i v a t i o n  of ph ospholipase from
bee ve nom  (Shipollni, Ca lle waert, Cottrell, Do onan and
Vernon, 1971). This c o n c e n t r a t i o n  was used in incubations
2 +instead of 0.25mM of Ca rec om me nded by Zwaal and 
Roelo fse n (1975). Final co n c e n t r a t i o n  of 1.6666mM EDTA 
Na^ was added to stop the enzyme activity as recom mended 
by Zwaal and Roelofsen  (1975 ). However, the degree of 
ha em olys is  (9.4%) was found to be much higher than the 
ac ceptable  3%, and some PS degra dation was found in intact 
cells due to this h aemo ly sis as PS became accessi ble to the 
added enzyme. Shipol lni e ^  al^. (1971) indicated that 
ad dit io n of both EDTA and calcium ions had a large a c t i v ­
ating effect providing that calcium ions were present in 
large excess. The active entity of the enzyme was a 
c a I ci um -p rotei n complex which dissociated giving in act ive 
protein as the calcium ions formed a complex with EDTA. 
However, add ition of EDTA and excess ca lc iu m ions led to 
a very large rate enhancement. It was proposed that EDTA 
or some ED TA- calci um co mp lex  interacted with the enzyme 
in such a way that the catalytic  activity of the ca lc ium- 
enzyme comple x was Increased (i.e. acting as an allosteric 
acti vat or) (Shipollni et aly, 1971). Cottrell (1981) 
offered the altern ative ex pl a n a t i o n  that when small am ounts
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of EDTA and a great excess of Ca^* were present there was
ch ela tion of inhibiting metal ions that bind both to EDTA
and to the enzyme more tightly than Ca^^ (as well as some
of the Ca^^), resu lting  in enhanced activity of the
enzyme. Either of these hy po the ses may explain the high
degree of haem olysis  % obtained in this work, if, under
2 +the Initial cond itions of Ca and EDTA, addition of EDTA 
gave a marked stim u l a t i o n  of enzyme activity which may 
have led to membrane d e s t a b i l i z a t i o n  due to rapid p r o ­
duc tio n of lys oph osph olipids . Mod ifi cations were then 
made to  use 0,25 mM CaClg in the incubation buffer and 
increased the amount of EDTA from 1.6666 mM to  16.6666 mM 
(final conce nt ratio n). The degree of haemolysis obtained 
thereafter was always less than 2%.
3.9.2 Amount of Enzyme  Added and the Incu batio n Time
According to Zwaal et. ëA* (1973), incubati on for 1 hr 
with 10 U of phosph olipase A v  (from bee venom) per 0.2 ml 
packed cells gave 55% degr a d a t i o n  of total PC and 9% degra dat ion 
of PE, In this work, the same conditions were examined 
for the non-lytic degr adati on  of the RBC, but results 
showed much lower degr a d a t i o n  of PC and PE, either due to  
inadequate amount of enzyme added or too short an in cu bation 
time. Extending the incubati on time to 2.5 hrs p r o g r e s s ­
ively with 10 U enzy me /0.2 ml packed cell was tried but 
non-ideal results still occurred. Thus increased a m o un ts  
of enzyme and extended inc uba ti on times were tried under 
conditions that hae mol ys is was kept below 3%. 20 U/0.2 ml 
packed cell and 2 hrs inc u b a t i o n  were finally found t o  be 
the most suitable c o n d it ions for the non-lytic maximal
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degradat io n of RBC phospholipids. Results are shown in 
Table 11,
3.9.3 Haem ol ytic Curve
The progress of haemolysis with time under the —
optimal co n d i t i o n s  just defined was determined in two 
experiments (Fig. 8 ),
Haemolysis may be taken as an index of mem brane 
integrity. It is likely that haemolyzed cells will u n d e r ­
g o  deg radat io n of the lipids of the inner layer of the 
lipid bilayer, since the enzyme can gain access to the 
inside of the cell. The maxi mum degree of hae m o l y s i s  
usually regarded  as acceptable for asymmetry studies is 
2 %. 2 % is likely to be a max imum error for inner leaflet
phospholipid degr adation  since in newly h a e m olyze d whole 
cells it is likely that the phospholipids will be less 
accessible to the phospholipa se at the cy toplasmi c 
leaflet due to the presence of, for example, spectrin, or 
to resealing of me mbrane fragments,
3.9.4 Susce pt ibility  of Glycer oph osph olipids t o  P h o s p h o - 
lipase A q At tack  in Intact Red Cells and Ghosts 
from Normal Controls and DMD Patients
The re sults of non-lytic lipid de gradati on in normal 
intact red cells is shown in Table 12, a thin layer 
chromato gr am showing lipids from e n zy me -treate d RBC is 
shown in Fig, 9.
Since SM is not a substrate for the enzyme, it is 
used as internal standard, deg ra da tion % of PC and PE is 
calculated  f rom SM% compared  to that of control (for 
details, see 2 .5 ),
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Fig. 9, Lipid Extracts of Normal RBC Incubated 
with Phospholipase A2 (20 U/0.2 ml 
Packed Cell for 2 hrs at 37°C). Loading 
Lipids from 0,3 ml Packed Red Cells.
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Lipid asymmetry of human erythrocytes was first 
proposed by Bretscher (1972) wh o stated that the two 
cho li ne-c on taining  phospholipids, PC and SM , are located 
chiefly in the outer half of the lipid bilayer, while-=
PS and PE are located on the inner (cytoplasmic) half 
of the bilayer. The erythrocyte membrane is the only 
bio logical mem br ane in which lipid asymmetry has been 
demonst rat ed in a convincing and con clusive way (Op den 
Kamp, 1979) and extensive work has been done on this cell 
type. Lipid asymmetry was studied by two kinds of methods. 
Firstly, using non-penetrating chemical reagents to label 
the a m i n o- group containing phospholipids, and secondly 
using various kinds of phospholipases to degrade the 
phospholipid non-hae mol ytically in intact cells and u n ­
seal ed gh o s t s .
Human RBC have few lipid amino gr oups avail ab le to
react with ch emical agents which cannot permeate the
membrane. Such reagents are designed to label free a m in o
groups, like those in PS and PE, but not the t ri me thyl-
amino groups of PC. Little PS and PE was found to be
labelled in intact cells by the fluorescent reagent,
disodium 4 - a c e t a m i d o  4'-thlocyano stilbene disulp honate
(Maddy, 1964) and little PE on the exterior of RBC was
35able to react with a radi oactive  reagent, S formly- 
methionyl (sulphone) methyl phosphate (Bretscher, 1972 ). 
Gordesky (1974) showed that when RBC were trea ted with 
2 , 4 , 6 -trinitro be nzene-s ul fonate for 24 hrs, a ma ximum of 
33% of the PE and none of the PS reacted with this reagent
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whereas in ghosts, 95% of PE and > 50% of PS reacted in 
90 mins under same co ndition. He concluded that all or 
nearly all of the PS and a minimum of 70% of PE is on 
the inside surface of the membrane. Another line of 
evidence for lipid asymm etry came from the studies with 
various phos pholipase s from natural sources. The use of 
a sea snake v e no m which possesses ph osp holipase A 
activity (Ibrahim and Thomson, 1964) indicated that SM 
and PC are the main pho spholipid components of the exteri or  
half of the biliyer. They found limited p h o s p ho lipase  
action occured in the absence of cell lysis. The only 
detectable product they found was LPC, with no LPS or 
LPE. P hosp ho lipase A^ from Naja ,0aja hydr ol yzed 68 % of 
the PC of the intact red cells, while s p h i n g o m y e l i n a s e  from 
Staphylococ cus aureus hy drolyzed 80-85% of the SM of the 
intact red cells (Verkleij, Zwaal, Roelofsen, Comfurius, 
Ka s t e l i j n  and van Deenen, 1973). They c o n c luded  that 
the majority of the choli ne -contai ni ng pho sp holip ids (PC 
and SM:) and some 1/5 PE forms the outer monolayer of the 
membrane. The inner half of the bilayer was compos ed 
mainly of PE and PS, and a minor fr actio n of choli ne - 
containing pho spholi pi d may also be present. A d i a g r a m 
indicating the proposed lipid asymmetry of red cells 
(after Verkleij e;t ^ .  , 1973 ) is shown in Fig. 10.
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Fig. 10. Proposed Di stribution of Phospholipids 
Between the Inner and Outer Layer of the 
H u man RBC Membrane, Abb reviation: TPL
Total Phospholipid,
The conclusions regarding lipid asymmetry from these 
experiments are only valid under the c o n d it io n that the 
rate of f l i p - f l o p  (exchange of the phospholipids between 
the two halves of the bilayer) is slow and ins ignif icant 
compared with the experimental period. F l i p -flop has 
been found to be very slow indeed, with a half- life  
measured in hours in intact human erythrocytes (Bloj and 
Zilversmit, 1976).
Pho sp ho lipase  Ag (from bee venom) has been used 
without further pur ific ation  to study the lipid asymmetry
..yj. A
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in h u m a n  red cells and was therefore used in this work.
This enzyme preferentia lly attacked PC in whole cells,
co nv er ting over 50% of the total PC into LPC without
causing lysis although the red cells became more osmotically
f r a g i l e  (Zwaal e_t al^. , 1973). In this work the fact
that hae mo lysis was always less than 2 % suggests strongly
that the phospholipids which were susceptible to the
d egrad at ive action of ph os pholipase were localized on
the outside of the cell membrane, i.e. 55% of PC and 9%
of PE were loc alized in the outer mon olayer of the
bilayer. The fatty acids and LPC produced by the action
of phosp h o l i p a s e  Ag seemingly remain in the mem brane
(Roe lof sen and Zwaal, 1977), organized in a bilayer c o n -
31f i g u r a t i o n  as observed by P-NMR of ghosts from  such 
e n z y m e-tr ea ted RBC (Van Meer , de Kruijff, Op den Kamp and 
Van Deenèn, 1980). The importance of this stable 
o r g a n i s a t i o n  of the fatty acids and LPC, which prevents 
h a e m o l y s i s  even though a large prop ortion of the gl ycer o-  
pho sph ol ipids are degraded, is ind icated by the lysis 
which occurs after the binding and removal of fatty acids 
by the addition of bovine serum albumin (Zwaal, Ro e l o f s e n  
and Colley, 1973). After the phospholipase  A^ (from bee 
ve nom) degrad ation, a stable bilayer structure is produced 
which con sists of a monolayer of ly sop hosph olipids and 
fatty acids on the outside and a monolayer of intact 
p h o s p h o l i p i d  on the inside (van Meer e ^  , 1980). It 
is r e m a r k a b l e  that p rod uc tion of LPC ^  situ does not lead 
to cell lysis, while exogene ous LPC is a lytic agent. The
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reason for this is thought to be beca use the fatty acids 
and LPC form  a complex whose conform at ion re sembles PC 
(Gain, van Echteld, Ramirez, de Gier , de Haas and 
van Deenen, 1980). In a study using 1-LPC and fatty 
acids in aqueous dispersion, Oain and de Haas (1981) 
found that acyl chain int eract io n between fatty acids 
and 1-LPC were maximized by close-pack ing such that the 
acyl chain s of both molecules aligned parallel to each 
other and the carboxyl group was located in the vicinity 
of the 2 -hydroxyl group of LPC. The shape and size of 
a f un ctional  dimer thus formed were similar but not 
id ent ical to those of PC.
The pho spholipid class distr i b u t i o n  of whole RBC 
of DMD patients is similar to that of control (Table 13), 
in agreement with the results fro m  other repo rts (for 
r e f s . see 1.4.1.1).
The rec ov ery % is low sometimes bec ause some n o n ­
lipid P-containing  contaminants, for example, g l y c e r o ­
phosphate, may be present due to absence of washing step 
in the lipid ex tr actio n method.
The degradati on of PC in DMD RBC was found to be 
higher than that of control and the diff ere nce was 
highly sign ificant (P < 0.01, Stud en t's t test). On 
average, 32% more PC was available at the outer surface 
of DMD RBC (Table 14 and Fig. 11). There was also no 
overlap between the ranges for PC degradation for DMD 
and controls.
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Table 13 Phospholipid Class Composition of Whole RBC 
(Expressed as % phosphorus -(-w/W)/)
Phospholipids Controls (n=12) EMD Patients (n=6)
PC 30.97±2.78 29.20+1.08
SM 26.89+2.05 29.67+2.37
PS 10.75+1.04 9.86+3.03
PE 31.21±1.79 31.27+1.19
Yield (y mole P/ml packed cell 3.10+0.50 3.16+0.38
Recovery after ILC (%) 89,85+8.70 84.21±11.3 0
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Patients
( n= 6 )
X t 6813±6 23 
### # # #
Controls
(n=6)
X tS .a =  5173+7-76 
• •  •  • *#
%Degradation 
of PC
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Fig. 1 1 , D e g r a d a t i o n  of PC in Whole RBC in Controls  
and DMD Patients.
Thi n-l ayer c h romato gr ams of lipids from control 
and en zyme-t re ated DMD RBC are shown in Fig. 12 and 13.
The phospho lip id class distribu tion of DMD ghosts 
were found to be similar to that of controls. (Table 15) 
and in both cases these correspond closely to the c o m p o s i t i o n  
o f w h o l e c e l l s .
When  DMD and control ghosts were treated with the
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enzyme, all of the g l y c ero ph ospholi pi ds underwent 
complete c o n v e r s i o n  to their corresponding lyso- 
derivatives, indicating that those phospholipids in the 
native mem bra ne are fully available to bee venom phos- 
pholipase where access to both sides of the membrane 
is possible. Thin-layer chromatog rams showing the lipids 
of en z y m e - t r e a t e d  normal ghosts, DMD ghosts and enzyme- 
treated DMD g h os ts are shown in Fig. 14, 15, 16 respectiv ely.
Increased  PC degrad ation at the outer surface of 
the me mbr ane of DMD red cells may be interpreted in at 
least two ways, either (i) the distribu tio n of PC is 
normal but during the course of the enzyme treatment, 
tra nsbilayer tr ans l o c a t i o n  (f lip -flop) of PC molecules, 
normally ass oci at ed with the cytoplasmic leaflet, occurs 
more readily than in normal erythrocytes; or (ii) a 
greater p r o p o r t i o n  of the total PC is localized in the 
outer l e a f l e t .
The half time of transbilayer movement of PC 
observed in intact human ery throcytes was 2-5 hrs and 
half times of the same order of magnitude were found for 
the transbilay er movement of am in ophospholipid s (PE and 
PS) (Bloj and Zilversmit , 1976). During the time- course  
of the incuba ti on used in this work (2 hr) ther efore  one 
would not expect any significant transbilayer movement 
of PC in the normal RBC. If the increased degradation of 
PC in DMD RBC was due to the increased fli p- flop of PC 
during the incubation, this must reflect some per turb at ion 
of or gan izati on in the DMD RBC membrane. Alter ations
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Fig. 12. Lipid Extracts of DMD RBC (Control),
Loading: Lipids from 0.3 ml Packed Cells
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Fig. 13. Lipid Extracts of DMD RBC Incubated 
with Phospholipase (20 U/0.2 ml 
Packed Cells for 2 hrs at 37°C). Loading 
Lipids from 0.3 ml Packed Red Cells.
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Table 15 Phospholipid Class Distribution of DMD Ghosts 
and Control Ghosts (expressed as % phosphorus 
(w/w)).
Phospholipids DMD Ghosts (n=5) Control Ghosts (n=5)
PC 28.419±1,46 30.93+2.78
SM 31.265±4.69 26.46412.90
PS 11.686±3.6 0 12.80511.87
PE 27.75110.65 29.42911.30
Yield (y mole 2.70 2.93lipid P/ml packed cell) ± 0.42 1 0.54
Recovery % 85.5 ±5.24 85.14 19.34
-118-
Fig. 14. Lipid Extracts from Normal Ghosts
Incubated with Phospholipase A2 (20 U/ 
0.2 ml Packed Cells for 2 hrs at 37°C). 
Loading: Ghosts Originated from 0.3 ml
Packed Cells.
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Fig. 15. Lipid Extracts from DMD Ghosts (Control) 
Loading: Ghosts Originated from 0.3 ml
Packed Cells.
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Fig. 16. Lipid Extracts from DMD Ghosts Incubated 
with Phospholipase (20 U/0.2 ml Packed 
Ceil for 2 hrs at 37°C). Loading: Ghosts
Originated from 0.3 ml Packed Cells.
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in spectrin may be a possible cause of the Increased 
tr ansbilayer moveme nt of PC. Spectrin, a component of 
the c y t o s k e l e t o n , was found to be important in maintaining 
the lipid asymmetry in ery throcytes (Haest, Plasa, Kamp 
and Denticke, 1978), It was found that changes in lipid 
asymmetry may occur after the oxidation and p h o s p h or ylatio n 
state of spectrin is changed. After using SH-oxidizing 
agents to c r o s s- link spectr in monomers to form oligomers, 
30% of the total PS and 50% of the PE became available 
for hydroly sis by pho sp holipas e (from bee venom) under 
no n-haemoly tic conditions. No PS and about 5% PE will 
normally be hyd ro lyze d in unoxidized erythrocytes, so that 
they suggested that a re lease of constra ints imposed by 
spectrin enabled PS and PE to move from the inner to the 
outer lipid layer of the RBC membrane and that spectrin 
in the native RBC, stabilized the ori entation of these 
phospholipids at the inner surface of the membrane. This 
is supported by the finding that between 19-25 PE m o l e ­
cules and 13-17 PS m o l ecu le s were covalently linked to 
each spectrin dimer by bif unct ional cross-linking rea ge nts 
(Marchesi, 1979). G a z i t t , Ohad and Loyter (1976) showed 
that in chick RBC, dephospho ry lation of membrane proteins 
(including spectrin) might induce the agg regation of 
intram emb rane particles (as seen in fr ee ze-frac tu re EM) 
and relatively inc rease the availability of the free lipid 
bilayer to p h o s p h o l i p a s e  A and tr initrobenz ene sulfonic 
acid, i.e. more phosph olipids were exposed. The effect 
of prot ein d e p h o s p h o r y l a t i o n  might be exp ressed in terms 
of changes in the co mpressib ility of the lipid bilayer
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(Demel, Geurts van Kessel, Z w a â l , Roelofsen and van 
D e e n e n , 1975) which is known to Influence the s u s ­
ceptibility of phosphol ip ids to phospholipases.
-= Franck, Roe lofse n and Op Den Kamp (1982) showed a 
complete exchange of PC fro m intact RBC was possible 
after protein cross- linkin g,  using specific PC exchange 
protein. So much evidence therefore has proved the I
close r e l a t ionship  bet ween spectrin and lipid asymmetry.
It is significant then that spectrin has bee n  reported 
to be abnormal in DMD erythrocytes. Teuchiya e^ a l .
(1981) and Nagam o ejt a_l. (1980) indicated spectrin 
e xtr actabil ity was si gnificant ly reduced in DMD ghosts.
Roses aJ^. (1975 ; 1976; 1977; 197 9; 1981) demon st ra ted  
the ph osphorylate d state of spectrin in DMD RBC was 
normal, but found an incre ased phospho ryl ation in Band II 
(one of two el ectropho retic bands for spectrin in SDS- 
PAGE ) although confl ict ing results have als o been presented. 
Altho ugh  some of the eviden ce presented above seems to 
relate only to an increase in PE and PS transfer to the 
outer lipid bilayer, ne vertheless , it seems likely that 
any changes in the c ytoskel et on may influence the lipid 
asymmetry and that some more subtle abn ormality in 
spectrin of DMD erythr oc ytes (such as phosph ory lation) 
may bring about the Incr ea sed PC deg ra dation found in 
this work. In sickled RBC, in which abnormality in the 
sp ectri n-actin lattice has been shown, more PE and PS 
are tran slo cated to the outer layer from the inner leaflet 
while PC is tr ansfer red from the outer leaflet to  the 
inner leaflet in exchang e for PE and PS (Lubin, Chin,
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Bas tac ky and Roelofsen, 1981).
If abnormal spectrin is considered to be the cause 
of the increased PC degradation found in this work, an 
abnormal spectrin and the -resultant change in lipid 
asymmetry may well be the cause of changes in def or mabili ty  i
of the DMD RBC found in some laboratories. Palek and Liu
(1979) proposed that the st om atocyte -d i s c o c y t e - e c h i n o c y t e  
eq uilibr ium depends on the relations hip be twe en the 
surface areas of the inner and outer halves of the m e m b r a n e  
bilayer. Since spectrin and actin form a two -d im e n s i o n a l  
network under the inner leaflet of lipid bilayer, r e ­
arrangement could produce a decrease in surface area.both 
of the spectrin -a ctin network and the closely associa ted 
inner half o f  the mem br ane lipid bilayer. The resulting 
mod ifica ti on  in bilayer asymmetry could then be r e f l e c t e d  |
in an echinocyte shape change. Reduced d e f o r m a b il ities 
and increased pe rc entag e of echinocytes in DMD RBC have 
been found in numbers of laboratories although almost 
the same number of contrary reports have been presented 
(for details, see 1.4.3.1). The sig nificance of the 
altered lipid asymm etr y in DMD RBC found in this work 
cannot be ignored in r e l a t i o n  to the def ormability 
and shape changes of DMD RBC. In sickle cell anaemia, 
an altered RBC shape (sickled) was found as the result 
of abnormal sp ectrin  and altered lipid asymmetry (Rice- 
Evans and Dunn, 1982). In hereditary spherocytosis, 
redu ced  defor mabil it y of RBC was found to be rela ted to 
the altered p h o s p h o r y l a t i o n  of spectrin (Rice-Evans and 
Dunn, 1982). F ro m the above evidence, an altered lipid
—  -JL '  '   .'i-----------i---------------------:———------------,
-124-
asymmetry might also be expected, although this has not 
been examined.
If a greater proportion of total PC genuinely 
localized in the outer leaflet is the e x p l a nation for the 
observation in this work, then, in order to maintain a 
constant pressure in the outer leaflet, some other c o m ­
ponents in the outer leaflet must either be red uced or 
tr an sfe rre d to the inner leaflet. Two c o m p on en ts can be 
proposed, i.e. lipids or integral protein. In the outer 
leaflet, SM and chol es terol  are the only t wo lipids 
present in substantial amounts, besides PC. If one or 
both of these comp onents are transferred pr eferentia lly 
to the inner leaflet to compensate for in creas ed PC in 
the outer leaflet, this would be expected to alter 
me m bra ne  properties considerably. Further experiments, 
such as probing their dist ributio n using sphing o m y e l i n a s e  
and chol es terol oxidase, can be proposed to examine this 
hypo th esis. Depl etion of integral protein ass ociated 
solely with the outer half of the bilayer, suich,as 
acetyl c h o l i n est e r a s e , could also co u n t e r - b a l a n c e  the 
increased pressure exerted by increased PC localized in 
outer leaflet. However, this enzyme has been shown to  
have normal activity in DMD erythrocyte (Ig i s u , Mawa tari, 
Kuroiwa and Miyoshino, 1980). Whatever the compensating 
mech an ism, such a change in lipid organization is likely 
to  lead to altered membrane  physical properties.
As more PC is located at the outer leaflet, a 
decreased SM/PC would be expected there. A n  altered
Î
..
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1SM/PC will produce profound effects on the properties of 
the bilayer (Barenholz and Thompson, 1980), S^Kinitzky 
and Inbar (1976) indicated in artificial phospholipid 
vesiclestha t an overall decreased SM/PC was coincident 
with an increase in fl uidity as SM normally contains 
more saturated fatty acids than PC. This was confirmed 
in sheep erythrocytes (Borochov, Zahler, Wibrandt and 
Shinitzky, 1977). A decre ased membra ne visco sity can 
also be expected to acc ompany the decreased SM/PC, In 
a theoretical study by Ba renhol z and Tho mpson  (1980) using 
a mixture of egg PC and brain S M , increased apparent 
microvisco si ty was observed in all systems examined at 
all t emper at ures in the range of 0°-60°C with increasing 
content of SM . In ab.eta-lipopr ot einemia , patients have 
acanthocytic RBC, with increas ed SM/PC as high as 1.56 
(normal value is 0.64). As sociated with this change was 
an increase in mic ro viscos it y and decreased membrane 
def ormability (Cooper, Dur ocher and Lestie, 1977). In 
summary, a dec reased SM/PC may lead to increased fluidity 
and decreased vis cosity in the outer leaflet of the 
membrane of erythrocytes.
Another possible ch ange which may result from 
increased PC in the outer leaflet of the lipid bilayer 
is a decrease in chol esterol  to give a decreased ratio 
of choleste rol to phos pho lipid s (Chol/PL). Decreased 
chol/PL has a similar ef fect.o n the membrane as does 
decreased SM/PC. In studies on guinea pig RBC, Kroes and
Ostwald (1971) demon st ra ted a tighter packing of the 
lipid component after c hole st erol loading. The addition
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of c h o l e st er ol to pure phospholipid membran e enhanced 
the degree of order within membrane lipid and caused 
decreased fluidity and increased viscosity (Cooper,
1977), So that, decreased choles terol  could induce 
increase fluidity and decreased viscosity in the outer 
leaflet of membrane of erythrocytes.
Altered fluidity in DMD ery th rocyte membranes 
was found by ESR in the polar and hy drophobic region of the 
lipid bilayer (for refs., see 1.4.3,3). Although some 
results (for example, decreased fluidity at the surface 
region observed by Wilkers on  jet (1978)) do not seem
to coincide with the effect (increased fluidity) of the 
proposed decreased SM/PC or decreased chol/PL, it must 
be reali sed that the effect of changes in lipid ratios 
does not necessary cause a sig nificant change in the 
bulk fluidity of the entire membrane but may cause critical 
changes within specific domains of the membra ne (Cooper,
1978). Thus it is still likely that the altered PC 
distrib ut ion may lead to some or all of the spectroscopic 
abnormalities found in DMD erythrocytes.
Osmotic fragility was found to be directly 
proportional to the degree of fluidi ty of the lipid • 
bilayer (Weed and Reed, 1966). Danieli and Marchesini
(1980) and others (for details, see 1.4,3.2) showed 
an increas ed RBC osmotic fra gility in DMD patients and 
carriers*.This could therefore be the result of increased 
fluidity due to decreased SM/PC or chol/PL in the outer 
leaflet. By a direct influence on fluidity or perhaps 
by some allosteric mechanism, lipid c o m p o si ti on modulates 1
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the activity of membra ne bound enzymes and the transport 
processes with which they are associated (Cooper, 1977), 
Changes in fl uid ity may influence the range of motion or 
the potential volume avail able to a membrane enzyme and 
its substrate during the enzymic process (Cooper, 1978).
It is worth recalling that ion-transport and enzymic 
activities in DMD RBC have been found to be altered by 
many laboratories; although contrary findings have also 
been presented (see 1 . 4 . 4.2. 1 and 1.4.5.1).
Incre ase d efflux was found in DMD RBC (Dise 
et al., 1977), which is consistent with decreased chol/PL, 
since when chol/PL dec reases, the membrane permeability 
to several substances that enter by ca rr ier-mediated 
transport, or facili ta ted diffusion is increased (Cooper, 
1977; Kroes and Ostwald, 1971). However decreased K^ 
efflux was re ported by Sze nti stvanyi £t (1980) and
Ca^^ influx and efflux was found to be normal (Shojl, 1981) 
in DMD RBC.
I nc re ased Ca^ ^- Mg^^ ATPase activity and altered basal 
activity and respons e to ouabain by Na -K ATPase could 
be explai ned by the abn ormal lipid domain adjacent to the 
enzymes. Although PS and PE were considered to be the 
main lipids con ne cted with the activities of ATPases 
(Roelofsen and Deenen, 1973), a change in fluidity may 
exert its effect on the enzymes via the influence on the 
physic al’ state of PS and/or PE. Other changes in 
membran e bound enzyme activities  (for details see, 1 .4 .5.2 ) 
could also be explain ed in a similar way.
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Plasma mem br an e lipid asymmetry has been conclusivel y 
established in ery throc yt es of various species and in 
lymphocytes. It would, of course, be of particular 
interest to know whet-h=er such asymmetry is also ref l e c t e d  
in sar colemma since the ge ner alized membrane defect p r o ­
posed as the under lying cause of DMD could well prove 
to be an abnor mal ity in the normal asymmetric organiza tion 
of plasma me mb r a n e  lipids. If the abnormality were 
specifically one of PC distribu tion then the fact that 
muscle membran es contain very high PC (50% total p h o s p h o ­
lipids (Kunze, 1977)) may explain why the defect produces 
such severe effects in muscle rather than other tissues.
If such an abnormality in sarcolemmal phospholipid 
asymmetry does exist then this would almost certainly 
result in profound changes in the physical propert ies  of 
the me mbrane as previously proposed for erythrocyt es  and 
consequently could account for some or all of the abn or ma l  
me mb ra ne-bo un d enzyme^and transport funct ions re po rt ed 
(see 1 . 4 . 4 . 1 .2 , 1.4 .4.2.3 and 1.4.5.2).
A noteworthy possible influence of abnormal lipid 
asymmetry in DMD muscle (if proved) may be on Ca^^ p e r ­
meability. An increa se in Ca^^ in DMD skeletal muscle 
was found by M a u n d e r - S e w r y  _et (1980) and Bod en steiner
and Engel (1978), Ca^^ has received much at tentio n  
because of its ability to activate various h y d r ol yt ic enzymes 
(ex. proteases), which may lead to muscle degen er at ion.
Kar and Pearson (1976, 1978 , 1980) have shown raised 
proteàse activity in DMD muscle. As stated above, increased 
fluidity of the mem brane will facili tate ion transport.
J
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It is perhaps releva nt here to review the hy pothesis 
of muscle d e g e n e r a t i o n  of Wrogemann and Pena (1976)
(see 1.3.2,). They proposed a sarcolemmal defect will i
2 4-increase the net influx of Ca which will in turn induce 
func t i o n a l  and structural damage to mi tochondri a, elevated 
cytoplas mic Ca^^ levels and cell necrosis. The 
'sarcolemmal defect' might be precisely a defect in 
lipid asy mmetry which produces the various a b norma li ties
24-observed in DMD muscle and particularly increased Ca 
permeability leading to muscle necrosis.
Ob se r v a t i o n s  in this work have presented strong 
evidence for ab norma l membrane organization in DMD, Further 
work is needed to explore (i) the cause of the incre ased 
PC in the outer leaflet of DMD erythrocytes, (ii) lipid 
asymmetry in the membrane of muscle, (iii) its r e l a t i o n ­
ship, if any, to the mec ha nism of muscle d e g e n e r a t i o n  and 
finally (iv) a method of curing the disease.
The fin di ng s of this work may have diagnostic value 
if similar abnormal membra ne lipid asymmetry is found 
in e ry th ro cytes  of carrier s and affected foetuses. How ever 
the proc edure would be time consuming and would probably 
only be worth using if the differences were as clear c u t  
as for the patients examined in this work.
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3.10 Possible Role of Plasma in Abnormal Phospholipid 
Asymmetry
The possibility that some or all of the 'membrane' 
abnormalities in non-muscle cells might be due to a 
circulating factor released from dystroph ic/necrot ic 
muscle has been suggested by two groups (Lloyd and 
Emery, 1981; Siddiqui and Pennington, 1977). This 
suggestion is based on the observation that the abnormal 
re spo ns e of the red cell Na -K ATPase to ouabain found 
in DMD ery throcytes can be mimicked innorm al erythroc ytes 
by incubating them with DMD plasma. To test whether 
such a factor might be resp o n s i b l e  for the abnormal 
phospholipid organization found in this work, normal 
cells were incubated in the presence of normal and DMD 
plasma prior to p h o s p h o l i p a s e  treatment in the normal 
way .
The c omposi ti on of the fouri major pho spholipid 
classes in normal red ce ll s incubated with normal plasma 
and DMD plasma are similar, and not significantly 
different from red cells not incubated with plasma.
Results are shown in Table 16.
The only diff erenc e is that both groups of incub ated 
cells gave a lower yield of total lipid phosphorus 
(P < 0.001, Stu dent's t test) than the red cells without 
incubation. The red cells incubated with plasma were 
subjected to five washings compared to the four washings 
of control red cells. The lower yield may be due to 
the loss of lipids from red cells in saline in glass
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(Lovelock, 1954) and repeated sàline washing may result 
in total ph os pho lipid loss of up to 25-28% (Rumsby, Little, 
White and Tovey, 1979). However, from the analysis of 
classes, if loss occurs there is uniform loss of all 
phospholipid classes.
The sus ceptib il ity of gly cer op ho spholi pi ds to 
phos pho lipase incubated with DMD and normal plasma 
were similar , but the PC degradation of both groups was 
slightly higher than those from red cells without i n ­
cubation. The d if ferenc e between PC deg radation of 
control red cells and red cells incubated with normal 
plasma was significant (P < 0.02, Student's t test).
But the difference in degradation between both groups with 
incubat ion  is insignificant. Results are shown in Tab le 17 
and Fig . 17.
cells incubated 
with DMD 
plasma 
(n = 6 )
X±S.D. = 56'47±5-3
cells incubated
with normal
plasma
(n-6)
X+S.D = 60 27B±2"79
# **#* #1 \ \ 1 t 1 1 \
^Degradation 
of pc
52 54 56 5& 60 62 64 66
Fig, 17. PC D e g r ada ti on in Whole Erythrocytes I n c u bate d 
with DMD and Normal Plasma.
-133-
H- pdH- (D H- P p pft P4 ft ptj O pltr tr po o cr oO  (D P n> p p
, S  M o_&^ rt Ma  M H H* H' MUi 3 Ui O W*xi p P _M  H- M  H- s;pj 5 H'Ui O no o ft3 0 H* P îtfu cr p tr Op (0 p Pft 3 ct ft(D P PPi Pi
cr> CTt P
UI OV Ul CAPcn O h-|• • • Hi4:5, tsj -0 0-J -J OJ ftIt 00 . It a PUI It •<1 MtoW • tJO -J o> P"vo 0Ui
ppH45. ; 45. CTi H-noUl OO to ■p*-J Ul 45. ÎS piIt It It wW ; U) 45 D* • • p00 00 to Ipo o W HPplPP^
5?»1+COO . o o Ui b
)_i . M , M K• PM ■ m ■ b PUl . It 45. 3It O It oM • o M• -j • Km UiO 00 H-m
oV>
gcrH*(D
H naP pO oP UiP TOP pft 0P h->P H-tJ5: PH- mft pP >n  toSD DpP LPP HiP PP25 P0 ftM H-3 OP PP Onj Hih-*p nap p3 0P wTOP0
j - iH-nop.pp
H-P
5:pOt-*Ps
?ooMr tCD(n
-134-
The total time course of incu bation  (with plasma and 
then with enzyme) of plasma-treated red cells was 4 hrs 
compared with 2 hrs for red cells without incubation.
It is possible that the extra incubation time in the 
presence of plasma depletes the cells of ATP which affects 
the p h o s p h o r y l a t i o n  state of the cytos ke leton and, in 
turn, allows more PC to be degraded at the outer surface.
These results suggest that a plasma factor, if 
indeed one exists, is not responsible for the increased 
degradation of PC in DMD erythrocytes treated with 
pho sph olipase  A^ .
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CHAPTER II MULTIPLE  SCLEROSIS
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1. INTR ODUCTION
1 .1 Epidemi ol ogy and General Features
Mu l t i p l e  Sclerosis (MS) is the commonest neurological 
disease affecting young adults in temperate reg ions (Millar, 
1977). It shows regions of high prevalence (30 to 80 cases 
per 1 0 0 , 0 0 0  population) in northern Europe between 6 5 ^ and 
45° north latitude and in the no rth ern United States and 
southern Canada, as well as in southern Aust ra lia and New 
Zealand (McFarlin and McFarland, 1982). Blacks of African  
origin and orientals, including Eskimos, red Indians and 
peoples of the Indian subcontinent rarely have this disease 
(Aches o n , 1977 ) .
The r is k of first developing symptoms rises steeply 
with age fro m early adolescence, reaches a peak in the early 
thirt ie s and falls away until it becomes trivial in the sixth 
decade, MS attacks women more fre que ntly than men and on 
average at a slightly earlier age (Acheson, 1977).
There is increasing evidence that part, if not all, of 
the g l obal va r i a t i o n  in the frequency of the disease is 
asso c i a t e d  with HLA hap l o t y p e  distribution. The h i s t o c o m p a t ­
ibility antige ns HLA-A^ and HLA-By occur substantially more 
commonly in patients with MS than in persons from the same 
area w i t ho ut the disease. This phenomenon may be secondary 
to an inc re ased frequency of another factor known as the 
mixed l y m p ho cyte culture determinant HLA-DW^* These findings 
give indire ct evidence of the existence of a gen etic factor 
asso ci ated with susceptibility to MS (Acheson, 1977).
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An e n v i r o n m e n t a l  factor has als o  been proposed as 
part, if not all, of the explanation of the global d i s ­
tribu tio n of MS. This proposal is supported by the p r e ­
val ence of this disease in immigrants. Migra nt s from areas 
of high r i s k  to  areas of low risk acquire the lower risk, 
provided that mi gration occurs before the age of 15. C o n ­
versely, people migrating in childhood from an area of low 
risk  to an area of high risk have an increased risk 
(McFarlin and McFarland, 1982). So now it is generally 
accepted that the disease is caused by a c o m b i n a t i o n  of 
genetic p r e d i s p o s i t i o n  and en vi ronmental factor(s ). The 
possible nature of these factors is discussed in the 
following sec tions.
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1.2 Sympt oms
MS is a demyelinating disease ch aracteriz ed by the 
occuiïrence of lesions (plaques) in the central nervous 
system (CNS).
Clinically, MS is highly variable. Sensory, visual 
and motor dysfunction are co mmon in patients with MS, In 
approximately 60% of patients, the disease is initially 
mani fes ted by exacerbations and remissions. In the early 
stages of disease  the r e m i ss ions are usually associated 
with complete  or nearly complete return of normal neurologic 
fun ction, but with each r e m i s s i o n  there is less improvement 
and greater neurologic dys function. The disease enters a 
chronic phase and becomes progressively worse over the 
years (McFarlin and McFa rl and, 1982).
1.2.1 The Plaques
The macros copic lesions range from 1 mm to 4 cm, 
scattered through out the white matter. They are known as 
plaques. New lesions are pink, whereas older ones are grey. 
M i c roscopi ca lly, the char ac teristi c feature is the b r e a k ­
down of the myelin sheath , with relat ive sparing of axons.
In new lesions products from  the break down of myelin, largely 
lipids (esterified ch ol esterol), are found free and in 
mac ro ph ages (McFarlin and McFa rland, 1982). Active 
plaques show glial pro liferation, vas cular izati on , lipid 
products of the breakdown of myelin, perivenular cuffing and 
a shelving or indefin ite edge to the surrounding myelin 
(Adams, 1977). The active plaque also contains macrophages, 
lymphocytes and plasma cells (McFarlin and McFarland, 1982).
-139-
A nal ysis of the plaque tissue shows replace ment of typi cal 
myelin proteins and lipids by glial fibrillar protein 
and cholestery l ester (Davision, 1978).
O l i g o d e n d r o g l i a ^  the myelin-prod ucing cells, are 
reduced in number and frequently absent, at least in 
relatively old lesions (Prineas and Connell, 1978). But 
it is suggested that the primary site of the pathology is 
the myelin me mbrane  rather than the oligodendroglia 
(McFarlin and McFa rland, 1982).
1.2.2 D is tr ibutio ns  of lesions
There are two kinds of lesions in MS. One kind 
extends along the course of a vein while the second kind is a 
c e n t r i f u g a l  ext ension from the edge of a plaque. The plaques 
have a particular preference to follow the contours of the 
third and fourth ventricles. Histological study of lesi ons 
shows a small vein in the centre of nearly all plaques, 
except the periventricular sort (Adams, 1977).
1.2.3 Pr og r e s s i o n  of lesions
Perivenular cuffs in normal or near-normal myelin may 
re pre sent the initial lesion. Coalescence of such small 
lesions along the course (long axis) of a vein or ve nu le  
may be the ini tial event in the formation of a plaque.
An established plaque extends at its periphery rather than 
in the long axis of a vein. The peripheral extension may 
in part depend upon the degradation of myelin by lysosomal 
enzymes (Adams, 1977).
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1.2.4 Re m y e l i n a t I o n
Some lesions may u n d e r g o  a degree of r e m y e l i n a t i o n  
in that a f ew lame llae of new myelin are formed (McDonald, 
1974). The presen ce of abnormally short inter nodes is 
chara cte ristic of r e m y e l i n a t i o n  in the CNS. At least part 
of the r e m y e l i n a t i o n  and repair in MS appears to depend 
on the ingrowth of Schwann cells from peripheral nerves 
and the for m a t i o n  of pe ri pheral-typ e myelin by such cells 
(Feigin and Ogata, 1971).
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1.3 Diagnosis
Although there is no  laboratory test that can be 
used to diagnose MS, changes in physiological condition may 
be helpful.
1.3.1 Physio lo gical tests
I n v e s t i g a t i o n  of visual, auditory, and somatic sensory 
pathways can provide eviden ce of lesions in the r e s p ectiv e 
r eg ions of the nervous system (McDonald and Halliday , 1977).
The fol lowing is a summary of the usually used 
physio log ical tests in the diagnosis of MS.
(a) Visually Evoke d P ot ential s (V E P )
When light falls on the retina, a volley of impulses is 
set up which is tra nsmi tt ed through the optic pathways to 
the occipital cortex, where a respon se  is evoked which can 
be rec or ded with scalp electrodes, using standard averaging 
techniques. MS patients may show a delay in the VEP. It 
is a sens itive  test (McDonald and Halliday, 1977).
(b) Audito ry Ev ok ed  Pote ntials
A high incidence of abnormality in the brain-stern 
component s of the potential evoked by auditory s ti mulati on  
has been reported  by R o b i n s o n  and Rudge (1975 ). Changes in 
amplitude or delayed re s p o n s e s  or both have been found in 
most of the MS patients (McDonald and Halliday, 1977).
(c) Blink Reflex
Most MS patients show delayed blink reflex  re corded 
by a surface electrode over the orb iculoris oculi muscle 
after electrical stimulat ion of the supra-orbital nerve 
(Kimura, 1975).
1
i?
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(d) Elec tro-o cu lograph y
Disorders of eye movement that are not obvious on 
physical exa mi nation may be detected by e l e c t r o - o c u l o g r a p h y .  |
(McDonald^and Halli day , 1977).
(e) E l e c t r o spinogr am
El ec trical stim u l a t i o n  of the median nerve wrist 
evokes a response in the cervical cord which can be dete c t e d  
with skin electrodes and standard averaging methods. MS 
patients will give an abnormal electros pinogram (Small,
Be a c h a m p  and M a t t h e w s , 1976).
(f) Somatosensory Evoked  Response
Abnormal it ies in the lemniscal system can be d e t ecte d %
by recording the so ma tosensory evoked res ponse. S i m u l t a n e o u s  
recording of this respons e and the e l e ct ro spinogr am  may permit ?
a distinction between spinal cord and intraranial lesions 
(Baker, Larson, Sances and White, 1968).
Evoked potential deficits provide evidenc e of a b n o r ­
mality in the sy ste m mediating a response  but are not 
specific to any particular disease process, and MS is not 
the only central lesion which will alter evoked poten tia ls. 
Evoked potential abnormali ti es provide a very sensi tive 
index of central lesions but are not dia gnostic  of MS or 
of any other specific disease process. The i n t e r p r e t a t i o n  
of the significance of an abnormal evoked potential d e p e n d s  
on the clinical context in which it is found (McDonald 
and Halliday, 1977).
i
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1.3.2 E l ectro ph oresis tests and llnoleic acid inh i b i t i o n
1.3.2.1 Red ce Ils 
MS red cells showed diminished ele ctrophoretic mobili ty
in the presence of-=linoleic or arachidonic acids (Field 
and Doyce, 1982; Seaman, Swank, Tamblyn and Zukoski, 1979) 
whilst RBC from normal or c^her neurological disease 
subjects showed increased mobility under these conditio ns.
Field and Ooyce (1982 ) suggested that all el ectro ph oretic  
mobility cha racter is tics of RBC were conditioned by the 
surrounding plasma, and this did not depend upon a chemic al 
interaction betwee n plasma constituents and RBC membra ne s 
but was an im mediate adsorptio n phenomenon. However this 
test is also the subject of contrary reports (Cuypers and 
Reddemann, 1980).
1.3.2.2 Lymphocyte s 
Lymphocytes from patients with MS are much more sus- g
ceptible to the inhibitory activity of linoleic acid on 1
their electrophoretic mobility. MS lymphocytes gave 
91% inhibition while lymphocytes from normal persons showed 
only 57% inhibition (Field, Shenton and Ooyce, 1974). They 
suggested that the ab nor mal handling of unsaturated fatty 
acids was a constant fe ature of the disease. But c o n ­
flicting results have been reported, therefore these tests 
-do not distinguish reliably between MS patients and normal 
subjects (Oenssen, K o h l a r , Gunther and M e y e r - Ri eneker,  1974),
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1.4 Theories for the Path ogene sis of MS
1.4.1 Emb olism
Games (1982) proposed a subacute emboli sm may be the 
cause of MS. Fat may lodge in the m i c r o c i r c u l a t i o n  of the 
nervous system and cause distal perivenous oe de ma  with the 
loss of myelin from axons. The m a i n  evidence to  support this 
hypothesi s is the finding that most of the small acutely 
demyelinated areas surround a cap illary or, more  usually, 
a small vein. In addition he drew attention to  the 
similarity of the neur ologi ca l symptoms observed in MS 
patients and divers suffering from nitrogen emboli resulting 
from too  rapid dec ompression. As vascular damage  and gl iosis 
are commonly found outside plaques, they mig ht be the primary 
event in MS and not secondary to the r e l e a s e  of any toxic 
products of demy elinatio n or to an i m mun ol ogical attack on 
m y e l i n .
The proposed events and fo rmation of plaques in MS 
are summ arized in the following figures.
Initial Pulmonary Secondary
event embolism embolism
(delay ) To:
Fat cell . lung
necrosis ' filter
Brain
I--------------------- f Cordve nous fat i
emboli --------------- > j ^ | — ----- ) Retin a
,  ^I & Men inges
I ^ I —  ) Skin
Fig. 18. Mec ha nism by which subacu te fat
embolism causes MS (after Games, 1982).
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)lus thrombascortex
capillary venule
plaque
area of hypoxica and endothelial damage
Fig. 19. Theor etical r e c o n s t i t u t i o n  of plaque 
f o r m at io n in MS (after Games, 1982; 
based on Dow and Berglund, 1942).
Games (1982) suggested that depot fat is the major 
source of embolic fat in acute fat embolism. The properties 
of depot fat may c o n t ribu te  to some fea tu res of the disease. 
Depot fat may be hydr o l y z e d  by endothelial lipases to 
r e l ea se  toxic fatty acids, and it may also contain cellular 
debris. The spectrum of fatty acids rel eased depends on the 
c o m p o s i t i o n  of body fat which in turn is a r e f l e c t i o n  of 
the diet.
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He also suggested h y p e r b a r icoxygen treat men t as an 
effective method  to treat MS patients, as it had been used 
on animals with e xper im ental allergic e n c e p h alomy el itis (the 
experimental-=model for MS) and produced good re sul ts 
(Prockop and Grasso, 1978). This hyp oth esis has been 
cr iticized by several clinicians including Adams and High 
(1982), who have not detected any fat embolism  in their 
MS ti ss u e - b a n k  which has CNS material from 104 cases. A l s o  
this hy pothes is  does not explain the i m mu no logica l fin di ngs  
in MS .
(Blood samples fro m  MS patients before and after 
hyperbaric tr eat men t were studied in this w or k to  c o m pa re 
their ac ti vit ies of peroxidati on  protective enzymes),
1.4.2 Virus infection in CNS and impaired immune r e s p o n s e  
(au toimmune r e s p o n s e )
Several lines of evidence lead to the suggestion that 
MS is a virus induced immune disease, i.e. a c o m b i n a t i o n  of 
envir onm ental fa ctor (virus infection) and impaired immune 
re spo nse (genetic factor).
Patients with MS were found to have had more chi l d h o o d  
infections, indicating there had been problems in con tr olling  
various types of childhood infections (Lamouneux, Giard, 
Golicoeur, T o u g h l i a n  and Desr osiers, 1976). Serum of MS 
patients show incre ased antibody levels, part of which was 
directed against the brain itself (Ryberg, 1976). W h il st  
a small p r o p or tion reacted with various my xo viruses ( p a r ­
ticularly measles) (Davison, 1978; Lamoureux et al., 1976; 
Adams and Imagana, 1962; McFarlin and McFarland , 1982).
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However the antibodies against many naturally occuring 
antigens (i.e. other viruses) were decreased  in serum of 
MS pat ients (Lamoureux £t aj.., 1976).
Most MS patients contained ol ig oclonal  IgG in their 
C S F , a small part of this IgG was measles vir us specific 
(Fraser, 1977). Measles -v irus genome has been found in 
the brains of some MS patients by in situ h y b r i d i z a t i o n  
(Haase, Ventura, Gibbs and T o u r t e l l o t t e , 1981), even 
though viral particles can not be vis u a l i z e d  (McFarlin and 
McFarland , 1982).
The whole idea is summarized by the h y p o th es is of 
Simon (1982), which was based upon expe ri ences with animal 
model systems of v i r u s - in du ced disease.
He proposed that a vir us can act as the initiator of 
an auto - r e a c t i v e  immuno p a t h o l o g y . Several ubi quito us  RNA 
and DMA virus, e.g. myxoviruse s, may be involved in the 
pathogenesis of MS. Their genome codes for peptides appearing 
on the plasma membrane of the host cell as neo-antigens.
The vir us initially attacks the mesoderm al cells of the CNS, 
from which it can spread to neuroectoderm.
A gene tically determined deficiency of the immune 
system then permits the persistant infection by the virus. 
V i r u s - s p e c i f i c  antigen and/or the c om binatio n of virus- and 
h o s t - s pe cific  antigens will change the antigen pattern of 
the ho st-cell membrane. Pathological cellular and/or 
hum oral immune and auto immune reactions prefe rentially  affect 
those infected cells and their processes since those cells, 
carrying the neo- antigen s and/or altered se lf-antigens , 
are more sensitive to immunolog ical inquiry than n o n i n ­
fected cells. A structure with a slow turnover may be
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par ticularly susc ept ible; such a structure is myelin. 
I m m u n o patholo gy  and cyt otoxic virus action can damage the 
myelin sheaths or the oligo dend rocytes  and lead to 
d e m y e l i n a t i g n .
This hypo th esis can explain the immuno logic al fin di n g s  
(which will be discussed in more detail in a later section) 
in MS and the pathology, du ration and course of MS are all 
co mpatible  with phenomena seen in var ious virus infections.
More work is needed to confirm this hypothesis, especially 
the isolat io n and cha rac teriza ti on of the viru ses involved,
1.4.3 Fatty acids
This theory proposed a dietary deficiency Ih unsaturated i 
fatty acids (PUFA) or an inborn error of fatty acid 
me tabol is m is the main factor in the pathogeneiss of MS, 
but does not exclude the possible assoc ia tion with the attack 
of a pathogenic agent, e.g. virus, and an autoimmune response. 
Swank (1953) suggested that the high prevalence of MS in 
the more nor th e r n  countries was due to  the high sat urated 
fat intake (relatively deficient in PUFA) of the gene ral 
po pulatio n in these areas.
An in her ited or acquired failure of fat tr ansport in 
the blood of MS patients would l e a d t o  intravasal a g g r e g a t i o n  
of red cells and platelets, and would bring about p e r ­
ivascular demye l i n a t i o n  by r e d u ctio n of oxygen avail ab il ity 
in brain tissue and, by an increased permeability of the 
mic r o c i r c u l a t i o n  of the brain, allow surface active ma t e r i a l s  
(probably virus) to invade brain tissue and un wr ap myelin 
sheaths (Swank, 1970). A predominance of saturated and m o n o - I
I
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u nsa turated  fatty acids might als o  bring about an increased 
rigidi ty of CNS membranes, rendering them more su sc eptible 
to the attack of a pathogenic agent (Alter, Yamoor and Harshe, 
1974). Eylar (1972) sugge ste d that a virus infecting the 
CNS might switch from its norma l behaviour of lipid 
i n c o r pora ti on to increased  inc orpora ti on of CNS protein 
into its envelope. Be c a u s e  of its large size and l i p o ­
protein nature, this complex would be highly im munog enic 
and cause a u t o i m m uni za tion.
Lipid changes in v a r ious tissue, e.g. CNS, serum, red 
cells and lympho cy tes will be discussed in more detail in 
the next section.
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1•5 Bioc hem ical Findings
1.5.1 Lipids
1.5.1.1 RBC and platelets
Ph os pholipi d class distribu tion was found to be normal )
in RBC from patients with MS (Homa, Belin, Smith, Mon ro
and Zilkha, 1980). The most consistent finding relating j
to the fatty acid c om positio n of red cells from MS patients 
was a significantly lower level of linoleic acid (18:2)
( K u r a u t s i n - M i l l s , Sainji, M o s c a r e l l o  and Boggs, 1982; Homa 
et al., 1980; Gui, Smith, Thompson, Pa yling-Wright and |
Zilkha, 1970) and there was a highly significant corre lat ion 
between serum li noleate  and red cell linoleate (Gul ejt , |
1970). A similar finding was reported in platelet (Gul 
et a l ., 197 0).
Kur ant sin- Mills e;fc , (1982) found that the lower 
level of linoleic acid was more prominent in in- patients 
than out-patient s, and suggested that this phenomenon might 
be related to the course of the disease. In healthy controls  
an inverse c o r r ela ti on was found between the percentage 
of linoleate and arachidonate, but in MS patients, such an 
inve rse  co rr e l a t i o n  was not found, even though the mean 
level of arac hi donate  was normal (Homa £t a_l., 1980). They }
sug gested that there was an abnormality in red cells of MS
'patients with regar d to the regulation of the relati ve amounts f
of un satur ated fatty acid. In a later report by Homa (1981) J
an increase in li gnoceric acid in the SM fraction of red 
cells was demonstrated  but its signif icance for the patho- |
ge nesis  of the disease is unclear.
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1.5.1.2 Lymphocyte s
Much less work has been done on the fatty acid 
comp one nts of lymphocytes from MS patients. The total 
fatty acid content of lymphocy tes is reduced in MS 
(Thompson, 1975). Linol ea te levels in lymphocytes 
obtained from  MS patients have been found to be si gn ificantly 
below the normal level (Tsang, Belin, Monro, Smith,
Thompso n and Zilkha, 1976 ), probably due to decreased 
linoleate inc orpora ti on rep orted  by Thompson (1975 ). A 
good corr e l a t i o n  was found between the linolea te level 
of the plasma non-ester if led fatty acids and that in the 
lymphoc yt es (Smith and Thompson, 1977).
1.5.1.3 Serum
L i n o l e a t e  was found to be significantly decreased in 
MS serum (Baker, Tho mpson  and Zilkha, 1964; Belin, Pettet , 
Smith, Th o m p s o n  and Zilkha, 1971; Rosnowska, Piesio and 
Cendrowski, 1979; Sanders, Thompson, Wright and Zilkha,
1968; Vymazal , Ticky and Vonkova, 1977) and the degree 
of decrease seemed co rr ela ted with the det er ioratio n in the 
patients conditi on  (Baker e ^  , 1964). Normal serai
linoleic acid in MS was also reported by several l ab or atories  
(Karlsson, Ailing and Svenne rholm, 1971; Shukla and Calusen, 
1978; Tuna, Lo gotheti s and Kammereck, 1963; turnings, Sh o r t m a n  
and Skulic, 1965). One grou p's  findings (turnings £t a l ., 
1965) of a normal, serai linoleic acid level were doubtful 
as they used non-fasting serum samples for the experiment 
and the number of patients used was small, and as minimal 
clinical details have been given as to the state or extent 
of the di sease it is hard to evaluate the r e sult s (Smith 
and Thompson, 1977).
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Triene and tetr aene fatty acids have  been reporte d 
to be normal (Shukla: and Clausen, 1978) and reduced
(especially linolenic and arachidonic acid) (Rosnowska 
et a l . , 1979). On the other hand, saturated and -= 
m o n œ n o i c  fatty acids of cholesterol esters were found to 
be increased (Vyma et. ëA.* » 1^77) while the level of 
triglyceride, cholest er ol, p h o s p h o l i p i d  and their fatty 
acid pattern were normal according to a not her'lab or at or y 
(Karlsson e;t , 1971). '
In summary, li nol eate was found to be decreased in 
red cells, platelet, ly mphoc ytes and serum and its 
decrease seems cor rel at ed with the progress of the disease. 
This phenomenon has led to the suggestion that the 
absorption or the m e t a bol is m of linoleate of MS patient 
may be defective. Supple menta ti on with linol ea te in the 
diet has been tried. But the rise in lino le ate.and  fall 
in oleate after the tre atment were the same in control and 
MS patients, proving that there was no defect in absorption 
from intestinal lumen in the patients (Belin e ^  1971).
These authors sug gested that when the amount of available 
linoleate increase d dramatically, the related metabolic  
pathway may be functioning normally, whereas in the absence 
of these large amounts of linoleate an al te rnative me tab olic  
pathway was in operation which was defective in MS. However, 
no finding of a defective lin oleate metabolic pathway has 
been report ed so far.
1.5.1.4  Brain
Very many reports  about the lipid and fatty acid profile 
of the norma l-loo king white matter and myelin and of plaques
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from MS have been published. They are summarized in the 
following tables (Tables 18 and 19).
No consistent change s in lipids in n or m a l -looki ng 
white matter can be found, except perhaps inc reased 
chol est erol esters which are known to be myelin -b reakdow n 
products and formation of cholesterol esters is there fore 
a likely initial lipid c h ange before true myelin- breakdown. 
Research on lipids in normal-look ing white matter is complicate' 
by the overlooking of minute lesions which are perhaps the 
reason  for conflicting r e s ults reporte d here.
Fewer reports are available concerning lipid compos it ion 
of plaques. This could be due to ava ilability of ma ter ial 
but also be cause study of normal-looking white matter can give î 
more inf o r m a t i o n  about the initial changes resulting in 
the lesions rather than examining the already deteriorating 
parts of the brain.; In plaques there was an increase in 
water content and an exte ns ive loss of all three classes 
of lipids - cerebroside, sul phatide and total phospholipid 
(Yanigihara and Cumings, 1969; Einstein, Dalai and Csejtey, 
1970). PE in plaques was decreased, and was balanced by 
in creased amounts of PC (Cuznen and Davison, 1979). Gang- 
lioside content of plaques was increased (Yu, Ledeen and 
Eng, 1 9 7 4 ) . and showed many changes in com po sitio n from the 
normal white matter. The major m y elin  gangliosid e, GM^, 
was dec re ased  in plaques and there was complete absence of 
sia lo sylg al ac tosyl  ceramide (Gy) (Cuzsez and Davison,
1979). As found in normal looking white matter and myelin, 
cholesterol esters were found to be incre ase d in plaques 
(Cuznez and Davison, 1973). This suggests that the initial
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Table 18 Lipids in Nor ma l-Looki ng  Whlite Matter and Myelin
Lipids Results Referenc es  |
total
lipids
normal Guzner and Davison (1973); Gerstl, ^ 
Tavastst .1er na , Hayman and Bond (1967):
d ec r e a s e d W i n t e r f e l d  and Debu c h  (1977) ^
total
ph os ph olipid'
normal Fewster and H i r o n o  (1976); 
W in ter fel d and Debuch (1977)
total normal Fewster and H i r o n o  (1976);
ch olesterol decreased Win te rf eld and Debuch (1977); 4 
Cumings and Goodwin (1968) |
i ncr eased Shah and Oohnson (1980)
PC normal Fewster and Hi ro n o  (1976); Win t e r f e l d  
and Debuch (1977)
increased Cumings and Goodwin (1968)
PS normal Einstein, Dalai and Csejtey (1970)
decreased Wi nterfeld  an d  Debuch ( 1 9 7 7 ) ;  , 
Clausen and Hansen (1970) J
incr eased Davison and Wajda (l962) I
PE normal iWi nt erfe ld  and Debuch (1977); | 
Cl ausen and Hansen (1970)
decreased Cumings and Goodwin (1968); Gerstl, | 
Tavastst jer na, Hay man , Eng and Smith ? 
(1965) 1
.... ..........  j
PI decreased
..........  ;
Clau sen  and Ha nsen (1970)
et han ol amine
pl asm alogen
decreased Gerstl et al. (1965); Win terfe ld  and 'I 
Debuch TT977) ;
plasmalog en normal Fewster and Hi ro n o  (1976); Suzuki, 
Kamoshita, Eto, Tour te H o t  te and f 
Gonatas (1973)
decreased Gerstl, Tavastst jerna, Hayman, Smith 1 
and Eng (1963); Da vi son and Wajda I 
(1962) .............
3
t
■
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Table 18 (Continued)
Lipids. Results References
cerebr osi de normal Eng, Chao, Gerstl, Pratt and 
T avastst ierna ( 1 96 81)
de creased Gerstl, Eng, Tavastst j er na, Smith 
and Kruse (1970); Cumings and G o o d ­
win (1968)
increased Clausen and Ha nsen (197u;
ch olester ol 
esters
increased Shah and Oohnson (1980); Cuzner 
and Davison (1973); D a v id son and 
Wajda (1962)
SM normal fewster and H i r o n o  (1976); Cumings 
and Goodwin (1968)
decreased Davison and Wajda (1982)
sulfatide normal Fewster and Hirono (1976); Gerstl, 
Eng, Hayman, Tavastst jerna and Bond 
(1967)
dec reased Clausen and H a ns en (1970)
increased Cumings and Goodwin (1968)
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Table 19 Fatty acids (FA) in Normal-Looking White 
Matter and Myelin
Fatty acids Results References
FA and aldehyde 
co mp o s i t i o n  of 
ch olester ol 
ester s ,
ph osph oglycer - 
ides and 
sph ingolipid
normal Fewster and H i r o n o  (1976); 
Gerstl et al_. (1970)
^16*1 total 
lipid fraction
increased Clausen and Ha ns en  (1970); 
Boggs and M a s c a r e l l o  (1980)
decreased Thompson (1972)
PC sat uration normal Arnetoli, Pazzag li and A m a ducc i 
(1969)
decreased Clausen and Hansen (1970)
increased Baker, Thompson and Zi lkha  
(1963)
^ 1 8 : 0 ’ ^18:1 
in PC
decreased Winterfeld and Debuch (1977)
^20:4 decreased Clausen and Hansen  (1970)normal Arnetoli (1969)
^16 :0 increased Winterfeld and Debuch (1977)
PE u n s a t urat io n increased Clausen and H a nse n (1970)
^18:1 decreased Arnetoli e_t al. (1969); W i n t e r ­feld and Debuch (1977)
^2 0:1 PE decreased Gerstl et a l . (197 0).normal . . Fewster and H i r o n o  (1976)
pol yenoic acid 
in PE
increased Ailing, Vanier and S v e n n e r h o l m 
.(1971) . ,
.e|
j
-1
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Table 19 (Continued)
Fatty acids . Results .References !
^18:1' ^ 20:1 
aldehydes
decreased W i n t er feld and Debuch (1977); 
Arnetoli e ^  H ., (1969)
mono-e noi c 
acid in SM
n ormal Clausen and H a n s e n  (1970)
^24:1
cerebroside
increased Ailing et al. (1971) 1
decreased Gerstl et a l . (l970)
■A
Polyenoic acid 
in P E , PC and 
other glyeero- 
ph osphatides
inormal Fewster and Hi rono  (1976)
1j
^ 1 8 : 3 ’ ^22:3' 
^24*1 total 
lipid fraction
decreased Boggs and M a s c a r e l l o  (1980)
FA content increased C la use n and Hansen (1970)
i
1
^22,4 PE decreased Geopfert (1980)
^ 20:1 PS decreased Geopfert (1980) 1
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lipid change in d e m y e li nation  is the fo r m a t i o n  of chol es terol 
esters, though the si gn i f i c a n c e  of this finding in the 
m e c h an is m of d e m y e li nation is still unclear.
The unsa turat io n of fatty acids was reported
to be decreased (Amaducci, Pazzagli.a nd  Pet ruzzi, 1965).
In a recent study of the sph ingolipid of the MS 
plaques (Yahara, 1982), the non-hydroxycer ebro side , 
h y d r o x y c e r e b r o s i d e , n o n - h y d r o x y s u l f a t i d e  and h y d r o x y s u l f a t i d e 
were decreased by over 99%, but the r e l a t i o n s h i p  with the 
de myelina tion process was not discussed.
Although there are many confli cti ng re po rts  about 
the fatty acid profile in normal looking white matter and 
plaques a general trend can still be established. Ce rt ai n  
mono- or p o l y u n satu ra ted fatty acids were low in one or 
other of the f r a c t i o n s  isola ted from MS brains. This 
supports the h y p o t h e s i s  that the myelin sheath may be 
chemically  altered during developmen t, principally due to 
a relat i v e  dietary deficiency  of unsaturated acids. Others 
suggest that the fatty acid changes observed in the di seased  
brain re fl ect some d i f f e r e n c e  in lipid met abo li sm leading 
to altered myelin either during initial synthesis or normal 
m a i n te na nce (Smith and Thompson, 1977).
1.5.1.5 CSF
It has been suggested that lipid changes in CSF may 
or ig inat e from lym p h o c y t e s  and serum due to d y s f uncti on  of 
the blo od- br ain barrier. So any changes rather reflect the 
changes in serum or blood cells and indicate  ^ dysfunction 
of blood-brai n barrier, than reflect a local change in CSF.
In creas e of SM in CSF was thought to originate
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from di si ntegr ated lymphocytes, (Seidel, 1980). Li n o l e a t e  
was found to be increas ed in CSF, which was sugge ste d to 
come from serum due to dysf un ction  of the br ain -blood 
barrier, although the same acid was found to  be decreased 
in serum (Seidel, 1980; 1981). Pedersen (1974) re por te d 
a decrease in phos pholi pi d and PE, but an inc re ase in 
esterified c h o l e st erol in CSF of MS patients
1.5,2 Enzymes
1.5.2.1 Red cells, ly mphoc ytes and serum
Decreased e r y t hroc yt e g l u t a th ione pe ro xidas e (GSH-Px) 
activity has been reported by Szeinberg (1979) who studied 
Israeli Jews and Shukla, Jemsen and Clausen (1977) who 
examined a Danish group. ' Both groups sugge ste d a selenium 
deficiency might be the cause of the observed decreased 
GSH-Px activity since seleni um is an essential part of the 
enzyme. However, Jensen (1980) found incr eased  selenium 
in MS red cells but normal levels in serum or whole blood. 
An other enzyme which is involved in pr otecti on  against 
pe rox idation, g l u t a t h i o n e  reducta se  (GR) was re port ed  to be 
slightly decreased (but n o n - s i g n i f l e a n t l y ) in red cells 
(Jensen, 1980), These findin gs  suggest that sus cept ibilit y 
to me mb rane lipid per oxidati on  is increased. If these 
changes in red cel ls reflect the same chan ges in CNS, 
these fi ndi ngs may have important sign i f i c a n c e  in the p a t h o ­
gene sis  of the disease. It has been shown that in rats, 
GSH-Px activity in red cells increases in parallel with 
that of brain during dev el opmen t (Sinet, De jeune and Jerome,
1979).
In serum, inc re as ed g-D-glu curon id ase activity and
“16 0 —
abnormal y -glutamyl tr an sferas e were reported (Jensen,
1980; Rieder , Zurfluh and Oegge, 1977). The latter ch ang e 
might reflect di sturbed  liver function, but no liver m a l ­
f u n ct ion has even been ass ociated with MS.
D e m y e l i n a t i o n  has been considered to be the re su lt 
of increased hyd r o l y t i c  enzyme activities. The source 
of those enzymes was suggested, in part, to be l y m p h o c y t e s 
which in fi ltr ate from a vein into the lesion region.
Some lysosomal enzymes, e.g. acid pho sphatase were in creased  
in gr an u l o c y t e s  and g-g lu curoni da se was also i n c r eased  
in lymphoc ytes during the relapse period (Riekkinen, and Palo, 
1977). They sugge sted lysosomal enzymes were act ivate d by 
some unknown m e c h a n i s m  during demyelination. Cuzner,
Da vi so n and Rudge (1978) demonstrated  increased neutral 
p ro tei nas e but de cre ased acid proteinase in MS leukocyt es, 
Rast ogi  and C l au se n (1981) studied the soluble e n z ym es  of 
p er iph era l poly m o r p h o n u c l e a r  leukocytes and found they 
de gra ded more basic protein and Wolf gram protein in MS 
myelin than normal myelin.
1.5.2.2 CNS
It is g e n er ally accepted that the observed incre as ed 
acid proteinase activity in and around the plaques is 
re sponsib le for the d eg radati on  of myelin basic protein 
(Einstein, Dalai and Csejtey, 1970; 1972; Riek ki nen,
Clausen, Frey, Fog and Rinne, 1970; Cuzner and Davison,
1973). Einstein et (1972) observed a g r a die nt  of
acid protein ase  activity, increased from control white 
matter with di st ance from the centre of the plaque. They 
proposed the enzyme might be derived from ly sosomes in the
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neurogl iai  cells which proliferate at the rim of active 
plaques. The smaller enc ephali togeni c peptides  that are 
re le as ed from the degraded myelin basic protein would be 
able to lelve the brain and stimulate im mu norecep to r sites 
and the resul ting antibody or sensitized cells (or both) 
could provoke further vascular and myelin damage (Einstein 
et a l ., 1972).
Other changes in the lysosomal and other enzymes in 
the pl aq ue s are summarized in the following table (Table 20).
The increase in phos ph atase and phos pho lipas e may 
explain phos pholip id  bre ak down in myelin while decreased 
activity of choleste rol ester h y d r ol ases was considered to 
be the cau se of the g e n e ra li zed increase of ch olest erol  
ester in the plaques and myelin. However^ the me ch anism of 
the activat ion of these lysos omal enz ymes and their source are 
still obscure and is an important question to be solved for 
the u n derst an ding of the actual m e c h an ism of demyeli nation.
1.5.2.3 CSF
The source of the enzymes in CSF in MS patients is 
probably largely from re gi ons  of ac tive demyelination.
Neutral and acid proteinase have been found to be 
ra is ed  in CSF (Cuzner, Davison and Rudge, 1978; Richardo,
Cu z n er,and  Cuzner, 1978). 2 ' 3 ' -cyclic n uc leotide  3^-
ph o s p h o hydrol as e is absent in normal CSF but was found to
be incr ea sed in CSF from  MS patients (Banik, Mauldin and
1Hogan, 1979; Eickhoff and Heipertz, 1979). Johnson and
Shah (1981) observed dec reased activity of neutral ch ol esterol
ester hydro la ses in CSF from patients with MS and this
enzyme may be resp o n s i b l e  for the increased chole sterol
ester o b s er ve d in CSF and in CNS. 1
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Table 20 Enzymes in the Plaques of MS Patients
Enzymes Ob se rv ati on Proposed
source
Re ferences
6 -a luc uronidase increased C u z n e r ,a rtd 
Davison, 1973ary Isulp ha tase increased
acid ohosohatase increased astr ocytes 
or
macrophag - 
es
Hirsch, Duquette 
and Parks, 1976; 
Allen, 1979
acid lipase- 
__esterase
decreased
lactic d e h y d r o ­
genase
incr eased
ester hydr ol yses decreased Shah and Johnson, 
198 0ester if ying enzyme
decreased
pho sphol ip as e increased W o e l k , Peiler - 
Ichikewa, 1974
cho leste ro l e s t e r - 
ifvino enzvme
decreased S h a h , Johnson, 
198 0
ch ol est er ol
ester
hydr olase
decreased
Cyclic AM Pase decreased Geopfert, Pytlik 
apd Debuch , 1982
    '     '  ^  '
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1.5.3 Basic protein and its fra gmen ts  in CSF and plaques
Basic protein is the main protein in myelin and during
demyelination, br ea kdown fragments of basic protein are 
rele as ed  i nto  CSF, and act as an indicator of myelin b r e a k ­
down (Gutstein and Cohen, 1978; Cohen, 1978 ; Bashir and 
Whit ake r, 1980). Carson, Barbarese, Braun and M c P h er so n 
(1978) detected these compo nents in CSF by r a d io im munoas sa y 
for myelin basic protein. In add ition to intact myelin and 
proteolytic f r a g men ts  of myelin basic protein, a protein of 
unknown origin was found, which was specific to MS patients. 
They proposed this unknown protein might be rel at ed to 
d emyel in at ion and might be one of the following, (i) an 
abnor mal  form of myelin basic protein in myelin which caused  ^
it to br ea k down, (ii) a modified form of myelin basic 
protein produced during demyelin at ion or (iii) a nonmyelin 
protein which, bec ause of its antigenic similarity to 
myelin basic protein, induced an autoimmune re sp onse direct ed 
against the p a t i e n t s ’ myelin. But the antigenic nature of 
this unknown protein and its r elati on ship with dem yeli natio n 
has not been confirmed.
P o l y a c ry lamid e gel el ectrophor esis of plaque proteins 
shows ex tensive loss of myelin proteins (especially basic 
protein) and an equally significant increase in a high 
molecular weight peptide fragment which might be the b r e a k ­
down products of basic protein (Newcombe, 1980). As in 
CSF, this is an indicator of active demyelination.
1.5.4 Serum factors
A serum factor from MS patients was foun d to inhibit 
RNA synthesis of normal lymphocytes (Knowles, Hughes,
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Caspary and Field, 1968; van den Noort.and Stjernholm,
1971) but this effect could not be reproduced by others 
(Anderson, Sweet and Arme nt rout, 1979). This factor 
has been identified as a lymph otoxic factor. A more 
accurate and specific d esigna ti on is lymphocyte t r a n s ­
f o r mation inhibiti on factor (LTIF). LTIF inhibited the 
blast t r a n s f ormati on  of normal cultured lymphocytes 
stimulated by phytoha emagg lu tinin (PHA) (Cendrowski and 
Niedziekka, 1970; And e r s o n  e_t a_l. , 1979) or in the pr esence 
(Armentrout, Sweet and Galant, 1981; Jenen, 1968) or 
absence (Schocket, Wein er, Walker, McIntosh and Kohler,
1977) of other mitogens. Anderson et. (1^79) indic ated 
that LTIF inhibit ed RNA protein and ONA synthesis, in later 
stages of the tran sf ormation. This factor has been is olated 
and identified by White, Armentrout and van den Noort 
(1975). It is a protein with small molecular weight, heat 
stable, n o ndialy za ble and was transient,being most often 
found during exa cerbati on  and with high grades of disab ility,
T-cells were particul arly sensitive to this factor (White
a_l. , 1975; Ar me ntrout  ^  a]^., 1981). LTIF may be a h u m or al  
co mpo nent found in MS patients, as an important mod ulat or  of 
the immune system (Armentrout £t , 1981). In ad d i t i o n  
a serum factor is thought to be responsible for the 
abnormal ele ctr op horetic  mobility seen in ery throcytes 
incubated with l i n ol eate (see section 1.3.3.1).
1.5.5 Im mu no g l o b u l i n s  in cerebrospinal fluid ( C S F )
In the majority of MS patients, the level of IgG in 
CSF is elevated (Kabat, Glusman and Kna^b, 1948). In MS,
IgG is synthesi zed locally, ise. within the CNS.
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The CSF IgG in MS is relatively homogen eous in charge  
and following e l e ctroph or esis is distributed in a small 
number of di screte  {oligoc 1 onal ) bands (Johnson and 
Nelson, 1977). The oligoclonal pattern shows the high est 
incidence of any abnormal finding in MS (Thompson, 1977).
It is a cons is tent finding that in about half the 
MS patients the K;X ra ti o for light chains in serum is 
normal (i.e. 1 .0 ), but the ratio is higher (approximately 
2.0) in CSF (Thompson, 1977). When the B lym phoc yt es from 
CSF were typed, they showed the same elevated K:A r a t i o  
for light chains (Sand berg-Woll heim and Turesson, 1975),
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1 .6 Physical Properties
1.6.1 Red cells 
An increase in red cell fragility in MS patients
has been reported by several laboratories (Stasiw,
Rosato, Mazza and Cerry , 1977; Schauf, Frisc her and Davis,
1980; Kurants in -Mills , Sainji, M o s c a r e l l o  and Boggs, 1982 ), 
Caspary , Sewell and F i e l d . (1967) reported ac ti ve cases of 
MS had more fragile red cells than the inactive ones 
which were in di stingui sh able from  controls,
A recent study (Pollock, Ha r r i s o n  and O ’Connell, 1982 ) 
on red cell def or mability demonst rat ed no signif icant 
differe nce  between MS patients and normal. An increase in 
diameter in red cells from patients with MS was reported 
by Prineas (1968). Kur ant sin-Mills ej^ aj^. (1982) reported 
normal membra ne fluidity and morphology in red cells from 
MS patients.
The changes in the physical properties in red cells 
tell little about the pathogenesis of dem yelina ti on, but 
may be related to the increased platelet stic kines s reported 
since platelet stickiness is known to be influenced  by the 
ad en osin e diphosphate (ADP) liberated by the red cells.
1.6.2 Platelets and myelin 
Caspary, Prineas, Miller and Field (1965); Sanders,
Thompson, Wright and Zilkha (1968); Wright, Thompson^a nd 
Zilkha (1965) reported increased platelet stickiness in 
MS patients and Sanders £t aJ^. (1968) found a significant 
inverse co rrelation  with ch ole steryl linoleate in serum, which ;
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is absent in healthy controls. Similarly, Wrigh t e^ t a^, (1965) 
proposed that the increased platelet a d h e s iv en ess might 
be due to lowered linoleate level in the serum. Field 
and Cas pary (1964) studied platelet stickin ess  by aT 
different approach. They found addition of a highly 
enceph alit og e nic factor derived from hum an  bra in  to plasma 
of MS patients in an acute phase increased the stickiness 
of their platelets and the stickiness ran parallel with the 
activity of the disease process. Surprisingly , addition 
of e n c e p h a li togenic  factor to normal human serum decreased 
platelet adhesiveness.
Besides proposing that lowered linolea te  in serum 
explains the increased platelet stickiness observed in MS 
patients, Prineas (1968) and Caspary (1967 ) related
increased platelet stickiness to changes in size and 
fragility in MS red cells. They suggested the changes in 
these physical properties might imply some change in RBC 
membrane properties, probably involving phospho lipid, which 
would in turn allow lib e r a t i o n  of excess ADP or other fact ors 
from red cells, resulting in increased platelet stickiness. 
Caspary ejb, aJL- (1967) discussed the important significance 
of increased  platelet stickiness in the pa thogenesis of MS. 
They indicated that platelet aggregati on might occlude the 
small vei ns within the nervous system and lead to re ve rsi ble 
or irr ev ersible  changes, depending on degree and duration 
of obstruction. This theory is rem iniscent of that of 
dames (1982) and provides a more plausible cause of blood 
vessel occlusion. However, the cri ticism that no abnormal 
vascular pathology has been observed is equally applicable
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10 this idea,
Boggs and M a s c a r e l l o  (1980) studied myelin fluidity 
by ESR and f l u o r e s c e n c e  polar i z a t i o n  spe ctroscopy and 
found there was no di fference in fluidity between MS myelin 
fro m nor mal-looking white matter and normal myelin. This 
might imply there is no gr os s change in the physical state 
of the lipids of MS myelin before demyelin ation .
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1.7 Immun ologi ca l F i n di ng s
1.7.1 Viruses
The idea that MS could be a slow virus disease or more 
likely, a vi r u s - i n d u c e d  immune disease came from the finding 
that there is the presen ce of a measles virus-s pe cific IgM 
in the serum and the ol ig oclonal synthesis of IgG in brain, 
part of which is measles virus specific (Fraser, 1977) in 
MS patients .
Attempts to isolate the virus have met with little 
success .
The results are summarized in the following table 
(Table 21).
Prineas (1972 ) sug gested that MS lesions might be 
initiated by seeding of lymphocytes bearing latent p a r a ­
myxovirus to white matter of the CHS. Viruses can modify 
major serologically determined  histo compat ib ility antigens 
(Doherty and Zw ike rnage l, 1975), which will become targets 
for cytotox ic r e a c tiv it y (Schrader, C u n n in gh am and Edelman, 
1975). Thus the in teractio n of a virus with neural tissue 
in MS could alter antigenicity, causing the induction of 
an immune reaction. If a virus is involved in the p a t h o ­
genesis of MS, it may well be a latent persistent virus, 
since the int erm itten t advance shown by MS may be related 
to acti vation and spread of a persistent virus (Fraser, 
1977). The presence of a virus in MS patients is further 
su ggested by the changes in cellular immunity and humoral 
fact ors  observed in MS pa tients.
•I':...-
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Table 21 Viruses Is olated in CNS of MS Patients
Virus S ource Refer en ce
virus 6/94 MS brain Lewandowsk i,  Wa ters
(type 1 par ainflue nza cultured and Koprowski, 1973 ■-!v i r u s ) cells
g p -1 parainfluen za fusion of MS Menlen, Kopro wski,
virus brain tissue Iwasaki, K a c hell Sculture cell and Muller, 1972
with indicator
cell
pa ram yxovirus mononuclear Pr ineas , 1972
nucleocapsids cells i n ­
filtrating the
zone of lesion %
a t h e r mo la bile CSF M e l nick and Seidelf i l t er ab le virus 1982 *
'"i
The results are inconsistent and highly doubtful 
as only one or tw o  MS patients were used.
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1.7.2 Cellular immunity
There are three properties of the immun e system in 
MS that have led to the theory that cell-me dia ted immune 
mechanisms may be involved  in the production of the' 
disease ;
(1) Lymp ho cytes are present at the sites of the lesions.
(2) There are changes in the types of lymphocytes and 
their fun ction s both in vit ro and vivo during the 
course of the disease.
(3) There are s imil ar ities bet ween MS and some known 
autoimmune diseas es both in human beings and animals.
Some a b no rmalit ie s were found in the lymphocy tes,  
which might be v i r u s - i n d u c e d  or genetically determined. A 
normal distrib ut ion of B. and T cells in MS patients was 
found by Lamoureux, Giard, Solicoeur, To ughlian and 
Desrosi ens  (1976) and Sant oli, Moretta, Gilden , Lisak, 
Koprowski (1978) and N o wak and Wajgt (1975) but Lisak, 
Levinson, Zweiman and Abdon (1975) reported an increase 
in B cells but decre as ed T cells. In a study of the 
su bpopula tion of T cells, Sant oli e^  (1978) indicated
the T.G cells (T cells which bind IgG immune complexes) 
were increased while Nowak and Wajgt (1975) found a 
significant r e d u c t i o n  in lymphocytes bearing rec ep tor 
in MS patients. These abnormaliti es might be ge ne tically 
det erm ined defects. A suppressed cellular response to v i r uses 
in MS have also been reporte d. Both Utermohlen and 
Zab riskie (1973) and Neighbour and B l o o m (1979) found a 
suppressed cellular r e s po ns e and decreased amount of i n t e r ­
fe ron produced by MS lym ph ocytes in response to measles virus.
i
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The cause of this may be an initial measles  infection which 
results in the e li minatio n of a clone of cells reacting 
to measles and thus in suppression of cellular  reactivity 
to the antigen. This may permit persi ste nce_o f measles in 
CNS and on going lateral infection (perhaps directly in 
ast rocytes) and may result in demyelinati on. An al terna tive 
ex pla nation of the sup pressed cellular immune resp ons es 
observed in MS patients might be that they are genetic ally 
de ter mined. MS patients were also unable to make an 
effective antibody against measles. As me as le s persisted 
the patient was stimulated to make a higher ti tr e of 
ine ffect iv e antibody, conti nuously. These high measles 
antibody titres might then suppress cellular reactivity to 
this antigen (Utermohlen and Zabriskie, 1973).
Macr oph ages, another cell type which is involved in 
the pro d u c t i o n  of immune responses, were found to be increased 
in number in the nervous system in MS patients (Bowen and 
Daviso n, 1974), these cells could be important  as a 
rese rv oir of virus or in transporting the virus to target 
sites in the body of MS patients. (Waters, Koprowski and 
L ew and ows ki, 1975).
The abnormalities observed in the ce llula r immune 
re spo ns e and its components, either due to a genetic error 
or virus induced, have a close r e l a t i o n s h i p  with measles 
virus. These phenomena empha siz e the i m p o rtan ce  of 
measles virus in the pathogenesis of MS and make this an 
interesting area to be explored.
.. < -----'. . i ^  -1 ....... - ._ .... ■ - 1 -  - ....... .,4
173-
1.7.3 Humo ral factors
I m mune -m ediated  infl ammati on  can lead to d emye li nation  
in MS if directed against myelin or a myelin component, 
or even, more spe culatively against a virus a n t ig en as so cia ted 
with myelin or oligodendroglial cells thus causing the 
ch aracte ristic plaques seen in MS (Caspary, 1977).
In cr ea sed antibody (Ab) against various viruses was found 
in the body fluids of MS patients. Greater than 90% of 
MS patients show oligoclonal Y-globulin bands in CSF 
(Thompson, 1979), part of which is measles specific (Fraser, 
1977). Locally synthesized Abs against measles, rubella, 
mumps and herpes simplex virus were observed in MS CSF 
(Nordal, Vendvik and Norrby, 1978) and brain (measles only) 
(Rastogi, 1979). Similar Abs were also found in serum 
of MS patients. In fact, the frequency of meas les Ab was 
significantly greater in MS group than in the control 
group (Brown, Cathola, Gajdusck and Gibbs, 1977). Other 
increased Ab against viruses in MS patient serum were 
against rubella (Synington, Mackay, Wittin gham, White 
and Backley, 1978), vac ci ni a (Brody, Sever,and Henson, 1971) 
va ri ce lla (Lamoureux, Giard, Oolicoeur, Tonghlian and 
Desrosiers, 1976) and EB- vi ru s (Sumaya, Myer and Ellison,
1980).
The only Ab which is most consistently found in MS 
patients is against measles, implicating the close 
rela t i o n s h i p  of this virus with the pathogenesis of MS.
Ab against nervous system com ponents was also 
reported. Michetti, M a s s a r o  and Murazio (1979) observed a 
nervous system specific S - 1 0 0  Ab in CSF in MS which was
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absent in the control group. The amount of this Ab seemed 
to correlate with the acute state of the disease. After 
elution of MS brain a higher content of i m mu noglob ul in 
(Ig) was found in th e= elu ate (Gilden and Tachovsky, 1979).
During relapse, there was increased in tracerebral  IgG 
synthesis in MS patients (Ewan, Lachmann, 1979). In 
serum of MS patients, there was an antimye lin Ab (Lisak, Sweimaï 
and Norman, 1975 ). On the other hand, a myelinotoxi c 
factor was found in MS patients serum, and its activity 
seemed parallel to the severity of the disease (Caspary,
1977), A recent study (Lebar, Boutry, Vincent, Voisin and 
Robineaux, 1976) showed that the demyelinating effect of 
this myelinoto xic factor was due to complemen t -fixing a u t o ­
antibody of the IgG^ class. This Ab was not di rected 
against myelin basic protein, but apparently against cere- 
br o s i d e .
To summarize the disease is probably initiat ed by a 
virus (probably measles) inf ection in early life and much 
of the de struc ti on in the nervous system involves an 
inflammatory immune reaction. The possible ex istence of a 
genetic error in immune system may control suscep tibilit y 
and response to the initial inf ection and als o  the immune 
response to an tigen potentially capable of causing 
inflammatory de myelinat ion. An autoimmune re s p o n s e  against 
a virus persistent in the CNS, or more precisely, the 
vi rus-indu ced change in surface antigens of the CNS might 
be re sponsi ble for the demyelination as suggested by the 
presence of anti-virus Ab and ant i-nervous system Ab in 
serum and CNS of the MS patients. However, ev idence for an
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agg res sive immune demyelinating  process in MS is far 
from  complete.
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1 .8 Membrane Lipid Peroxidation
1,8.1 General features
P e r o x idat io n of membrane lipids is an au toc ata lytic, 
free radical - mediated series of reactio ns. It occurs 
both in normal phy siological processes e.g. prostaglandin 
synthesis, phagoc ytosis and aging, and in abnormal con- 
ditionse.g. haem olytic anaemia, lung damage, liver necrosis 
and muscle atrophy ( M c C a y , 1981).
Pol yun sa turate d fatty acids (PUFA) occur most 
freque ntl y in membranes. PUFA have a high potential to 
form lipid peroxides because the double bonds are p a r ­
ticularly suscep tible  to hydrogen abstra ction, resulting 
in the f o r m ati on  of a fairly stable free r a di cal and, in 
the presence of 0 ^ » in the initiat ion  of a radical chain 
leading to aut oxidation (Mead, 1980).
Under normal condit ion s, the extent of membrane lipid 
pe roxidatio n is very small and non-damaging due to ( 1 ) the 
ope ration of efficient protective mechanisms ; (ii) the normal 
s e g r eg at ion in the cell of the principle rea ct ants of the 
radical chain process; and (iii) the normally low partial 
pressure of oxygen in most tissues. All of these factors 
serve to limit the existence of peroxides to a very t r a n s ­
itory one and to prevent the efficient propagat ion of radical 
chains (Mead, 1980 ), However, under pathological conditions 
where there is either an overpro duction of oxidants and/or 
fr ee- ra di cal generating species or a def iciency in one or 
more protective mechanisms, extensive membra ne damage can 
occur .
'^ 91
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1.8.2 Cellular damage due to lipid peroxidation and free 
r adicals
Lipid pe ro x i d a t i o n  in membranes can bring about lipid- 
lipid or lipid-pr otein cr os slinking; pilote in damage (e.g, 
enzyme in activat ion) and loss of membrane integrity 
(Mead, 1980).
Free r a d ic al s, esp ecially hyd ro peroxid e radicals  
(ROO* ) occur during lipid peroxidati on and can cause 
hae moglobin to breakdown by oxidizing thiol (-SH) groups.
(Aebi and Suter, 1974). One of the br eak-do wn  products can 
bind to the red cell me mbr an e resulting in increased 
osmotic fragi lit y (Goldbery and Stern, 1977).
Ess ential thiol groups  of enzymes can be oxidised 
which will c a us e a change in con forma ti on and thus inhibition 
of the enzymes fu n c t i o n  (Slater, 1972 ).
Membran e lipid per oxidation  causes a loss of s p e c i a l ­
ised me m b r a n e  f u n c t i o n  (e.g. in mi tochondria)  and will J
cause production of mal ondialdehy d e , a bre ak do wn
product of lipid peroxidation, which can c r o s s-link proteins, 
lipids and DMA causing chromos om al abnor malities,  membrane 
damage as well as inhibiting enzymes by altering their 
structure (Slater, 1972). Thus, unc ontrolled  lipid p e r ­
oxidation is ext remely damaging.
1.8.3 Potential intracellular oxidants
The potential intracellular oxidants mostly are the
derivatives of act ivated oxygen. They are in terco n v e r t i b l e  
and are contin ually formed in the cell. The main oxidants 
are super oxide ( 0^ ~ , peroxide (Op^ “ ), singlet oxygen ( ’0 -)
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and most reactive of all is the hy droxyl radicàl (OH») 
(Halliwell, 1978).
Halliwell (1978) suggested that activated oxygen was 
produced in the four step r e d uction  of oxygen to water.
« 2  ---------- » 0 ^  — ^ ,  O 2 ' ' -5 ----------------- H g O
energy E E E
Supe ro xide is easily convertibl e to other activated species;- 
0 - + 0 | dis muta tlon^  2 „^- ^
0 ^  + HgOg ---------------------------------- > ' 0 H  + OH"  + Og
Other sources of these oxidants in the red cell are 
(Halliwell, 1978):-
(1) Aut oxidation of oxyhaemogl obin to methaemogl obin can 
cause displacement of super oxide Og if a random 
f l u c t u a t i o n  in the haem pocket of haemo globin allows 
water to enter. Any factor which increases flex ibili ty  
or dist or tion of the haem  pocket will increase Og
pr e d u c t i o n .
(2) Heavy metal ions (especially those with a divalent 
charge) will react with o x y h a e m o g l o b i n . One of the 
products is O g .
(3) Free porphyrins can u l t i l l s e u l t r a v i o l e t  ra dia tion to 
ac tivat e oxygen, probably to singlet oxygen (*0g).
( 4 ) Oxidases e.g. Xanthine oxidase produce O g .
1.8.4 Chemistry of PUFA per oxid ation
PUFA can unde rgo  a h y d roge n a b s t r act io n to give a 
radical which will initiate lipid per oxidation in the 
presence of oxygen (Witting, 1980).
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(i) I n i t iatio n
( - C H = C H - C H g - )
PUFA
-Ç > ( - C H = C H - C H - )
free radical initiator (R-)
(ii) Pro pagat io n ^
) ( - C H = C H - C H - )  + Op-------------» ( - C H = C H - C H - )  ( R O :  )
I .0-0
FA per oxyradical 
( - C H = C H - C H - )  + ( - C H = C H - C H -  ) ----- » ( - C H = C H - C H - )  + ( -CH = C H - C H  -  )3
0-0 PUFA O-OH  
hydr oper oxide
Chain re a c t i o n
etc.
O-OH
(iii) Branching
2 ( - C H = C H - C H - ) -
O-OH
m a l ondi al dehyde
^ t i s s u e  
damag e
OH
> ( - CH = C H - C H  -  ) +
o-d
( - C H = C H - C H - )  
0*
[R- ) [R-]
free radical m u l t i p l i c a t i o n
(iv) T erm in ation
2: R» ------------------- )r R - R
2 RO,
RO,
______________ Og + ROOR
+ r ’ --------------  ^ ROOR
polymeric peroxides
(Witting , 1980)
A n t i o x i d a n t s ,  e.g. vitamin E can break  the propag ation  
of the chain re a c t i o n  mainly by scavenging the f ree- ra dicals 
(Horwitt, 1965) and terminating the chain r e a c t i o n  as above.
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1.8.5 Pr ot ect ive mechani sms
Cells contain several protective mechanisms against 
lipid peroxidation. These consist of several enzymes and 
antioxi dan ts which act at different stages,
1. Super oxide dismu tas e (SOD)
There are three types of SOD, classified by the metal 
ions associated with them: Cu/Zn SOD (found in eukaryote
cytosol), Mn-S O D  (in eukaryotic mitochondria and prokaryotes) 
and FeSOD (prokaryotes) (Bannister and Bannister, 1981).
SOD catalyz es the follo wing reaction:
2 0^‘ f 2H^--------> HgOg + Og
super oxide
radicals (Witting, 1980)
In red blood cells SOD and catalase are collected in the 
same fra ct ion as hae mogl ob in during repeated washings of 
lysed cells, indicating they are both in the cytosol. It 
is suggested that one important fu n c t i o n  of SOD and catalas e 
is t o  act against bursts of oxygen radicals formed from 
oxyhaemogl obin (Cohen and Hoch stein, 1963).
SOD is a very stable enzyme and is resistant to 
proteolysis and ina cti vatio n by heat (Fridovich, 1974).
2. Catalase
Catalase destroys the hydroge n peroxide (H^O^) 
produced by the action of SOD and other reactions  
2 HgOg — ca ta la se  ^g H g O  + Og (Tappel, 1978)
As indicated above the main purpose of red cell 
catalase is to decom pose HgO^ formed as a result of bursts 
of oxygen rad ic al s formed by oxyhaemogl o b i n .
' • h
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I nt er action of ox yh aemog l obin with me ta bolites or 
drugs can cause bursts of Og followed by HgOg. The
of ca ta la se for HgOg is co nsi derab ly higher than that of
g l u t a th ione peroxidase. Therefore, cat al as e of red 
cells would be better for scavenging sudden elevated HgOg 
rather than low steady state levels of HgOg (Cohen and 
Hochstein, 1963).
3. G l u t a t h i o n e  Peroxidase (GSHrPx)
GSH'Px is a tetramer of M W ^ 8 4 , 0 0 0 .  It has no haem
or fl avin prosthetic gr oups which is unusual for peroxidases. 
Each subunit has a s e l en iu m atom associated with it which 
is essenti al  for catalysis (Flohe and Gunzler , 1974).
The r e a c t i o n  catalyz ed is:
2 GSH + HgOg (or R O O H )  fGSSG + H g O  (or ROH)
reduced peroxyacid oxidised hydr ox yacid
g l u t at hi one glut athione
(Witting , 1 980) .
It scavenges HgOg and destroys lipoper oxides preventing 
*0H fo r m a t i o n  ( W e s t e r m a r c k , 1982).
This enzyme is highly specific for GSH as the h y d ro gen 
donor (Flohe and Gunzler, 1974).
4. Glutathione redu ct ase (GR)
This enzyme is important for recycling reduced 
g l u t a th ione (GSH)'Which is converted to oxidized g l u t a t h i o n e  
(GSSG) by GSH-Px .
The reac ti on is;
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gl u t athion e
reducta se
GSSG » 2 GSH
H + NADPH NADP
The enzyme is not specific for acceptor sub strat es 
and will re du ce  other dis ulph id es as well as GSSG, 
although at a much lower rate (Beutler, 1974).
5. NADPH generating d e hydro ge nases
As can be seen above NADPH is essential for g l u t a t h i o n e  Î 
r ed uctase to generate GSH which is in turn an essential 
substrate for GSH*Px. Most of the NADPH is generate d 
by the dehydroge na se enzymes of the pentose phosphate 
pathway i.e. g 1 uc o se-6 -ph os phat e dehyd rogenase and 6 -phos- 
phog luc onate dehy dt ogenase (Aebi and Suter, 1974).
The r e a c ti ons which link  GSH-Px, GR and dehydrogenases 
are shown below:
reduced 
substrate 
(e.g. G —6 —P)
oxidised 
substrate 
(e.g. 6 -P- 
gluc onate)
D e h y d ro genase  1 NADP'
^ NADPH
G S H •Px
2 GSH
GSSG
(ROOH )
(ROH)
(Cohen and Hochstein, 1963)
6 . A n ti ox id ants e.g. Vi tami n E (a-t oc opher ol )
Vitamin C (ascorbic acid)
The primary phy sio logical func ti on of vitamin E is 
not clearly under stood yet. It is thought that v i ta min E
i
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has an important role in terminating per oxidative re a c t i o n s
of PUFA, because of its free radical scavenger (R* »RH)
character and lipophi lic structure which enable vitamin 
E to participate in a strong physical i n t e raction  with PUFA 
in the membrane (^onings and Drijver, 1979). It will 
also reduce becoming a more stable and less r e a c t i v e
tocophe rol  ra di cal  (Halliwell, 1978). Vitamin C is a 
similar ant ioxidant acting as a free rad ical scavenger 
(Bannister and Bannister , 1981) in the w a te r-solu bl e phase.
Sel eni um also appears to act as an antiox idant in 
its own right but is important in the re a c t i o n  of GSH'Px 
(Metzler , 1977).
There are many other substances in cells which als o  
act as anti oxidants to protect the cell from oxygen stress 
and lipid peroxidation.
Summary of potential oxidative m ech an isms and enzymic 
pr ot ec tion against p erox id ation (After W ester ma rck, 1982 ):
RH + Og
2 R ^  Enzyme systems; xan thine oxidase
etc. Oxidant stressors: bivalent 
metals. H ae moglob in  antio xi dation
* 2 H _0
SOD
HgOg + O2
i_->chemical damage to critical -SH proteins !
catal as e________  ^Og + H g O
GSH' Px________ \2 H - O
u n s a t u r a t e d  ^-------- »RQOH-  - d Ê Ê H L _ ^ R O H  + H . O
j  GSH'Px
Lipid Per oxidation 
M a i o n d i a l d e h y de 
Cell-Damage 
L ipopi gm ents
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1.9 Pos si ble Links Betw een MS and M e m br ane Lipid 
Per oxidation
Shukla et a3^, (1977) and Szeinberg (1979}=found that 
GSH* Px was significantly decreased in MS red cells and 
suggested that the susceptibility to lipid peroxidation 
might be increased in MS patients, which may be the cause 
of the pathological changes in MS.
Fi nl and has a high incidence of MS which is associated 
with low levels of selenium (Alter and Oli vares, 1970).
A higher incidence of MS is seen in populations who 
consume a high proportion of animal fat in their diet which 
would be associated with a reduced vita min  E intake since 
vitamin E is found predominantly in association with plant 
lipids (Belin, 1971).
CNS myelin of MS patients has decreased con cen tr ations 
of the acidic phospholipid classes (see 1.5.1,4). This 
could be due to their preferential per oxi da tion as these 
cla sses contain the highest prop ortion of PUFA (Clausen,
1970).
Mi cke l (1975) suggested MS may be attrib utable to 
lipid peroxide absor ption from the gut. These could cau se 
fr agi lity of lysosomal membranes, re le as e of lysosomal 
pe rox idases and enhance au tox idati on of myelin PUFA, 
Oligodendr oglia may have little an tioxidant  and thus be 
especia lly  susceptible to the action of lipid peroxides.
-185-
1.10 Aims of This Work
Although the lipid compositio n of MS red cells was 
found to be normal (Homa e^ a_l^ . , 1980), it is still 
possible that the lipid organizations within the two 
halves of the bilayer is perturbed, and that this might 
lead to the observed change in physical prop erties (see
1,6.1) in MS red cells. It is also possible that the 
tra nsbil ay er  d i st ri bution  of pho sph olipids in MS red cells 
may give some info r m a t i o n  about lipid organiz at ion in 
myelin. The organisati on of er ythrocyte  mem br ane p h o s p h o ­
lipids was examined using bee venom p h o s p h oli pa se A^ as 
in Chapter I .
In the light of the eviden ce given  above, it would 
be r e a s o n a b l e  to suggest that membrane lipid p eroxid at ion 
is involved in the pathogenesis of MS. M e m b r a n e  lipid 
pe ro x i d a t i o n  could account for many of the change s seen 
in MS es pe cia lly those in the red cells.
In order to test this hypothes is pro tec ti ve mechanism s 
against me m b r a n e  lipid peroxidation were exami ne d to see 
whether any deficien cy might result in increases s u s ­
ce ptibil ity to peroxidation  d a m a g e .  If protecti ve enzymes 
were foun d to be increased, this might also  repr esent an 
induced re s p o n s e  to increased mem br ane lipid peroxidation. 
The stress test, a direct me as urement of lipid
’p e r o x i d i s a b i l l t y ’ (i.e. antioxidant capac ity ) in red cells, 
and assays of the four protective enzymes, i.e. - SOD 
catalase, GR and/GSH Px were carried out in this work.
Oames (1982) proposed that the cause of the
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d em ye l i n a t i o n  in MS may be fat emobi (for details see
1.4.1). Hyperba ric  oxygen (HBO) treatment has been the 
subject of controlled clinical trials and is currently 
being used in several countries. The effect of HBO 
tr eatment on the four anti oxidant protective enzymes 
was also  investigated.
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2. MAT ER IALS AND METHODS
2 . I The Patients
All patients had definite MS according to the 
McAlpi ne criteria; they are or have been patients at 
Dundee Royal Infirmary. Controls were healthy volunt ee rs 
with no family history of MS. Patients' (9F, 5M ) ages 
ranged fro m 25-61 whilst those of the controls (5F, 13M) 
were 2 0-42.
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2 ,2 Asymmetric Lipid Org aniz ation of RBC Membrane
The procedures were exactly as described in 
Chapter I, sections 2 .2 . - 2.9.
. .  ^ - '  - ' - ' - '   '
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2 .3 Lipid P e r o x i d a t i o n  in MS RBC
2.3.1 Isolation of washed packed RBC 
This was carried out exactly as in s e c ti on  2,2. of
Chapter I .
2.3.2 Haemoglobin D e t e r m i n a t i o n  
The method of Dacie and Lewis (1975) was followed.
The following were made up to 1 L with di sti lle d water:
200 mg potassium ferr i c y a n i d e  ; 50 mg potassium cyanide;
140 mg 1 ml n o n i d e t  0.1 ml packed cell
su spension  was diluted 200 x with the above reagent and the 
O . D . ^ ^ q  read against a reagent blank. The haem o g l o b i n 
con centr at io n can be cal cu la ted from the fol lowing expression:
O.D.c, „ X M.W. Hb X dilut i o n  factor Hb (mg/L) = _____________________________________
molar ex ti nction  coefficient x d
molecular weight of Hb = 64500 
dilution factor = 200 
molar e x t i n c t i o n  coefficient = 44.0 
path length (d) = 1
2.3.3 Hyd ro ge n Peroxide Stress Test (Stocks and D o r m a n d y ,
1 9 7 1 )
2.3.3.1 Principle
An accelerated form of non-enzymic oxidative b r e a k ­
down was induced in red cells by exposure to hydroge n 
peroxide The f o r m a t i o n  of ma 1 ony Idialdehy de (MDA ) ,
a secondary f r a g m e n t a t i o n  product of poly un saturated fatty 
acid peroxides, can be estimated as a measure of p o l y u n ­
saturated fatty acid (PUFA) autoxidation in red cells
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incu bat ed with HgOg in vitro. This is therefore an i n ­
direct way to measure lipid au toxidation by assaying 
the colour developed f r o m  MDA-TBA (thi obarbit ur ic acid) 
colour reaction.
Reacti o n s :
O g "  + H g O g ------------------- » -OH + OH" + Og
(super oxide ra di cal  
gene rat ed from the 
conversion of o x y haem- 
oglobin to m e t h aemo - 
globin)
RH + ‘ OH ----------------------> R* + H^O
(PUFA)
R ‘ + Og ------------ > RO 2
ROg + R H ---------------------- >ROOH + R" »!
ROOH ------------------------- > C H _ ( C H O _ )0 ^  ^ .2 oxida tion MDA
MDA + TBA    ----- ---- ) red- orange colour complex
c o n d e nsation
Sodium azide was added to inhibit catala se activity, 
which otherwise will brea kdown the H^Og added very rapidl y,  
also help to preserve the oxidation product (MDA). Under 
these conditions, the peroxide stress test measures the 
antioxidant capacity of the red cells. Since catalase 
is inhibited and the rel a t i v e l y  high H 2 O2 con cent ration  is 
vastly in excess of the for glutathione peroxidase, it 
is likely that the a n tioxi da nts involved would be at a
later stage in the overall process than H^D^ destruction.
'1In fact, this test c o r r elate s well with the vitamin  E #
status of some, though not all, individuals. Tr ic hl oroacet ic  i
acid (TCA) was added t o  precipitate the cells, which were
removed before boiling, preventing the coloured complex I
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formed be tw een h a e m  compounds and TBA, and bet ween g - 
fo rmy lp yurvic acid and TBA (absorption max imu m 550 n m ) 
in the TCA boiling mixture. The addition of arseni te at 
the end of the incubatio n stage stabilizes the MDA 
chromogen.
2 .3 . 3 .2 Reagent s
1. 0.9% NaCl
2. Reagent I
1 volume of 0.15 M K H 2PO 4 /O . I 5 M KgHPO^ (pH 7.4) mixed 
with 9 vo lu mes of 0.9% NaCl.
3. 2 . mM so dium azide in Reagent I.
4. 20 mM H 2 O2 in Reagent I.
5. Reagent II
28% (w/v) trichlo roa cetic acid (TCA) and 0.1 M sodium 
arsenite.
6 . Reagent III
1% (w/v) thi obarbitur ic acid (TBA) in 0.05 M NaOH.
2.3.3.3 Procedure
0.5 ml aliquot of washed 
packed red cells in 19.5 
ml 0.9% NaCl to give 
packed cell volume (PCV) 
of 2.5%
incubated for 60 mins on 
roller shaker in universal 
bottle at 37°Cir e d  c e l l s  s e d i m e n t e d  at 1,500 
X g f o r  10 m i n s
 ^
Pellet sup ernatant
I 1
resuspended accurately  
to PCV of 5% in buffered 
saline with 2 mM Na azidei0,1 ml aliquot removed to 
determine Hb content 
1
discarded
-192-Iequal volume of 2 0 mM H^Og 
in buffered saline added
incubated at 37^C on a 
roller shaker
4.0 mlsu spensio n withdrawn 
at 10, 20, 30, 60, 90, 120 
mins. intervals for MDA 
estimât i o n .
MDA estimation
4.0 ml suspensioni2 ml Reagent II 
added
centrifug ed  at 1 ,500 g for 10 mins
pellet
discarded
s uper natant 
:4.0 ml aliquot withdrawn  
into boiling tube
i1.0 ml Reagent III added
iincubated in boiling 
water bath with marbl e 
on top for 15 minsicooled immediately in cold 
water (centrifuged if 
turbid) 1spectrum scanned b e t w e e n  
4 5 0 -6 00  nm on Sp 800 
using reagent bl an k*
* Reagent blank was prepared by adding 1.0 ml Rea gent III 
to 4 ml of mixt ure  made by mixiing 2 ml 2 mM Na azide,
2 ml 20 mM ^2^2 ^ ml Reagent II. The mixture was
boiled for 15 mins and cooled.
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MDA c o n c e n t r a t i o n  can be calculated by the following 
expres sio n :
MDA (n mol/g Hb) = (0 .D .5 3 p-O.D.,^)X1 jclO^X^^200
molar extinction coefficient x Hb
0 , D .^30 - - correct for yellow colour from
s od ium azide.
91 X 10 - converts M t o  nM
5molar e x t i n c t i o n  co efficient of MDA = 1.56 x 10
^/ ^oo “ conve rts c o n c e n tratio n of MDA t o  amount of MDA 
in the 5 ml mixture 
Hb g Hb in the 5 ml mixture
2:3.4 G l u t athi on e R e d u ctase  (GR) Assay
2.3.4.1 Principle
Reaction: GSSG — NADPH
2GSH — >NADP +
gl utath i one 
re d u c t a s e
Notes :
GSSG oxidized g lutat hi one
GSH re du ced glut a t h i o n e
0 . D . g, is monitored to detect the decrease of NADPH ^4 u
2.3.4.2 Prep a r a t i o n  of hae molysa te  (Beutler , 1977)
0.5 ml packed cells was mixed with 0.5 ml 0.9% NaCl 
and 9 ml s t a b i l i z a t i o n  solution  (2.7 mM EDTA Na^; pH 7,0 
and 0.7 mM 2 - m e r c a p t o e t h a n o l ). The s t a b i li za tion solutio n 
is stable for several weeks stored at -20^C. The 
hae mo ly sates are stable for at least one year stored at 
-20°C.
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2,3.4.3 Reagents
1. Buffer
0.5 M Tris-HCl/2.5 mM EDTA Na^ pH 8.0
2. 9.9 mM neutralized GSSG
3. 1 mM NADPH
since NADPH is more stable in alkaline solution, 10 
fold diluted buffer was used to prepare the NADPH 
solution
4. 0.3 mM FAD (flavine adenine dinucleotide)
2. 3. 4.4 Procedure (Beutler, 1977)
Both glutathione reductase activity with and 
without FAD were determined.
Assay without FAD
Added in this order Blank , , . .Sanplè . . .Gone, .in .the cuv^ ettes
Buffer
Water
Haemolysate
300 yl
1.37 ml 
30 yl
300 yl
1.37 yl 
30 yl
0.05 M Tris-HCl, 0.25 mM EDTA
Incubated at 37°C for 10 mins
GSSG (1 ml H^ O) 1 ml 3.3 m
Incubated at 37°C for 10 mins
NADPH 300 yl 300 yl 0.1 mM
Blanks and tests were assayed in duplicate.
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Assay with FAD
Added in this order Blank . . Sample .Cbhc, in cuvettes
Buffer
H O^
FAD
Haemolysate
300 yl
1.36 ml 
10 yl 
30 yl
300 yl
1.36 ml 
10 yl 
30 yl
0.05 M Tris-HCl 0.25 mM EDIA
1 yM
Incubated for 10 mins at 37°C
GSSG (1 ml H20) 1 ml 3.3 nM
Incubated for 10 mins at 37°C
NADPH 300 ul 300 yl 0.1 mM
Duplicate cuvettes were assayed as before.
Glutathione reductase activity was expressed as ymoles 
of NADPH per min. per g. of haemoglobin, and was calculated 
from the following expression;
GR activity (ymoles/min./g Hb)
AO.D.g. X 1x10^ X. 1000
molar extinction coefficient x Hb x 3
3molar extinction coefficient of NADPH = 6.22 x 10 
Hb “ haemoglobin in the 3 ml cuvette.
2.3.5 • Catalase Assay
2.3.5,1 Principle (Abeliovich and Cohen, 1978)
0^ evolved from ^ 2^2 the catalysis of catalase was 
measured by an oxygen electrode.
2H O ------------
^ ^ catalase ■+2H2O + Og
“ 196 —
2.3.5.2 Prep arati on  of haem olysa te
Haem ol ysate was prepared as described at 2.3.4.2, 
but diluted 5 times with s tabil iz ation solution before 
assay .
2.3.5.3 Procedure
A Clark oxygen elec tr ode was used at 37°C.
1. Used saturated KCl to cover the 0^ electrode.
2. KCl solution and 0^ ele ctrode covered with teflon 
membr an e (without bubbles in the KCl solution).
3. Ele ct rode set up by injecting water into the chamber, 
setting 30% of the chart as 100% air sat urated H^O. 
(Og electrode set up this way will detect Og levels 
above that of 1 0 0 % air saturated water).
4. So dium dithionite introduced into the chamber to 
absorb all the oxygen present to zero the electrode.
3. Water removed by suction, 3 ml of 30 mM HgO^ pipetted
int o  the chamber and chart run until it gave a steady
b a s e l i n e .
6 . Standard  enzyme or h aemol ys ate introduced by syringe 
and rate recorded.
2. 3. 5. 3.1 Assay with commer cial catalase
In order to invest igate the linearity of the
r e l a t i o n s h i p  between the rate of 0^ evolved and the
amounts (units) of catalase  added, commercial ca talase  
(0.2 U, 0.4 U . . . 2.0 U in 3 y l ) was used.
Since 100% air saturated H^O at 3 7 %  cont ains 6.77 
mg Og/l; the amount of 0^ evolved can be calculated.
  - A 1.1 ■ .-j-r 'S.vt •
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2.3.5,3.2 Assay with haemol ysate
3 yl of 5 X diluted h ae mo lysate was used to assay 
catala se activity which was expressed as mg 0 ^ evolved/ 
min./g Hb
2.3,6 G l u t a th ione Peroxid ase  Assay (Beutler, 1 9 7 7 )
2 .3.6.1 Principle
Hydrogen  peroxide is the most abundant
physiological substrate for GSH*Px but as it is r elative ly  
unstable and catalase will interfere with the result, an 
artificial substrate t-butyl hydroperoxide (TBH or TB-OOH) 
is commonly used. The r e a ctio n is linked to GR which 
oxidizes NADPH.
Rea ct ion :
NADPHTB-OOH 2GSH
TB-OH GSSG - NADP.
GSH'Px GR
Notes :
TB-OH tertiary butyl hydroxide
2 . 3 . 6 .2 Reag ents
1. Buffer
1 M Tris-HCl/5  mM Na^ EDTA pH = 8.0. 
6 mM GSH .
1 mM NADPH Na^ in 10 fold diluted buffer 
Gl ut athi on e redu ctase. (200 U/ml)
21 mM TBH.
-198-
2.3,6,3 Procedure
Added in this order Blank Sanple Conoentration in. the curvettes
1 2
Buffer.. 300 PI' ' 300 ill ' 300 yl- 0.1 M. Tris-HCl0.5 mM EDTA
H2O 1.075 ml 1.055 ml 1.045 ml -
GSH 1 ml 1 ml 1 ml 2 mM
NADPH 600 yl 600 yl 600 yl 0.2 irM
GR 15 yl 15 yl 15 yl 3 U
Incubated 10 mins at 37°C
Haemolysate — 30 yl 30 yl -
Incubated lO mins at 37^ C
TBH 10 yl — 10 yl 70 yM
T r i p l i c a t e  assays were done on each sa mple and blan k 
A c t i v i t y  of g l u t h i o n e  peroxidase can be c a l c ulated  from 
the f o l l o w i n g  e x p r e s s i o n : -
GSH'Px (ymoles NADPH/min. /g H b )
= ( A O . D . 2^0 in sample - (AO .D.^^Q in B l a n k  1 + A O . D . ^ ^ q  
. in B l a n k  2)^X ^ / j q o O ^  10^
molar exti n c t i o n  co ef ficient x Hb
Notes :
molar e x t i nct io n coeffi cient of NADPH = 6.22 x 10
10^ = c o n verts  M to yM
Hb = g Hb in the 3 ml c u v e t t e
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2,3,7 Sup ero xi de D l s mu ta se (SOD) Assay
2.3.7.1 Principle (Crape, McCord and Fridovich, 1978)
The substrate of SOD is the unstable super oxide free 
r a d ical ( O ^ ” ). As it is rapidly broken down, even if it 
were possible to add 0 ^ at the start of the assay the 
c o n c e n t r a t i o n  in the assay will be unknown and con stantly 
changing. An indirect assay was used instead. Super oxide 
is ge ne rated at a constant rate by xanthine oxidase, c o n ­
verting xanthine into uric acid. Cytochrome c was used 
as a detection reagent for 0^ .
(red)
3+ ,
Cytochrome c Fexanth in e
uric acid Cytochrome c Fe
SODxanthine
oxidase
Super oxide free r a d i c a l  acts as a reducing agent. As 
it has a single unpaired electron and a negative charge, 
it loses the electron easily due to r e p u l s i o n  of like 
c h a r g e s .
Increase in of cytochrome c as it is reduc ed
at a constant rate can be measured. If SOD is added, the 
reducti on  of cyt ochrome c will be inhibited and this rate  
decreased. The change can be calculated as a % i n h i bit io n  
which over a cer tain finite  range will increase in p r o ­
portion to the amount of SOD added,
2.3.7.2 Pre pa ra tion of SOD extract (Winterbourn £t a^» , 1975) ;
1 ml of washed packed cells were h ae molyze d by the 
additio n of 1,5 ml disti lled water. The ha em oglobin  |
co n c e n t r a t i o n  of the haemo ly sate was adjusted to 10 g /100 ml I 
when possible. If the haemoglobin c o n c e n t r a t i o n  was much |
less than  10 g /100 ml, more packed red cells were added J
to the h ae mo lysate  and the h aemog lo bin con ce ntrat ion r e -  j
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calc ulate d and adj usted to 10 g /100 ml.
H a e m ob lo gin interferes with the SOD assay and must 
be removed. This is done by chi or of orm-ethanol p r e ­
cipitat io n .
0.5 ml h ae molysat ei30 ml glass cent ri fuge tube 13.5 ml distilled water added 
mixed
1 ml absolu te ethanol 
mixed1
0.6 ml chlo roformI
mixed 1 min.
i
centrif ug ed 1,550 x g 
10 mins. at 4^C
f 1clear top layer bottom layer
(containing SOD) (red pellet)Istored at -20°C discarded
All rea ge nts were ice cold and mixed as quickly 
as possible.
2.3.7.3 Reagents
1. Buffer
50 mM NagCOj 
10 yM KCN 
0.1 mM EDTA
adjusted to  pH 10.0 by adding 50 mM NaHCOj
M o d i f i c a t i o n s :
(i) Original method used pH 7.8 in K ^ P O ^  buffer, but
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assaying at pH 10.0 can increase sensitivity.
(ii) KCN abolishes interferen ce from cytochrome oxidase. 
This co n c e n t r a t i o n  gives 100% inhibition of 
cyti5chrome oxidase without affecting SOD. The 
buffer is stable at for several weeks.
2. Xanthine
1.0 mM in buffer 
This must be heated to dissol ve the xanthine. Xanthine 
c o n c e ntra ti on was increased from 0.5 mM in the original 
method to 1.0 mM to increase sensitivity.
3. F e r r i c yt oc hrome c 
0.1 mM in buffer
Commercially available cyt och ro me c contains some water and 
fe r r o c yto ch rome c as well as ferr icy to chrome c. It was 
necessary to cal culate s p e c t rop ho tometri ca lly in a more 
concent ra ted solution then dilute to 0.1 mM . A pp ro ximate ly
1.0 mM cytochrome c (in buffer) was diluted 30 fold in a 
cu ve tte and O . D . ^ ^ q read (X). Then a few crystals of 
s odi um dithionite was added t o c o m p l e t e l y  reduce the 
cytochrome. was again read (Y ) . The true c o n ­
ce n t ration  of ferricyt ochr ome c can now be obtained f rom 
the following expressi on ;-
(ferricyt ochr ome c] = Dilution  factor (Y-X)
molar exti nct ion coefficient
dil uti on factor = 30
molar ext inction  coeffi cient = 21,000
Once the true conc en t r a t i o n  of ferr icyt ochr ome c is 
known, this can be diluted to 0.1 m M . All dil utions of 
cy to chro me  c were done in buffer. The xanthine and
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cy tochrome  c are stable at -20^C for several weeks.
4. Mix tur e A
10 ml xanthine and 10 ml cyto chrome c were made up to 
100 ml with buffer. It is stable for several weeks -art 
-2 0°C .
5. Xanthine Oxidase
Commercial xanthi ne oxidase is supplied as a suspe ns ion 
in (NH^ÏgSO^, 28 U/ml. The enzyme suspen sion was diluted 
with disti lled water such that 30 yl catalyzed a change 
at of 0 .0 2 /min. due to red u c t i o n  of cyto chrome c.
The d i l ut ion facto r should be adjusted to give 0.02±
0.002 units at O.D.^^q. This b l ank rate had to be chec ked 
regularly during the assay (at least once per working day) 
as the xanth in e oxidase loses activity over a period of 
time in dilute solution. The precise value of blank rate 
is critical since a small change can lead to a large 
error in the ca lc u l a t i o n  of % inhibit on.
2.3.7.4 Procedure (Crapo ^  a^^. , 1978)
(i) E s t a b lishme nt  of blank  rate at 0.02 units/
min
3.0 ml mi xt ure A and 40 yl distilled water were 
added to a 3 ml cuv ette and incubated at 37°C for 10 
mins. 30 yl of xanthine oxidase (with approp riate dilution) 
was added and the moni tor ed. If the rate was not
0 .0 2 ± 0.002 O. D. ^^q  units/min, the xanthine oxidase
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c o n c e n t r a t i o n  was alt ered appropriately and the above 
repea ted  until 0 .0 2 +0.002 O.D.^^^  units/min. was 
a c h i e v e d .
(ii) Pr eparati on of calibrat ion curve for SOD 
C o m m e r c i a l  SOD purified from bovine RBC (2900 U/mg)
was made up to give sta ndards of 0.5 yg/ml and 1.0 yg/ml 
from a more c o n c e n t r a t e d  stock solution. To a 3 ml 
cu vette  3.0 ml mi xtu re A and varying amounts (10-40 yl ) 
of the above soluti on s (to give 0.005 yg SOD - 0.0 4 yg 
SOD) were added. The final assay volume before xanth in e 
oxidase was added was always adjusted to 3.04 ml with 
distilled water. This was incubated at 37^C for 10 mins. 
30 yl xanthine oxidase (with appropriate dil ut ion to give 
a blank rate of 0 .0 2 ± 0.002 units per min.) was
then added and O . D . ^ ^ q mon itored for several minutes.
% inh ib ition was cal cu lated from:- 
Blank rate = X (^ 0.02)
Rate with SOD or sample = Y 
% in hi bition = 1 - (Y/X) x 100
A c a l i b r a t i o n  curve of % inhibition ve rsus SOD 
c o n c e ntra ti on was prepared. This was linear up to 0.03- 
0.04 yg SOD. A cal ib ration curve was set up at the 
beginning of each working day.
(iii) Assay SOD activity in crude SOD extracts fro m  RBC 
3 ml mi xtur e A and 10-40 yl of SOD extract (diluted
10 times) were pipette d into a 3 ml curvette and incubated 
at 37^C for 10 mins. 30 yl xanthine oxidase was added and
the rate of c h a n g e  of 0 .0 .^^^ was measured
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A range of vo lum es  were added to ensure % inhibiton 
is in the linear range of the cal ibration curve. In 
addition, it is important for an unknown sample to ensure 
that the % in hi bit ion is linear with the amount of 
extract added since the linear range for a crude SOD sample 
was fou nd to be slightly different from that for purified 
SOD standa rd (see results  section). The SOD c o n c e n t r a t i o n 
of the sample can then be calculated using the ca li b r a t i o n 
c u r v e .
Results were calcula te d both as mg SOD/g Hb and mg.
SOD/ml packed cell.
2.3.8 Effect of H y p e rbari c Oxygen (HBO) Treatment to the 1
Lipid P e r o x id at ion Protective Enzymes
Patients recei ving HBO treatment were given 20 se s s i o n s , !  
each of 90 mins, on c o n s ecu ti ve days except that there  was |
no tr eat men t on the 7th and 14th days of the programme. )
Blood was taken f rom four patients (GE, HP, TG and MG) 
within 30 mins of their 20th treatment and also before the 
co mm ence me nt  of the programme. Patient LL had compl ete d 
a 20 treatme nt course 1 week prior to providing the :
a f t e r - tr eatme nt  sample but had also, immediatel y prior to :
v e nepu nc tu re, just rec eived  a 90 minute ”t o p ~ u p ” se ssion 
in the chamber. HBO treatment consisted of air at 2 
a tm os pheres  and patients were in a sitting position for the 
tr eatment period.
The four enzyme. (GR, GSH-Px, catalase and SOD) 
assays for the red blood cells from MS patients after 
HBO trea tme nt were performed as described above,, as was
the peroxide stress test.
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3. RESULTS AND DISCUSSION
3.1 Me m b r a n e  Pho spholipid Organizat ion of RBC of MS 
Patients
The phospholipid class c omposi ti on of RBC from MS 
patients was normal, as shown in Table 22 which is 
c on sis ten t with the previous report (Homa ej^ > 1980).
The tran sbi layer organization of pho spholipid in MS 
patients was a l s o  found to be not sig nificantl y different 
from that of control, as shown in Table 23 and Fig. 20.
The phospholipid class composi ti on of MS ghosts was 
als o found to be similar to that of controls (Table 24) 
and to that of intact cells. When ghosts f ro m both groups 
were tre ated with the enzyme, all of the gly ce r o p h o s p h o l i p i d s  
underwent complet e co nversion to their cor responding lyso- 
de rivative s, indicating that these pho spholipids in the 
native membra ne  are fully available when access of the 
enzyme to both sides of the membrane is possible. The TLC 
patterns of the MS whole ery throcytes and gh ost s and the 
e n z y m e - t r e a t e d  er yth roc ytes and ghosts are shown in Figs.
21, 22 , 23 and 24.
Lipid asymmetry of the red cell mem bra ne is thought 
to be ma intain ed  by the c y t o s keleton  (Marchesi, 1979), so 
that from these results , it can be suggested that there is 
no gross abnorm ality in the red cell c y t o s keleton  in MS 
p a t i e n t s .
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Table 2 2 Phospholipid Class Composition of Whole
Erythrocytes of MS Patients and Healthy 
Controls (expressed as lipid phosphorus 
w/w)
Phospholipids Controls %n=12) MS patients (n=6)
PC 30.97±2.78 29.11±2.10
SM 26.89±2.05 28.82±2.58
PS 10.75+1.04 10.16±2.44
PE 31.21+1.79 29.7+1.37
yield (y mol lipid P/ml packed cells) 3.10±0.50 3.14+0.56
recovery % 89.85+8.70 88.85+7.50
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Table 23 Degradation of Glycerophospholipids in Whole 
Red Cells Incubated with Bee Venom Phospho- 
lipase
% Total pj^ ospholipid class dégradé (X ± S.D.) Haemolysis % (Xi S.D.)
n PC PE PS
Controls 6 51.73±7.76 6.24+4.23 0 1.04+0.68
MS Patients 6 59.86*7.00 2.85+2.79 0 1.24+0.50
Controls 
(n= 6)
X± S.D.:: 51-73 ±7-76 
* # • « # #
MS 
Patients 
( n =6)
X±S.D.= 59-86±7'00 
1 • 1 *1 •
^Degradation 
of PC
45 50 55 60 65
Fig. 20. Degradation of PC in Whole RBC in Controls 
and MS Patients.
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Table 2 4 Phospholipid Class Distribution of Normal
Ghosts and MS Ghosts (expressed as lipid 
phosphorus w/w)
Phospholipid MS Ghosts (n=6) Normal Ghosts (n=6)
PC 28.88±2.00 20.9312.78
SM 29.0712.30 26.4612.90
PS 12.6011.80 12.8011.87
PE 28.0011.90 29.4311.30 1
yield (y mollipid P/ml 2.6210.40 2.9310.54 B.packed cells) I
recovery % 86.8519.40 85.1419.34
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s m  
r LPc
J
Fig. 21 Lipid Extracts of MS RBC, Loading: Lipids 
from 0.3 ml packed red cells.
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Fig, 22 Lipid extracts from MS ghosts. Loading:
ghosts originated from 0.3 ml packed cells
jT'"
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-
PC
» S M
% LPC
t o
Fig. 23 Lipid extracts of MS RBC incubated with
phospholipase (20 U/0.2 ml packed cells 
ofor 2 hrs at 37 C). Loading: Lipids from
0.3 ml packed cells.
I
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I  k - i
LPE
LPS
SM 
I  LPC
Fig, 24 Lipid extracts from MS ghosts incubated
with phospholipase (20 U/0.2 ml packed 
cells for 2 hrs àt 37°C). Loading: ghosts
originated from 0.3 ml packed cell.
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Szeinberg (1973) and Shukla el^ a^* (1977) found 
decr eas ed activity of red cell glutathione peroxid ase in |
MS red cells. Another per oxi datio n protective enzyme, 
gl ut athi on e reducta se, was also found to be slightly 
decreased by Oensen (1980). The normal phospholipid class #
di str ib ut ion in MS eryt hrocy tes found in this wor k indicates 
that the decreased activities of these two enzymes does 
not result in losses of phospholipids of the more un-f- 
saturated type, such as PE and PS, although the sus cept ib ility 
to peroxidation of the MS RBC lipid might be expected to 
be increased.
Changes in membrane lipid organization have been 
suggested to be r e s p o n s i b l e  for many of the changes found 
in the physical properties and membrane-bound enzymes in 
RBC, in co nd ition s such as sickle cell anaemia (Lubin,
Chiu, Bastacky, Roel of se n and van Deenen, 1981) and 
D uch enne muscular dystrophy (Chapter I of this work).
Incr eas ed red cell size (Prineas, 1968) and increased 
osmotic fr agi lit y (Stasiw elk , 1977; Schauf , 1980;
Ku rants in -M ills , 1982 ) were found in MS erythro cytes. In 
addition, increased platelet stickiness was found in MS 
patients (Caspary ej^ a_l., 1965). Prineas (1968) and 
Caspary e_k a_l. (1967) relat ed this phenomenon with the 
change in size and fra gility of MS red cells. They 
su ggested the changes in those physical properties might 
imply change in the RBC membrane, probably related to 
ph osp holipid s which induced leakage of ADP or other fa ctors 
and these in turn, inc reased platelet stickiness. From
i "
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this work) it can be concluded that red c e l l-as so ciated 
changes are therefore  not due to alterations in lipid 
organization. In agreement with these findings, normal 
red cell def or mability in MS patients demonstrat ed by 
Pollock e^ aj^. (1982) also implies a normal intrinsic 
me mbr ane structure in MS erythrocytes.
E r ythr oc ytes from MS patients have also  been reported  
to exhibit reduced electrop horet ic mobility when incubated 
with linolenic acid (Field e_^ al_. , .1974; Field and Joyce, 
1976), although this finding is rather con trover si al  
(Kurantsin-Mills , 1982) and there have been suggesti ons 
that this may be a property of MS plasma and an ab so rptio n 
phenomenon (Field and Joyce, 1982). This effect may be 
the result of a co nform ational r e ar ra ngemen t of charged 
group in the outer half of the bilayer induced by linoleat e 
(Zukoski, Tamblyn, Swank and Seaman, 1979), If this is 
the case, it is also clear from the results of this work 
that the difference  between normal and MS ery throcyt es  is 
not one of altered transbilayer pho sph olipi d distribution.
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3.2 Protective Mech a n i s m s  Against Lipid Peroxidation  
in RBC from MS Patients
3.2.1 Stress Test— z — z---------------  _=
As shown in Fig. 25, the kinetics of MDA production
are similar in both patients and controls, both of them
show MDA production peaking and plateauing at 60 m i n s .
As shown in Table 25 and Fig. 26, the product ion
of MDA is much de cre ase d in MS patients compared with
contr ols  and the results are highly significant (P < 0.001, 
St ud ent' s t test).
This result suggest s that MS red cells are better 
protected against oxidative challenge and lipid p e ro xidatio n 
than normals. One possible explanation is the vitamine E 
(an antioxidant and free radi cal scavenge r,(Horwit t, 1965)). 
level in MS patients is higher than controls. Since this 
test, performed under the carefully controlled cond itions 
of Stocks e;t (1971), co rr elate s well, although not
inv ariably with vitamin E status. It was considered 
possible that the MS pat ie nt s had been receiving suppl em entary 
vi tamin E, since many patients taking oils such as sun 
flower seed and evening primrose oil also take additional 
v it ami n E. However after contacting all the patients in this 
study it was establis hed that only one patient (TG) was 
re ceiving supplem ent ary vita min E. The activities of 
all f our antioxidant enzy mes  in MS patients were found to 
be normal (results shown in Tables26, 27, 28 and 29, Fig.
27, 28, 31 and 33). The increased resista nce to peroxida tion 
fou nd in the peroxide stress test is therefore not due to
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Fig, 25 ^2^2 stress test.
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time course experiment.
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Table 25 Stress Test (Expressed as nmol MDA
hr ^/g  ^Hb in controls and MS Patients)
Controls (n = 13) MS Patients (n = 11)
1 1054.23 HF 675.23
2 942.92 NH 295.17
3 775.43 SMc 655.94
4 601.27 ID 204.98
5 939.40 LL 259.65
6 989.00 lA 302.15
7 733.20 PR 252.28
8 810.50 TG 254.06
9 861.10 HG 473.04
10 712.70 GE 649.13
11 747.70 MG 512.44
12 735.90
13 643.90 ‘
X±S.D. 810.601138.10 XiS.D. 412.24+184.64
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CONTROLS
(n=13)^
X± SO. = 810-60 ±138-10
#
MSPATIENTS(n=1)
XiS.D. = 412-24 ±184-6 4
#f *v . . , .
nmol MDA 
hr* ÿ Hb
20 40 60 80 100
-1Fig. 26 ^2^2 test (expressed as nmol MDA hr /
g""^  Hb) in -controls and MS patients.
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increased act ivi ties of these enzymes but may be the 
consequen ce  of elevated intracellular g l u t a t h i o n e  c o n ­
centrat io n or some other unrecognized ant ioxid an t in the 
red cells. Further experiments which suggest the mse lves 
are to assay the c o n c e n t r a t i o n  of glu tathio ne , other 
antioxidants or vitamin E in the cells. Although vitamin 
E levels were found to be normal in MS patients in 
Finland (Wikstrom, W e s t e r m a r c k  and Palo, 1976), different 
vitamin E levels may still be possibly found in British 
MS patients due to dif ferences in race, diet and soil 
(Wikstrom e ^  , 1976). It is of interest that, although 
in their paper Wikst rom e ^  conclude the re is no
significant di fference in vitamin E conce nt r a t i o n s ,  n e v e r ­
theless the mean value quoted for MS patients is higher 
than that for controls. The resist ance to per ox id ative 
damage found in MS patients in this work may als o  be a 
property of MS plasma which was suggested to be the origin 
of the altered electrophoretic mobility of MS red cells in 
the presence of linoleic acid (Field and 3oyce, 1982 ;
Seaman e1^ aj^. , 1980). The experiments, su ggested above ^
may also be applied to plasma. Another area worthy of 
i n ve stigat io n would be to modify the conditio ns of the 
stress test (e.g. use a different oxidant stressor, such 
as dialuric acid) so as to produce a clear cut difference 
between MS patients and controls and perhaps develop it 
i nt o a diagnostic test.
-220-
3.2.2 Antioxidant Enzyme Activities
3.2.2.1 Gluta thi one peroxidase (GSH-Px)
The GSH'Px activities for MS patients and controls
are shown in Table 26 and Fig. 27.
The di fference betw een normal and MS patients in red 
cell GSH'Px activities was non-significant. This finding 
is in contrast to the work of others (Shukla ^  al^. , 1977; 
Szeinberg ei^ aj^. , 1979) who found a sig nificant r e d u ctio n  
in this enzyme in MS, using the same subst rate (tert-butyl 
hydrop er oxide)  as in this assay. The control values
reported in the Shukla e ^  a_l. (1977) article are extremely |I
low (8.3±2.4) compare d with others in the literature and I
those present here (21.81±4.30) which may suggest metholo-  I
1gical shortcomin gs. The re ason for this di screp ancy is not |1clear but may be due to population diff ere nce since in the fIstudy of Shukla ejt a l . (1977) patients and controls were |
all Danish while the subject of Szeinberg e ^  (1979)
were all Israeli Dews. |
3.2.2.2 Gl uta thione Reducta se  (GR) |
iResults are shown in Table 27 and Fig. 28. |iGR activity of MS red cells was normal as compared . I
to contr ols in the presence and absence of exogene ous FAD 
which is a cofactor of this flavopr ote in enzyme. This 
finding is in contrast with that of Densen £t (1980)
who found a slight decrease in GR activity in red cells
Jof patients with MS. This enzyme is important for re cycling I
!reduced glut at hione (GSH) which is converted to oxidized I
g l u t at hi one (GSSG) by GSH'Px. The fact that additi on of II
-221-
Table 26 GSH'Px Activities of Normal Controls and 
MS Patients (expressed as ymol NADH min. 
g“  ^Hb)
-1
Controls (n = 7) MS Patients (n = 14)
1 23.42 GE 20.09
2 17.57 HF 17. 98
3 25.29 NH 12.90
4 27.73 MH 26.22
5 20.77 HG 24.79
6 22.56 ID 28.06
7 15.35 SMcL 20.35
PR 19.87
ED 19.58
LL 19.03
lA 19.44
TG 14.48
MG 12.50
AT 10.85
1 X+S.D.
I
21.8114.30 X+S.D. 18.88+5.30
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CONTROLS
(n=7)
X±S.D.=21-81±4-30 
# # • • • • •
MS
PATIENTS
(n=14)
X±S.D.=18 8 + 5 30
• I*» I» i ? 'V 1 1* f f>imol NADPH
.-1 -1 min.g Hb
12 14 16 18 20 2 24 26 28
Fig. 27 GSH'Px activities of normal and MS patients.
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Table 27 GR Activities of Controls and MS Patients
4\ T*7-îüTir» (expressed as umol NADH min“^ -1■ q Hb
(
Controls (n = 9) MS Patients (n = 14)
,4
1 4.22 SMcL 3,36
2 5.00 PR 4.86
3 2.76 NH 4.10
4 5j39 LL 6.02 i
5 6.38 MG 3.86
6 4.23 GE 3. 63
7 6.38 HF 2.92
8 3.39 HG 3.73 1
9 4.12 ID 9.58
MH 4.24 'f
AT 3.51 4
ED 5.68 ■ii
TG 4.52
lA 4.27
X±S.D. 4.65+1.25 X+S.D 4.5911.67
ii) with EAD
Controls (n = 9) MS Patients (n = 14) 1
1 5.96 SMcL 5.09
2 5.68 PR 5.58
3 4.23 NH 4.69
4 6.43 LL 7.81
5 8.76 ’ MG 5.49
6 5.06 lA 6.31
7 7.63 GE 5.98
8 4.48 HF 4.56 119 5.44 HG 4.90
ID 11.77
MH 4.64
AT 5.17
ED 7.197
TG 5.76
X+S.D. 1 5.96+1.46 X±S.D. 6.0711.89
I  ■ ■ ' , 4
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(i)WlTHOUT FAD
CONTROLS 
(n=9 )
X±S.D.=4-65±1-25
MS
PATIENTS
(n=14)
X±S.D.= 4-59±1-67
, "f . , I ♦ I
jimol NADPH 
min^ Hb
2 4 6 8 10
(i) WITH FAD
CONTROLS
(n=9)
X±S.D.=5 961-46
e# #e » # # #
MS
PATIENTS
(n=14)
X±S.D.=6-07±1-69
# # e _$ ##*# # » e& 1-1 p1[ 1 1 1
jimol NADPH 
min^ ^ Hb
4 6 8 10 12
Fig. 28 GR activities of controls and MS patients.
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FAD res ults in the same degree of sti mulation of GR in 
MS patients and controls suggests that deficiency of 
ribo f l a v i n  or its m etab ol ism is not a f e ature of MS, as 
it is in some other disease states (Beutler , 1974).
3.2.2.3 Catal as e 
The linearity of the 0^ electrode assay was i n v e s ­
tigated using increasing amounts of commerc ial catalase 
and h a em ol ysate.  Fig. 29 and 30 show that the evo lution of 
0^ is linear up to 2.0 units of ca talase and 10 yl of 
undi lut ed hae moly sate. All subsequent assays were carried 
out within this linear range. Infact, 3 pi of 5 x diluted 
ha emolys ate were normally used so that 0^ evolved was in 
direct pr op ort ion to the amount of catalase present.
Tabel 28 and Fig. 31 show the results for controls and MS 
patients and no significant difference  was found between 
the two groups.
3. 2.2.4 Supe ro xide dismutase (SOD)
Fig. 32 shows that the linear range for a crude SOD
sample (up to about 60% inhibiton) was different from 
that for purified SOD standard (up to  about 40% inhibiton), 
and this was taken into account when assaying samples.
Bec aus e this assay is extremely sensitive to minor changes 
in co nditions,  a c alibra ti on curve was co nstruct ed once 
per working day.
SOD a c t i vi ti es of MS patients and controls is shown 
in Table 29 and Fig. 33.
When SOD activity was expressed as mg SOD/ml packed 
cells, the SOD activity of MS patients was found to be ;
s ig ni fic antly decreased (P < 0.05, Student's t test)
46
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Table 28 Catalase Activities of Controls and MS
—1 —1Patients (expressed as ygO^ niin Hb)
Controls (n = 8) MS Patients (n “ 14)
1 1.8569 NH 1.0092
2 1.3256 LL 2.2323
3 2.6116 MG 0.6965
4 1.9243 HF 0.5912
5 1.0843 AT 1.1776
6 1.1516 GE 2.0919
7 0.4409 ED 0.9039
8 0.8178 HG 2.4096
SMcL 1.2490
PR 0.9262
lA 2.4972
ID 1.2974
MH 0.98%3
TG 1.5449
X+S.D. 1.401610.6900 XIS.D. 1.401010.6569
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CONTROLS
(n=8)
X±S.D =1 4016 + 0 690 
• # #  # #• #
MS
PATIENTS(n=14)
X±S.D. = 1-4010±0-6569
*. • . * 1 • L . i , * ,* f .
A9O2-1 -1 min g Hb
0 6 10 14 18 2- 2 6 <
Fig. 31 Catalase activities of controls and MS patients.
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Table 2 9 SOD Activities of Normal and MS Patients
-1 '(i) Expressed as mg SOD r'l Packed Cells
Controls (n = 8) MS Patients (n = 14)
1 0.1403 NH 0.1286
2 0.1675 LL 0.1581
3 0.1676 AT 0.1774
4 0.1485 ID 0.1109
5 0.1657 HF • 0.1989
6 0.1552 MG 0.1457
7 0.1659 TG 0.1141
8 0.1725 GE 0.1611
ED 0.1369
HG 0.0734
SMcL 0.1156
PR 0.1228
lA 0.1354
MH 0.1058
XiS.D. 0.1604±0.0110 XiS.D. 0.1346*0.0320
(ii) Expressed as mg SOD g ^ Hb
Controls (n = 8) MS Patients (n = 14)
1 0.5983 NH 0.4570
2 0.5606 LL 0.5688
3 0.6806 AT 0.5399
4 0,6665 ID 0.6838
5 0.6283 HF 0.8684
6 0.6304 MG 0.5682
7 0.6040 TG 0.2741
8 0.4981 GE 0.6702
ED 0.4198
HG 0.2489
SMcL 0.4108
PR 0.4505
lA 0.5738
MH 0.3235
XiS.D. 0.6090+0.0586 X+S.D. , 0.50,41i0.1706. .
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(i)
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(n=8)
XlS.D.=0'1604l010
# * # ## #
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• 1 1 f 1» *1 ««I • 1 • . «1 <mg SOD mM PACKED CELS
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(i) ;
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## ###*#*MS
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mg SOD 
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02 0-4 06 0-8 1-0
Fig. 33 SOD activities of controls and MS patients.
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when compared to controls. But the difference became 
non- sig nifican t when the SOD activity was expressed as 
mg SOD/g H b , and no dif fe re nces in mean cell h aem og lobin  
content between patients and control groups was found. 
Calc ul ation of SOD activity will be more accurate  when 
expressed on the basis of haemo glo bin content rather than 
on the basis of vo lume of packed cells, since the vo lum e  
of packed cells may vary with the rate of c e n t r i f u g a t i o n  
and the com pleten es s of the removal of saline after the 
final wash.
The activities of the four most important er ythrocyte  
enzymes (SOD, catalase, GR , GSH'Px) involved in the 
des tru ction of 0^ and H^O^ are found to be unimpaired in 
the disease. It can be therefore concluded that if there 
is increased lipid per ox id ation damage in the red cells in 
MS, this is not due to de fective enzymic protection. 
However, in vie w of the reduced per oxidisability of MS red 
cells it seems unlikely that such damage is the cause of 
other abnormali ties , such as increased fragili ty (Stasi'vv 
et a l . , 1977; Schauf e;t aj^. , 1980; K urantsin-Mills e;t a l . , 
1982) and incre ase d cell size (Prineas, 1968) found in 
MS erythrocytes. Althou gh the activities of four p r o ­
tective an tio xidant enzymes are found to be normal in MS 
red cells, it is still worthwhile to investigate the 
activities of these enzymes in CHS, since these anti ox idant  
protective m e c hani sm  may btill.lbe impaired CNS.
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3.2.3 Effects of HBO treatment on antioxidant protective 
Mechanisms
Table 30 GR Activity of MS Patients Before and After 
HBO Treatment (expressed as pmol NADH min  ^
g~^ Hb) (n = 5)
(i) without FAD
Patients Before HBO Treatment After HBO Treatment
LL 6.0155 4.3556
MG 3.8570 3.8184
GE 3.6257 4.2537
HF 2.9155 2.6520
TG 4.2726 6.7993
X±S.D. 4.1859+1.1700 4.375811.5141
(ii) with FAD
Patients . . . Before HBO Treatment , , After. HBO Treatment
LL 7.8135 7.4321
MG 5.4884 5.2802
GE 5.9856 7.3106
HF 4.5562 5.0461
TG 5.7617 7.8368
X+S.D. 5.921011.1890 6.581111.3100
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Table 31 Stress Test of MS Patients Before and
After HBO Treatment (expressed as nmol MPA 
~1 —1hr Hb) (n = 2)
Patients Before HBO Treatment After HBO Treatment
TG 245.06 357.80
GE 649.13 409.97
X±S.D. 451.591279.35 383.88136.88
Table 32 GSH«Px Activity of MS Patients Before and
After HBO Treatmeht (expressed as llinol .HADH 
-1 -1min Hb) (h = 5)
Patients Before HBO Treatment After HBO Treatment
GE 20.0905 16.1434
HF 17.9795 27.1446
LL 19.0305 25.9634
TG 14.4781 20.9586
MG 12.5044 16.8538
TlS.D. 16.816613.2029 21.412715.0576
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After HBO Treatment (n = 5)
-1(i) Expressed as mg SOD lïil Packed Cells
Patients Before HBO Treatment After, HBO Treatment I
LL 0.1581 0.0585
HF 0.1988 0.1860 1?
MG 0.1457 0.0886 ;■
TG 0.1141 0.1525
GE 0.1611 0.1780 j
X±S.D. 0.155,5+0.0305 , 0.1327+0.0563
(ii) Expressed as mg SOD g  ^Hb
Patients Before HBO Treatment After HBO Treatment
LL 0.5688 0.1722
HF 0.8684/: 0.6473
MG 0.5682 0.2907
TG 0.2741 0.4728
GE 0.6702 0.6330
X+S.D. 0.5899+0,2148 0.4432+0.2093
  :— ^ _ _ _ 1   •
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Table 34 Catalase of MS Patients Before and After
-1HBO Treatment (expressed as min
g“^Hb (n = 5)
Patients Before HBO Treatment After HBO Treatment
LL 2.2323 2.4552
MG 0.6965 3.4416
HF 0.5912 3.2980
GE 2.0919 3.4879
TG 1.5449 . 3.5863
X+S.D.
'(LL omitted))
1.231110.7152 3.453410.1199
V
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Fig. 34 Superoxide dismutase (SOD), M D A  production, 
glutathione peroxidase (GPx), glutathione 
reductase (GR) and catalase (CAT) of 
erythrocytes from MS patients before | j 
and after j hyperbaric oxygen
treatment.
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From Table 30, 31, 32 and 33 and Fig. 34 it 
is clear that HBO treatment had no consistent eff ec t:on  
SOD, GR, GSH*Px or peroxidisability of red cells (Student's 
paired t-test, P > 0.1). Unless enzyme activities  -= 
fluctua te d very rapidly during and after treatment, it 
seems unlikely that HBO under the conditions defined here 
affects these particular enzymes in humans since four of 
the five patients, at the time of venep un ct ure had just 
(within 30 mins.) completed the 2 0th daily 90 mins. 
period in the chamber.
From Table 34 and Fig. 34 catalase activity is 
markedly increased (P < 0.01, S t u d e n t ’s t test) by HBO in 
four out of five  patients. It is significant that the 
one patient (LL) who showed only a moderate increase in 
catalase activity as a result of HBO had comp le ted the 
20 treatmen t course one week prior to blood sampling but 
had also rec eiv ed on ’t o p - u p ’ treatment prior to v e n e ­
puncture. Alt ho ugh based on one patient this may indicate 
that (i) i n d uc ti on and/or activation of c a t al as e re qu ir es  
more than one 90 mins. treatment period and (ii) enzyme 
activity re turns to near normal within one week of 
cessation  of treatment. There is little lit er at ure on 
the effects of HBO on antioxidant enzymes in ani mals and 
humans but ca t a l a s e  was found to be HBO -i n d u c i b l e  in 
fungi (Ahmad and Pritchard, 1970).
HBO has been shown to produce a 22% inc rease in 
lipid p er ox idatio n (as, measured by MDA release) in rat brain 
after exp os ure to 5 ATA pure 0^ for 5 mins., which 
returns to normal within 3 hrs of cessation of treatment
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(Noda, McGeer  and McGeer , 1983). If it is possible to 
compare th ese cond itions  of HBO to those used in this 
work and to e x t r a po la te from rat to human brain then, 
considering the" data in this work, it is possible to 
speculate that the long term protective effect of raised 
catalase may outweigh the potentially damaging 
increased lipid peroxidation which may accompany HBO. 
In te re sting ly , exogenous catalase, but not super oxide 
dismutase, is reported to offer protection against HB#r 
induced c o n v u l s i o n  in mice (Hilton, Brown and Proctor, 
1980), so that this enzyme may be generally of greater 
importance than other antioxidant systems in the CNS.
It would be of interest for future resea rch ers in 
this area to under tak e a more detailed study of the 
activity of these antioxidant enzymes, especially catalase, 
with time after HBO treatment to get a more accurate 
picture of the kinetics of any induction process.
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SUMMARY
( 1 ) Duchenne Muscular Dystrophy ( DMD)
Mud'cle fibres and erythrocytes in DMD exhibit many 
abnormalities of membrane-as sociated properties which 
have led to the 'Membrane H y p o t h e s i s ’ . The Membrane 
Hypothesi s states that the primary lesion in DMD involves 
a g e n e ra lized defect in the plasma membrane. Since 
phospholipids play a crucial part in the structure, 
organization and f u n c t i o n  of membranes, subtle changes 
in these lipids could well be responsible for the observed 
ab n orma lit i e s .
One possible alt er at ion is a per turbation of the 
asymmetri c distribut ion of phospholipids in the plasma 
membrane. Such asymmetry may be studied in erythrocytes
using ph osph olipases . In this work, bee ven om pho spholip ase ri
A^ was used to treat intact cells and derived ghosts. Two- |
dimensional TLC was used to separate the extracted lipids,
which were quantified by phosphorus assay. Results showed 
the lipid composition is normal but the degradatio n of 
PC in DMD ery throcytes  was higher and the differences were 
highly significant (P < 0.01). Increased PC degradation  
in erythrocytes may be explained in at least two ways:
(i) transbilayer t r ans lo cation of PC occurs more readily 
during the course of the experiment, or (ii) more PC is 
localized in the outer leaflet. If the results can be 
explained by (i) then spectrin, which is essential in 
maintaining lipid asymmetry, may be of abnormal structure 
and in fact, abnormalities of spectrin in DMD erythrocytes
- V  -
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have already been reported. If the exp lanat io n for the 
results is (ii), lipid rea rran gement and changes in 
viscosity and fluidity can be expected, which would a l s o  
result in abn orma lities  in spectroscopic data, osmotic 
fragility, ion transport and enzyme activities reported 
in DMD eryth rocytes.
Na^-K^ A T Pase activity of normal erythrocytes was 
reported to become 'Duchenne like' after incub ation of 
cells with DMD plasma. A circulating factor from  necrotic 
muscle was proposed to  be re spo nsi ble. The effect of 
DMD plasma on the asymmetry of membrane lipid was i n - 
vestigated but results showed that DMD plasma did not 
result in altered asymmetry in control cells. So the 
factor, if one exists, is not responsible for the increased 
PC deg radation found in DMD erythrocytes and also the 
change in Na -K ATPa s e  activity is not due to a change 
in lipid asymmetry of the erythrocytes.
(2) Mul ti ple Scleros is  (MS)
MS is a demyelinating disease of unknown cause. A 
dietary defect and abnormal immune response have been 
proposed. Lipid organization of the membrane of MS 
erythrocytes was investig ated in this work to explore 
whether the rep orted  abnormal physical properties in 
MS ery throcytes were due to abnormal lipid asymmetry. 
Results showed the membrane lipid compositio n and a s y m m ­
etrical org ani za tion of MS is normal. So the re porte d 
increased cell size, increased osmotic fragility and 
reduced elec tr ophoretic mobility of erythrocytes as well
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as increased platelet stickiness in MS patients is not 
due to changes in lipid organization in the MS erythr ocyte 
membra n e .
Glutathione peroxidase, one of the enzymes whi^h 
protects against membrane lipid peroxidation was report ed  
to be decreased in MS erythrocytes. This might result in 
inc reased subscept ib ility to lipid peroxida tio n of MS 
erythrocytes. The p e r o x i d i s a b il ity (using stressor)
and the activities of the four enzymes, gluta thion e 
peroxidase, g l u t athion e reductase, catalase and super oxide 
dismutase, were investigated. Results showed the p e r - 
oxidisability of MS eryt hrocy tes was significantly 
decreased (P < 0.001) which indicates that the membrane 
lipids of MS eryth ro cytes are less susceptible to p e r ­
oxidation. This may be due to increased content of a n t i ­
oxidants (e.g. vita min E, etc.) in the cells since the 
activities of the antio xidant enzymes were found to be 
normal in this work.
Hyperbaric oxygen (HBO) treatment has been proposed 
for treatment of MS patients. The effect of HBO t r e a t ­
ment on the four ant ioxidant enzymes were in vesti gated.
Only catalase activity was found to be increased in 
erythrocytes of MS patients after HBO treatment. So 
raised catalase may be an important -effect and ou tw eigh 
the potentially damaging increased lipid pe rox idati on 
which may also accompany HBO treatment.
 ---------- ^ ^  :± . j
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